| CONSOLIDATED SCHEDULE OF INVESTMENTS£ in Thousands, $ in Thousands
 | 3 Months Ended | 12 Months Ended |  |  | 
| Mar. 31, 2024  USD ($)  shares | Dec. 31, 2023  USD ($)  shares | Mar. 31, 2024  GBP (£)  shares | Dec. 31, 2023  GBP (£)  shares | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment, basis spread, variable rate |  | 8.50% |  | 8.50% |  | 8.50% |  | 8.50% |  | 
| Investment cost |  | $ 3,574,576 |  | $ 3,247,033 |  |  |  |  |  | 
| Investments, at fair value: |  | 3,571,641 |  | $ 3,248,046 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Series Class A Units |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [1],[2] | 238 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1] | $ 158 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [1],[3] | Dec. 27,  2022 |  |  |  |  |  |  |  | 
| Shares | shares | [1] | 69,239 |  |  |  | 69,239 |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Electronics & Computer Hardware (1.05%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 1.05% |  |  |  | 1.05% |  | 
| Investment cost | [5] |  |  | $ 18,348 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 18,982 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Electronics & Computer Hardware and Locus Robotics Corp., Senior Secured, June 2026, Prime + 4.50%, Floor rate 8.00%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6] |  |  | 2026-06 |  |  |  | 2026-06 |  | 
| Investment, basis spread, variable rate | [6],[7] |  |  | 4.50% |  |  |  | 4.50% |  | 
| Investment, interest rate, floor | [6],[7] |  |  | 8.00% |  |  |  | 8.00% |  | 
| Investment exit fee | [6],[7] |  |  | 4.00% |  |  |  | 4.00% |  | 
| Principal amount | [6] |  |  | $ 18,281 |  |  |  |  |  | 
| Investment cost | [5],[6] |  |  | 18,348 |  |  |  |  |  | 
| Investments, at fair value: | [6] |  |  | $ 18,982 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Manufacturing Technology (0.44%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.44% |  |  |  | 0.44% |  | 
| Investment cost | [5] |  |  | $ 8,064 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 8,006 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Medical Devices & Equipment (1.20%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 1.20% |  |  |  | 1.20% |  | 
| Investment cost | [5] |  |  | $ 21,572 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 21,572 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Biotechnology Tools (2.66%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 2.66% |  |  |  | 2.66% |  | 
| Investment cost | [5] |  |  | $ 47,010 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 48,027 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Biotechnology Tools and Alamar Biosciences, Inc., Senior Secured, June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[9] |  |  | 2026-06 |  |  |  | 2026-06 |  | 
| Investment, basis spread, variable rate | [7],[8],[9] |  |  | 3.00% |  |  |  | 3.00% |  | 
| Investment, interest rate, floor | [7],[8],[9] |  |  | 6.50% |  |  |  | 6.50% |  | 
| Investment, interest rate, paid in kind | [7],[8],[9] |  |  | 1.00% |  |  |  | 1.00% |  | 
| Investment exit fee | [7],[8],[9] |  |  | 5.95% |  |  |  | 5.95% |  | 
| Principal amount | [8],[9] |  |  | $ 15,049 |  |  |  |  |  | 
| Investment cost | [5],[8],[9] |  |  | 15,069 |  |  |  |  |  | 
| Investments, at fair value: | [8],[9] |  |  | $ 15,508 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Biotechnology Tools and PathAI, Inc., Senior Secured, January 2027, Prime + 2.15%, Floor rate 9.15%, 9.81% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [10] |  |  | 2027-01 |  |  |  | 2027-01 |  | 
| Investment, basis spread, variable rate | [7],[10] |  |  | 2.15% |  |  |  | 2.15% |  | 
| Investment, interest rate, floor | [7],[10] |  |  | 9.15% |  |  |  | 9.15% |  | 
| Investment exit fee | [7],[10] |  |  | 9.81% |  |  |  | 9.81% |  | 
| Principal amount | [10] |  |  | $ 32,000 |  |  |  |  |  | 
| Investment cost | [5],[10] |  |  | 31,941 |  |  |  |  |  | 
| Investments, at fair value: | [10] |  |  | $ 32,519 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Communications & Networking and (1.62%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 1.62% |  |  |  | 1.62% |  | 
| Investment cost | [5] |  |  | $ 28,182 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 29,272 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Communications & Networking and Aryaka Networks, Inc., Senior Secured, July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6],[8],[10] |  |  | 2026-07 |  |  |  | 2026-07 |  | 
| Investment, basis spread, variable rate | [6],[7],[8],[10] |  |  | 3.25% |  |  |  | 3.25% |  | 
| Investment, interest rate, floor | [6],[7],[8],[10] |  |  | 6.75% |  |  |  | 6.75% |  | 
| Investment, interest rate, paid in kind | [6],[7],[8],[10] |  |  | 1.05% |  |  |  | 1.05% |  | 
| Investment exit fee | [6],[7],[8],[10] |  |  | 3.55% |  |  |  | 3.55% |  | 
| Principal amount | [6],[8],[10] |  |  | $ 25,153 |  |  |  |  |  | 
| Investment cost | [5],[6],[8],[10] |  |  | 24,943 |  |  |  |  |  | 
| Investments, at fair value: | [6],[8],[10] |  |  | $ 26,000 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Communications & Networking and Cytracom Holdings LLC, Senior Secured, February 2025, 3-month SOFR + 9.72%, Floor rate 10.62% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [11],[12],[13] |  |  | 2025-02 |  |  |  | 2025-02 |  | 
| Investment, basis spread, variable rate | [7],[11],[12],[13] |  |  | 9.72% |  |  |  | 9.72% |  | 
| Investment, interest rate, floor | [7],[11],[12],[13] |  |  | 10.62% |  |  |  | 10.62% |  | 
| Principal amount | [11],[12],[13] |  |  | $ 3,267 |  |  |  |  |  | 
| Investment cost | [5],[11],[12],[13] |  |  | 3,239 |  |  |  |  |  | 
| Investments, at fair value: | [11],[12],[13] |  |  | $ 3,272 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services (28.24%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 28.24% |  |  |  | 28.24% |  | 
| Investment cost | [5] |  |  | $ 507,063 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 509,053 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Altumint, Inc., Senior Secured, December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[14] |  |  | 2027-12 |  |  |  | 2027-12 |  | 
| Investment, basis spread, variable rate | [7],[12],[14] |  |  | 3.65% |  |  |  | 3.65% |  | 
| Investment, interest rate, floor | [7],[12],[14] |  |  | 12.15% |  |  |  | 12.15% |  | 
| Investment exit fee | [7],[12],[14] |  |  | 2.50% |  |  |  | 2.50% |  | 
| Principal amount | [12],[14] |  |  | $ 10,000 |  |  |  |  |  | 
| Investment cost | [5],[12],[14] |  |  | 9,905 |  |  |  |  |  | 
| Investments, at fair value: | [12],[14] |  |  | $ 9,905 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and AppDirect, Inc., Senior Secured, April 2026, Prime + 5.50%, Floor rate 8.75%, 7.12% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [10] |  |  | 2026-04 |  |  |  | 2026-04 |  | 
| Investment, basis spread, variable rate | [7],[10] |  |  | 5.50% |  |  |  | 5.50% |  | 
| Investment, interest rate, floor | [7],[10] |  |  | 8.75% |  |  |  | 8.75% |  | 
| Investment exit fee | [7],[10] |  |  | 7.12% |  |  |  | 7.12% |  | 
| Principal amount | [10] |  |  | $ 55,790 |  |  |  |  |  | 
| Investment cost | [5],[10] |  |  | 57,653 |  |  |  |  |  | 
| Investments, at fair value: | [10] |  |  | $ 59,507 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Carwow LTD, Senior Secured, December 2024, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[15],[16] |  |  | 2024-12 |  |  |  | 2024-12 |  | 
| Investment, basis spread, variable rate | [7],[8],[15],[16] |  |  | 4.70% |  |  |  | 4.70% |  | 
| Investment, interest rate, floor | [7],[8],[15],[16] |  |  | 7.95% |  |  |  | 7.95% |  | 
| Investment, interest rate, paid in kind | [7],[8],[15],[16] |  |  | 1.45% |  |  |  | 1.45% |  | 
| Investment exit fee | [7],[8],[15],[16] |  |  | 4.95% |  |  |  | 4.95% |  | 
| Principal amount | £ | [8],[15],[16] |  |  |  |  |  |  | £ 19,146 |  | 
| Investment cost | [5],[8],[15],[16] |  |  | $ 26,834 |  |  |  |  |  | 
| Investments, at fair value: | [8],[15],[16] |  |  | $ 25,157 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Houzz, Inc., Convertible Debt, May 2028, PIK Interest 8.50% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[17] |  |  | 2028-05 |  |  |  | 2028-05 |  | 
| Investment, interest rate, paid in kind | [7],[8],[17] |  |  | 8.50% |  |  |  | 8.50% |  | 
| Principal amount | [8],[17] |  |  | $ 23,340 |  |  |  |  |  | 
| Investment cost | [5],[8],[17] |  |  | 23,340 |  |  |  |  |  | 
| Investments, at fair value: | [8],[17] |  |  | $ 23,244 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Jobandtalent USA, Inc., Senior Secured, February 2025, 1-month SOFR + 8.86%, Floor rate 9.75%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [15],[16] |  |  | 2025-02 |  |  |  | 2025-02 |  | 
| Investment, basis spread, variable rate | [7],[15],[16] |  |  | 8.86% |  |  |  | 8.86% |  | 
| Investment, interest rate, floor | [7],[15],[16] |  |  | 9.75% |  |  |  | 9.75% |  | 
| Investment exit fee | [7],[15],[16] |  |  | 3.00% |  |  |  | 3.00% |  | 
| Principal amount | [15],[16] |  |  | $ 14,000 |  |  |  |  |  | 
| Investment cost | [5],[15],[16] |  |  | 14,095 |  |  |  |  |  | 
| Investments, at fair value: | [15],[16] |  |  | $ 14,259 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Plentific Ltd, Senior Secured, October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[15],[16] |  |  | 2026-10 |  |  |  | 2026-10 |  | 
| Investment, basis spread, variable rate | [7],[12],[15],[16] |  |  | 2.55% |  |  |  | 2.55% |  | 
| Investment, interest rate, floor | [7],[12],[15],[16] |  |  | 11.05% |  |  |  | 11.05% |  | 
| Investment exit fee | [7],[12],[15],[16] |  |  | 2.95% |  |  |  | 2.95% |  | 
| Principal amount | [12],[15],[16] |  |  | $ 875 |  |  |  |  |  | 
| Investment cost | [5],[12],[15],[16] |  |  | 853 |  |  |  |  |  | 
| Investments, at fair value: | [12],[15],[16] |  |  | $ 853 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Provi, Senior Secured, December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [14] |  |  | 2026-12 |  |  |  | 2026-12 |  | 
| Investment, basis spread, variable rate | [7],[14] |  |  | 4.40% |  |  |  | 4.40% |  | 
| Investment, interest rate, floor | [7],[14] |  |  | 10.65% |  |  |  | 10.65% |  | 
| Investment exit fee | [7],[14] |  |  | 2.95% |  |  |  | 2.95% |  | 
| Principal amount | [14] |  |  | $ 15,000 |  |  |  |  |  | 
| Investment cost | [5],[14] |  |  | 14,904 |  |  |  |  |  | 
| Investments, at fair value: | [14] |  |  | $ 15,046 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and RVShare, LLC, Senior Secured, December 2026, 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[9],[14] |  |  | 2026-12 |  |  |  | 2026-12 |  | 
| Investment, basis spread, variable rate | [7],[8],[9],[14] |  |  | 5.50% |  |  |  | 5.50% |  | 
| Investment, interest rate, floor | [7],[8],[9],[14] |  |  | 6.50% |  |  |  | 6.50% |  | 
| Investment, interest rate, paid in kind | [7],[8],[9],[14] |  |  | 4.00% |  |  |  | 4.00% |  | 
| Principal amount | [8],[9],[14] |  |  | $ 28,876 |  |  |  |  |  | 
| Investment cost | [5],[8],[9],[14] |  |  | 28,404 |  |  |  |  |  | 
| Investments, at fair value: | [8],[9],[14] |  |  | $ 28,888 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Rhino Labs, Inc., Senior Secured, June 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[14] |  |  | 2024-06 |  |  |  | 2024-06 |  | 
| Investment, basis spread, variable rate | [7],[8],[14] |  |  | 5.50% |  |  |  | 5.50% |  | 
| Investment, interest rate, floor | [7],[8],[14] |  |  | 8.75% |  |  |  | 8.75% |  | 
| Investment, interest rate, paid in kind | [7],[8],[14] |  |  | 2.25% |  |  |  | 2.25% |  | 
| Principal amount | [8],[14] |  |  | $ 4,710 |  |  |  |  |  | 
| Investment cost | [5],[8],[14] |  |  | 4,704 |  |  |  |  |  | 
| Investments, at fair value: | [8],[14] |  |  | $ 4,704 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Riviera Partners LLC, Senior Secured, April 2027, 3-month SOFR + 8.26%, Floor rate 9.26% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[13] |  |  | 2027-04 |  |  |  | 2027-04 |  | 
| Investment, basis spread, variable rate | [7],[12],[13] |  |  | 8.26% |  |  |  | 8.26% |  | 
| Investment, interest rate, floor | [7],[12],[13] |  |  | 9.26% |  |  |  | 9.26% |  | 
| Principal amount | [12],[13] |  |  | $ 36,868 |  |  |  |  |  | 
| Investment cost | [5],[12],[13] |  |  | 36,339 |  |  |  |  |  | 
| Investments, at fair value: | [12],[13] |  |  | $ 34,659 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and SeatGeek, Inc., Senior Secured, July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[10],[18] |  |  | 2026-07 |  |  |  | 2026-07 |  | 
| Investment, basis spread, variable rate | [7],[8],[10],[18] |  |  | 2.50% |  |  |  | 2.50% |  | 
| Investment, interest rate, floor | [7],[8],[10],[18] |  |  | 10.75% |  |  |  | 10.75% |  | 
| Investment, interest rate, paid in kind | [7],[8],[10],[18] |  |  | 0.50% |  |  |  | 0.50% |  | 
| Investment exit fee | [7],[8],[10],[18] |  |  | 3.00% |  |  |  | 3.00% |  | 
| Principal amount | [8],[10],[18] |  |  | $ 77,642 |  |  |  |  |  | 
| Investment cost | [5],[8],[10],[18] |  |  | 77,170 |  |  |  |  |  | 
| Investments, at fair value: | [8],[10],[18] |  |  | $ 79,119 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and SeatGeek, Inc., Senior Secured, May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[11],[18] |  |  | 2026-05 |  |  |  | 2026-05 |  | 
| Investment, basis spread, variable rate | [7],[8],[11],[18] |  |  | 7.00% |  |  |  | 7.00% |  | 
| Investment, interest rate, floor | [7],[8],[11],[18] |  |  | 10.50% |  |  |  | 10.50% |  | 
| Investment, interest rate, paid in kind | [7],[8],[11],[18] |  |  | 0.50% |  |  |  | 0.50% |  | 
| Investment exit fee | [7],[8],[11],[18] |  |  | 4.00% |  |  |  | 4.00% |  | 
| Principal amount | [8],[11],[18] |  |  | $ 25,199 |  |  |  |  |  | 
| Investment cost | [5],[8],[11],[18] |  |  | 25,126 |  |  |  |  |  | 
| Investments, at fair value: | [8],[11],[18] |  |  | $ 25,869 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Skyword, Inc., Senior Secured, November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[9] |  |  | 2026-11 |  |  |  | 2026-11 |  | 
| Investment, basis spread, variable rate | [7],[8],[9] |  |  | 2.75% |  |  |  | 2.75% |  | 
| Investment, interest rate, floor | [7],[8],[9] |  |  | 9.25% |  |  |  | 9.25% |  | 
| Investment, interest rate, paid in kind | [7],[8],[9] |  |  | 1.75% |  |  |  | 1.75% |  | 
| Investment exit fee | [7],[8],[9] |  |  | 3.00% |  |  |  | 3.00% |  | 
| Principal amount | [8],[9] |  |  | $ 9,169 |  |  |  |  |  | 
| Investment cost | [5],[8],[9] |  |  | 9,189 |  |  |  |  |  | 
| Investments, at fair value: | [8],[9] |  |  | $ 9,311 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Tectura Corporation, Senior Secured, July 2024, FIXED 8.25% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [19] |  |  | 2024-07 |  |  |  | 2024-07 |  | 
| Investment, interest rate, paid in cash | [7],[19] |  |  | 8.25% |  |  |  | 8.25% |  | 
| Principal amount | [19] |  |  | $ 8,250 |  |  |  |  |  | 
| Investment cost | [5],[19] |  |  | 8,250 |  |  |  |  |  | 
| Investments, at fair value: | [19] |  |  | $ 8,250 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Thumbtack, Inc., Senior Secured, April 2026, Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[10],[12] |  |  | 2026-04 |  |  |  | 2026-04 |  | 
| Investment, basis spread, variable rate | [7],[8],[10],[12] |  |  | 4.95% |  |  |  | 4.95% |  | 
| Investment, interest rate, floor | [7],[8],[10],[12] |  |  | 8.20% |  |  |  | 8.20% |  | 
| Investment, interest rate, paid in kind | [7],[8],[10],[12] |  |  | 1.50% |  |  |  | 1.50% |  | 
| Investment exit fee | [7],[8],[10],[12] |  |  | 3.95% |  |  |  | 3.95% |  | 
| Principal amount | [8],[10],[12] |  |  | $ 10,258 |  |  |  |  |  | 
| Investment cost | [5],[8],[10],[12] |  |  | 10,317 |  |  |  |  |  | 
| Investments, at fair value: | [8],[10],[12] |  |  | 10,639 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Total SeatGeek, Inc |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  |  |  | 102,841 |  |  |  |  |  | 
| Investment cost | [5] |  |  | 102,296 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 104,988 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Total Veem, Inc., |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  |  |  | 10,217 |  |  |  |  |  | 
| Investment cost | [5] |  |  | 10,365 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 10,516 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Total Worldremit Group Limited |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  |  |  | 94,500 |  |  |  |  |  | 
| Investment cost | [5] |  |  | 95,626 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 95,997 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Udacity, Inc., Senior Secured, September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[10] |  |  | 2024-09 |  |  |  | 2024-09 |  | 
| Investment, basis spread, variable rate | [7],[8],[10] |  |  | 4.50% |  |  |  | 4.50% |  | 
| Investment, interest rate, floor | [7],[8],[10] |  |  | 7.75% |  |  |  | 7.75% |  | 
| Investment, interest rate, paid in kind | [7],[8],[10] |  |  | 2.00% |  |  |  | 2.00% |  | 
| Investment exit fee | [7],[8],[10] |  |  | 3.00% |  |  |  | 3.00% |  | 
| Principal amount | [8],[10] |  |  | $ 53,000 |  |  |  |  |  | 
| Investment cost | [5],[8],[10] |  |  | 53,989 |  |  |  |  |  | 
| Investments, at fair value: | [8],[10] |  |  | $ 53,130 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Veem, Inc., Senior Secured, March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[9] |  |  | 2025-03 |  |  |  | 2025-03 |  | 
| Investment, basis spread, variable rate | [7],[8],[9] |  |  | 4.00% |  |  |  | 4.00% |  | 
| Investment, interest rate, floor | [7],[8],[9] |  |  | 7.25% |  |  |  | 7.25% |  | 
| Investment, interest rate, paid in kind | [7],[8],[9] |  |  | 1.25% |  |  |  | 1.25% |  | 
| Investment exit fee | [7],[8],[9] |  |  | 4.50% |  |  |  | 4.50% |  | 
| Principal amount | [8],[9] |  |  | $ 5,107 |  |  |  |  |  | 
| Investment cost | [5],[8],[9] |  |  | 5,176 |  |  |  |  |  | 
| Investments, at fair value: | [8],[9] |  |  | $ 5,230 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Veem, Inc., Senior Secured, March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[10] |  |  | 2025-03 |  |  |  | 2025-03 |  | 
| Investment, basis spread, variable rate | [7],[8],[10] |  |  | 4.70% |  |  |  | 4.70% |  | 
| Investment, interest rate, floor | [7],[8],[10] |  |  | 7.95% |  |  |  | 7.95% |  | 
| Investment, interest rate, paid in kind | [7],[8],[10] |  |  | 1.50% |  |  |  | 1.50% |  | 
| Investment exit fee | [7],[8],[10] |  |  | 4.50% |  |  |  | 4.50% |  | 
| Principal amount | [8],[10] |  |  | $ 5,110 |  |  |  |  |  | 
| Investment cost | [5],[8],[10] |  |  | 5,189 |  |  |  |  |  | 
| Investments, at fair value: | [8],[10] |  |  | $ 5,286 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Worldremit Group Limited, Senior Secured, February 2025, 1-month SOFR + 9.35%, Floor rate 10.25%, 3.20% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6],[15],[16],[18] |  |  | 2025-02 |  |  |  | 2025-02 |  | 
| Investment, basis spread, variable rate | [6],[7],[15],[16],[18] |  |  | 9.35% |  |  |  | 9.35% |  | 
| Investment, interest rate, floor | [6],[7],[15],[16],[18] |  |  | 10.25% |  |  |  | 10.25% |  | 
| Investment exit fee | [6],[7],[15],[16],[18] |  |  | 3.20% |  |  |  | 3.20% |  | 
| Principal amount | [6],[15],[16],[18] |  |  | $ 6,250 |  |  |  |  |  | 
| Investment cost | [5],[6],[15],[16],[18] |  |  | 6,308 |  |  |  |  |  | 
| Investments, at fair value: | [6],[15],[16],[18] |  |  | $ 6,344 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Consumer & Business Services and Worldremit Group Limited, Senior Secured, February 2025, 3-month SOFR + 9.40%, Floor rate 10.25%, 3.20% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6],[10],[11],[15],[16],[18] |  |  | 2025-02 |  |  |  | 2025-02 |  | 
| Investment, basis spread, variable rate | [6],[7],[10],[11],[15],[16],[18] |  |  | 9.40% |  |  |  | 9.40% |  | 
| Investment, interest rate, floor | [6],[7],[10],[11],[15],[16],[18] |  |  | 10.25% |  |  |  | 10.25% |  | 
| Investment exit fee | [6],[7],[10],[11],[15],[16],[18] |  |  | 3.20% |  |  |  | 3.20% |  | 
| Principal amount | [6],[10],[11],[15],[16],[18] |  |  | $ 88,250 |  |  |  |  |  | 
| Investment cost | [5],[6],[10],[11],[15],[16],[18] |  |  | 89,318 |  |  |  |  |  | 
| Investments, at fair value: | [6],[10],[11],[15],[16],[18] |  |  | $ 89,653 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Diversified Financial Services (3.17%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 3.17% |  |  |  | 3.17% |  | 
| Investment cost | [5] |  |  | $ 56,764 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 57,096 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, September 2026, FIXED 11.50% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [19],[20] |  |  | 2026-09 |  |  |  | 2026-09 |  | 
| Investment, interest rate, paid in cash | [7],[19],[20] |  |  | 11.50% |  |  |  | 11.50% |  | 
| Principal amount | [19],[20] |  |  | $ 25,000 |  |  |  |  |  | 
| Investment cost | [5],[19],[20] |  |  | 24,663 |  |  |  |  |  | 
| Investments, at fair value: | [19],[20] |  |  | $ 24,663 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, September 2026, FIXED 11.95% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [19],[20] |  |  | 2026-09 |  |  |  | 2026-09 |  | 
| Investment, interest rate, paid in cash | [7],[19],[20] |  |  | 11.95% |  |  |  | 11.95% |  | 
| Principal amount | [19],[20] |  |  | $ 10,000 |  |  |  |  |  | 
| Investment cost | [5],[19],[20] |  |  | 9,815 |  |  |  |  |  | 
| Investments, at fair value: | [19],[20] |  |  | $ 9,815 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Hercules Adviser LLC, Unsecured, June 2025, FIXED 5.00% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [19],[21] |  |  | 2025-06 |  |  |  | 2025-06 |  | 
| Investment, interest rate, paid in cash | [7],[19],[21] |  |  | 5.00% |  |  |  | 5.00% |  | 
| Principal amount | [19],[21] |  |  | $ 12,000 |  |  |  |  |  | 
| Investment cost | [5],[19],[21] |  |  | 12,000 |  |  |  |  |  | 
| Investments, at fair value: | [19],[21] |  |  | $ 12,000 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Next Insurance, Inc., Senior Secured, February 2028, Prime - (1.50%), Floor rate 4.75%, PIK Interest 5.50% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6],[8],[12] |  |  | 2028-02 |  |  |  | 2028-02 |  | 
| Investment, basis spread, variable rate | [6],[7],[8],[12] |  |  | (1.50%) |  |  |  | (1.50%) |  | 
| Investment, interest rate, floor | [6],[7],[8],[12] |  |  | 4.75% |  |  |  | 4.75% |  | 
| Investment, interest rate, paid in kind | [6],[7],[8],[12] |  |  | 5.50% |  |  |  | 5.50% |  | 
| Principal amount | [6],[8],[12] |  |  | $ 10,469 |  |  |  |  |  | 
| Investment cost | [5],[6],[8],[12] |  |  | 10,286 |  |  |  |  |  | 
| Investments, at fair value: | [6],[8],[12] |  |  | 10,618 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Diversified Financial Services and Total Gibraltar Acquisition, LLC |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  |  |  | 35,000 |  |  |  |  |  | 
| Investment cost | [5] |  |  | 34,478 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 34,478 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development (66.60%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 66.60% |  |  |  | 66.60% |  | 
| Investment cost | [5] |  |  | $ 1,184,022 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 1,200,667 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and ATAI Life Sciences N.V., Senior Secured, August 2026, Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [15],[16] |  |  | 2026-08 |  |  |  | 2026-08 |  | 
| Investment, basis spread, variable rate | [7],[15],[16] |  |  | 4.55% |  |  |  | 4.55% |  | 
| Investment, interest rate, floor | [7],[15],[16] |  |  | 8.55% |  |  |  | 8.55% |  | 
| Investment exit fee | [7],[15],[16] |  |  | 6.95% |  |  |  | 6.95% |  | 
| Principal amount | [15],[16] |  |  | $ 10,500 |  |  |  |  |  | 
| Investment cost | [5],[15],[16] |  |  | 10,695 |  |  |  |  |  | 
| Investments, at fair value: | [15],[16] |  |  | $ 10,904 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Akero Therapeutics, Inc., Senior Secured, January 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[12],[16] |  |  | 2027-01 |  |  |  | 2027-01 |  | 
| Investment, basis spread, variable rate | [7],[9],[12],[16] |  |  | 3.65% |  |  |  | 3.65% |  | 
| Investment, interest rate, floor | [7],[9],[12],[16] |  |  | 7.65% |  |  |  | 7.65% |  | 
| Investment exit fee | [7],[9],[12],[16] |  |  | 5.85% |  |  |  | 5.85% |  | 
| Principal amount | [9],[12],[16] |  |  | $ 12,500 |  |  |  |  |  | 
| Investment cost | [5],[9],[12],[16] |  |  | 12,525 |  |  |  |  |  | 
| Investments, at fair value: | [9],[12],[16] |  |  | $ 13,065 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Aldeyra Therapeutics, Inc., Senior Secured, October 2024, Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [11] |  |  | 2024-10 |  |  |  | 2024-10 |  | 
| Investment, basis spread, variable rate | [7],[11] |  |  | 3.10% |  |  |  | 3.10% |  | 
| Investment, interest rate, floor | [7],[11] |  |  | 8.60% |  |  |  | 8.60% |  | 
| Investment exit fee | [7],[11] |  |  | 8.90% |  |  |  | 8.90% |  | 
| Principal amount | [11] |  |  | $ 15,000 |  |  |  |  |  | 
| Investment cost | [5],[11] |  |  | 15,152 |  |  |  |  |  | 
| Investments, at fair value: | [11] |  |  | $ 15,152 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Alladapt Immunotherapeutics Inc., Senior Secured, September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 5.30% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9] |  |  | 2026-09 |  |  |  | 2026-09 |  | 
| Investment, basis spread, variable rate | [7],[9] |  |  | 3.65% |  |  |  | 3.65% |  | 
| Investment, interest rate, floor | [7],[9] |  |  | 8.40% |  |  |  | 8.40% |  | 
| Investment, interest rate, cap | [7],[9] |  |  | 10.90% |  |  |  | 10.90% |  | 
| Investment exit fee | [7],[9] |  |  | 5.30% |  |  |  | 5.30% |  | 
| Principal amount | [9] |  |  | $ 35,000 |  |  |  |  |  | 
| Investment cost | [5],[9] |  |  | 35,173 |  |  |  |  |  | 
| Investments, at fair value: | [9] |  |  | $ 36,855 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [14] |  |  | 2027-01 |  |  |  | 2027-01 |  | 
| Investment, basis spread, variable rate | [7],[14] |  |  | 2.50% |  |  |  | 2.50% |  | 
| Investment, interest rate, floor | [7],[14] |  |  | 9.50% |  |  |  | 9.50% |  | 
| Investment, interest rate, cap | [7],[14] |  |  | 10.75% |  |  |  | 10.75% |  | 
| Investment exit fee | [7],[14] |  |  | 5.85% |  |  |  | 5.85% |  | 
| Principal amount | [14] |  |  | $ 24,000 |  |  |  |  |  | 
| Investment cost | [5],[14] |  |  | 24,120 |  |  |  |  |  | 
| Investments, at fair value: | [14] |  |  | $ 24,514 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Axsome Therapeutics, Inc., Senior Secured, January 2028, Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [10],[11],[16],[18] |  |  | 2028-01 |  |  |  | 2028-01 |  | 
| Investment, basis spread, variable rate | [7],[10],[11],[16],[18] |  |  | 2.20% |  |  |  | 2.20% |  | 
| Investment, interest rate, floor | [7],[10],[11],[16],[18] |  |  | 9.95% |  |  |  | 9.95% |  | 
| Investment, interest rate, cap | [7],[10],[11],[16],[18] |  |  | 10.70% |  |  |  | 10.70% |  | 
| Investment exit fee | [7],[10],[11],[16],[18] |  |  | 5.78% |  |  |  | 5.78% |  | 
| Principal amount | [10],[11],[16],[18] |  |  | $ 143,350 |  |  |  |  |  | 
| Investment cost | [5],[10],[11],[16],[18] |  |  | 143,646 |  |  |  |  |  | 
| Investments, at fair value: | [10],[11],[16],[18] |  |  | $ 150,255 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Bicycle Therapeutics PLC, Senior Secured, July 2025, Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [10],[11],[15],[16] |  |  | 2025-07 |  |  |  | 2025-07 |  | 
| Investment, basis spread, variable rate | [7],[10],[11],[15],[16] |  |  | 4.55% |  |  |  | 4.55% |  | 
| Investment, interest rate, floor | [7],[10],[11],[15],[16] |  |  | 8.05% |  |  |  | 8.05% |  | 
| Investment, interest rate, cap | [7],[10],[11],[15],[16] |  |  | 9.05% |  |  |  | 9.05% |  | 
| Investment exit fee | [7],[10],[11],[15],[16] |  |  | 5.00% |  |  |  | 5.00% |  | 
| Principal amount | [10],[11],[15],[16] |  |  | $ 11,500 |  |  |  |  |  | 
| Investment cost | [5],[10],[11],[15],[16] |  |  | 11,880 |  |  |  |  |  | 
| Investments, at fair value: | [10],[11],[15],[16] |  |  | $ 11,783 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and BiomX, INC, Senior Secured, September 2025, Prime + 5.70%, Floor rate 8.95%, 6.55% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [11],[15],[16] |  |  | 2025-09 |  |  |  | 2025-09 |  | 
| Investment, basis spread, variable rate | [7],[11],[15],[16] |  |  | 5.70% |  |  |  | 5.70% |  | 
| Investment, interest rate, floor | [7],[11],[15],[16] |  |  | 8.95% |  |  |  | 8.95% |  | 
| Investment exit fee | [7],[11],[15],[16] |  |  | 6.55% |  |  |  | 6.55% |  | 
| Principal amount | [11],[15],[16] |  |  | $ 6,448 |  |  |  |  |  | 
| Investment cost | [5],[11],[15],[16] |  |  | 6,807 |  |  |  |  |  | 
| Investments, at fair value: | [11],[15],[16] |  |  | $ 6,790 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Braeburn, Inc., Senior Secured, October 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8] |  |  | 2028-10 |  |  |  | 2028-10 |  | 
| Investment, basis spread, variable rate | [7],[8] |  |  | 2.45% |  |  |  | 2.45% |  | 
| Investment, interest rate, floor | [7],[8] |  |  | 10.95% |  |  |  | 10.95% |  | 
| Investment, interest rate, paid in kind | [7],[8] |  |  | 1.10% |  |  |  | 1.10% |  | 
| Investment exit fee | [7],[8] |  |  | 5.45% |  |  |  | 5.45% |  | 
| Principal amount | [8] |  |  | $ 52,601 |  |  |  |  |  | 
| Investment cost | [5],[8] |  |  | 52,185 |  |  |  |  |  | 
| Investments, at fair value: | [8] |  |  | $ 52,185 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and BridgeBio Pharma, Inc., Senior Secured, November 2026, FIXED 9.00%, 2.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[9],[10] |  |  | 2026-11 |  |  |  | 2026-11 |  | 
| Investment, interest rate, paid in cash | [7],[8],[9],[10] |  |  | 9.00% |  |  |  | 9.00% |  | 
| Investment exit fee | [7],[8],[9],[10] |  |  | 2.00% |  |  |  | 2.00% |  | 
| Principal amount | [8],[9],[10] |  |  | $ 38,167 |  |  |  |  |  | 
| Investment cost | [5],[8],[9],[10] |  |  | 38,124 |  |  |  |  |  | 
| Investments, at fair value: | [8],[9],[10] |  |  | $ 35,498 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and COMPASS Pathways plc, Senior Secured, July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[15],[16] |  |  | 2027-07 |  |  |  | 2027-07 |  | 
| Investment, basis spread, variable rate | [7],[8],[15],[16] |  |  | 1.50% |  |  |  | 1.50% |  | 
| Investment, interest rate, floor | [7],[8],[15],[16] |  |  | 9.75% |  |  |  | 9.75% |  | 
| Investment, interest rate, paid in kind | [7],[8],[15],[16] |  |  | 1.40% |  |  |  | 1.40% |  | 
| Investment exit fee | [7],[8],[15],[16] |  |  | 4.75% |  |  |  | 4.75% |  | 
| Principal amount | [8],[15],[16] |  |  | $ 24,144 |  |  |  |  |  | 
| Investment cost | [5],[8],[15],[16] |  |  | 23,798 |  |  |  |  |  | 
| Investments, at fair value: | [8],[15],[16] |  |  | $ 24,601 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Cellarity, Inc., Senior Secured, June 2026, Prime + 5.70%, Floor rate 8.95%, 3.75% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[14] |  |  | 2026-06 |  |  |  | 2026-06 |  | 
| Investment, basis spread, variable rate | [7],[9],[14] |  |  | 5.70% |  |  |  | 5.70% |  | 
| Investment, interest rate, floor | [7],[9],[14] |  |  | 8.95% |  |  |  | 8.95% |  | 
| Investment exit fee | [7],[9],[14] |  |  | 3.75% |  |  |  | 3.75% |  | 
| Principal amount | [9],[14] |  |  | $ 29,193 |  |  |  |  |  | 
| Investment cost | [5],[9],[14] |  |  | 29,482 |  |  |  |  |  | 
| Investments, at fair value: | [9],[14] |  |  | $ 30,051 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Corium, Inc., Senior Secured, September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[18] |  |  | 2026-09 |  |  |  | 2026-09 |  | 
| Investment, basis spread, variable rate | [7],[9],[18] |  |  | 5.70% |  |  |  | 5.70% |  | 
| Investment, interest rate, floor | [7],[9],[18] |  |  | 8.95% |  |  |  | 8.95% |  | 
| Investment exit fee | [7],[9],[18] |  |  | 7.75% |  |  |  | 7.75% |  | 
| Principal amount | [9],[18] |  |  | $ 105,225 |  |  |  |  |  | 
| Investment cost | [5],[9],[18] |  |  | 107,667 |  |  |  |  |  | 
| Investments, at fair value: | [9],[18] |  |  | $ 108,545 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Curevo, Inc., Senior Secured, June 2027, Prime + 1.70%, Floor rate 9.70%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [14] |  |  | 2027-06 |  |  |  | 2027-06 |  | 
| Investment, basis spread, variable rate | [7],[14] |  |  | 1.70% |  |  |  | 1.70% |  | 
| Investment, interest rate, floor | [7],[14] |  |  | 9.70% |  |  |  | 9.70% |  | 
| Investment exit fee | [7],[14] |  |  | 6.95% |  |  |  | 6.95% |  | 
| Principal amount | [14] |  |  | $ 10,000 |  |  |  |  |  | 
| Investment cost | [5],[14] |  |  | 9,821 |  |  |  |  |  | 
| Investments, at fair value: | [14] |  |  | $ 10,076 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Eloxx Pharmaceuticals, Inc., Senior Secured, April 2025, Prime + 6.25%, Floor rate 9.50%, 6.55% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [14] |  |  | 2025-04 |  |  |  | 2025-04 |  | 
| Investment, basis spread, variable rate | [7],[14] |  |  | 6.25% |  |  |  | 6.25% |  | 
| Investment, interest rate, floor | [7],[14] |  |  | 9.50% |  |  |  | 9.50% |  | 
| Investment exit fee | [7],[14] |  |  | 6.55% |  |  |  | 6.55% |  | 
| Principal amount | [14] |  |  | $ 3,099 |  |  |  |  |  | 
| Investment cost | [5],[14] |  |  | 3,789 |  |  |  |  |  | 
| Investments, at fair value: | [14] |  |  | $ 3,731 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and G1 Therapeutics, Inc., Senior Secured, November 2026, Prime + 5.65%, Floor rate 9.15%, 11.41% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [10],[11],[14] |  |  | 2026-11 |  |  |  | 2026-11 |  | 
| Investment, basis spread, variable rate | [7],[10],[11],[14] |  |  | 5.65% |  |  |  | 5.65% |  | 
| Investment, interest rate, floor | [7],[10],[11],[14] |  |  | 9.15% |  |  |  | 9.15% |  | 
| Investment exit fee | [7],[10],[11],[14] |  |  | 11.41% |  |  |  | 11.41% |  | 
| Principal amount | [10],[11],[14] |  |  | $ 38,750 |  |  |  |  |  | 
| Investment cost | [5],[10],[11],[14] |  |  | 39,679 |  |  |  |  |  | 
| Investments, at fair value: | [10],[11],[14] |  |  | $ 40,421 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Geron Corporation, Senior Secured, April 2025, Prime + 4.50%, Floor rate 9.00%, 6.55% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[10],[16] |  |  | 2025-04 |  |  |  | 2025-04 |  | 
| Investment, basis spread, variable rate | [7],[9],[10],[16] |  |  | 4.50% |  |  |  | 4.50% |  | 
| Investment, interest rate, floor | [7],[9],[10],[16] |  |  | 9.00% |  |  |  | 9.00% |  | 
| Investment exit fee | [7],[9],[10],[16] |  |  | 6.55% |  |  |  | 6.55% |  | 
| Principal amount | [9],[10],[16] |  |  | $ 30,200 |  |  |  |  |  | 
| Investment cost | [5],[9],[10],[16] |  |  | 31,005 |  |  |  |  |  | 
| Investments, at fair value: | [9],[10],[16] |  |  | $ 31,210 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Gritstone Bio, Inc., Senior Secured, July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[9] |  |  | 2027-07 |  |  |  | 2027-07 |  | 
| Investment, basis spread, variable rate | [7],[8],[9] |  |  | 3.15% |  |  |  | 3.15% |  | 
| Investment, interest rate, floor | [7],[8],[9] |  |  | 7.15% |  |  |  | 7.15% |  | 
| Investment, interest rate, cap | [7],[8],[9] |  |  | 8.65% |  |  |  | 8.65% |  | 
| Investment, interest rate, paid in kind | [7],[8],[9] |  |  | 2.00% |  |  |  | 2.00% |  | 
| Investment exit fee | [7],[8],[9] |  |  | 5.75% |  |  |  | 5.75% |  | 
| Principal amount | [8],[9] |  |  | $ 30,532 |  |  |  |  |  | 
| Investment cost | [5],[8],[9] |  |  | 30,717 |  |  |  |  |  | 
| Investments, at fair value: | [8],[9] |  |  | $ 30,909 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Heron Therapeutics, Inc., Senior Secured, February 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[12],[14] |  |  | 2026-02 |  |  |  | 2026-02 |  | 
| Investment, basis spread, variable rate | [7],[8],[12],[14] |  |  | 1.70% |  |  |  | 1.70% |  | 
| Investment, interest rate, floor | [7],[8],[12],[14] |  |  | 9.95% |  |  |  | 9.95% |  | 
| Investment, interest rate, paid in kind | [7],[8],[12],[14] |  |  | 1.50% |  |  |  | 1.50% |  | 
| Investment exit fee | [7],[8],[12],[14] |  |  | 3.00% |  |  |  | 3.00% |  | 
| Principal amount | [8],[12],[14] |  |  | $ 20,095 |  |  |  |  |  | 
| Investment cost | [5],[8],[12],[14] |  |  | 19,788 |  |  |  |  |  | 
| Investments, at fair value: | [8],[12],[14] |  |  | $ 19,788 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Hibercell, Inc., Senior Secured, May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[14] |  |  | 2025-05 |  |  |  | 2025-05 |  | 
| Investment, basis spread, variable rate | [7],[9],[14] |  |  | 5.40% |  |  |  | 5.40% |  | 
| Investment, interest rate, floor | [7],[9],[14] |  |  | 8.65% |  |  |  | 8.65% |  | 
| Investment exit fee | [7],[9],[14] |  |  | 4.95% |  |  |  | 4.95% |  | 
| Principal amount | [9],[14] |  |  | $ 12,535 |  |  |  |  |  | 
| Investment cost | [5],[9],[14] |  |  | 13,117 |  |  |  |  |  | 
| Investments, at fair value: | [9],[14] |  |  | $ 13,181 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and HilleVax, Inc., Senior Secured, May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[14] |  |  | 2027-05 |  |  |  | 2027-05 |  | 
| Investment, basis spread, variable rate | [7],[8],[14] |  |  | 1.05% |  |  |  | 1.05% |  | 
| Investment, interest rate, floor | [7],[8],[14] |  |  | 4.55% |  |  |  | 4.55% |  | 
| Investment, interest rate, cap | [7],[8],[14] |  |  | 6.05% |  |  |  | 6.05% |  | 
| Investment, interest rate, paid in kind | [7],[8],[14] |  |  | 2.85% |  |  |  | 2.85% |  | 
| Investment exit fee | [7],[8],[14] |  |  | 7.15% |  |  |  | 7.15% |  | 
| Principal amount | [8],[14] |  |  | $ 20,524 |  |  |  |  |  | 
| Investment cost | [5],[8],[14] |  |  | 20,685 |  |  |  |  |  | 
| Investments, at fair value: | [8],[14] |  |  | $ 20,335 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Kura Oncology, Inc., Senior Secured, November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[14],[16] |  |  | 2027-11 |  |  |  | 2027-11 |  | 
| Investment, basis spread, variable rate | [7],[12],[14],[16] |  |  | 2.40% |  |  |  | 2.40% |  | 
| Investment, interest rate, floor | [7],[12],[14],[16] |  |  | 8.65% |  |  |  | 8.65% |  | 
| Investment exit fee | [7],[12],[14],[16] |  |  | 15.13% |  |  |  | 15.13% |  | 
| Principal amount | [12],[14],[16] |  |  | $ 5,500 |  |  |  |  |  | 
| Investment cost | [5],[12],[14],[16] |  |  | 5,532 |  |  |  |  |  | 
| Investments, at fair value: | [12],[14],[16] |  |  | $ 5,752 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Locus Biosciences, Inc., Senior Secured, July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [14] |  |  | 2025-07 |  |  |  | 2025-07 |  | 
| Investment, basis spread, variable rate | [7],[14] |  |  | 6.10% |  |  |  | 6.10% |  | 
| Investment, interest rate, floor | [7],[14] |  |  | 9.35% |  |  |  | 9.35% |  | 
| Investment exit fee | [7],[14] |  |  | 4.95% |  |  |  | 4.95% |  | 
| Principal amount | [14] |  |  | $ 5,399 |  |  |  |  |  | 
| Investment cost | [5],[14] |  |  | 5,651 |  |  |  |  |  | 
| Investments, at fair value: | [14] |  |  | $ 5,686 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Senior Secured, May 2026, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [16] |  |  | 2026-05 |  |  |  | 2026-05 |  | 
| Investment, basis spread, variable rate | [7],[16] |  |  | 2.45% |  |  |  | 2.45% |  | 
| Investment, interest rate, floor | [7],[16] |  |  | 8.25% |  |  |  | 8.25% |  | 
| Investment exit fee | [7],[16] |  |  | 5.35% |  |  |  | 5.35% |  | 
| Principal amount | [16] |  |  | $ 78,200 |  |  |  |  |  | 
| Investment cost | [5],[16] |  |  | 78,728 |  |  |  |  |  | 
| Investments, at fair value: | [16] |  |  | $ 81,945 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, December 2027, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.15%, 7.29% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[10],[12],[14],[16],[18],[22] |  |  | 2027-12 |  |  |  | 2027-12 |  | 
| Investment, basis spread, variable rate | [7],[8],[10],[12],[14],[16],[18],[22] |  |  | 1.35% |  |  |  | 1.35% |  | 
| Investment, interest rate, floor | [7],[8],[10],[12],[14],[16],[18],[22] |  |  | 9.85% |  |  |  | 9.85% |  | 
| Investment, interest rate, paid in kind | [7],[8],[10],[12],[14],[16],[18],[22] |  |  | 2.15% |  |  |  | 2.15% |  | 
| Investment exit fee | [7],[8],[10],[12],[14],[16],[18],[22] |  |  | 7.29% |  |  |  | 7.29% |  | 
| Principal amount | [8],[10],[12],[14],[16],[18],[22] |  |  | $ 129,699 |  |  |  |  |  | 
| Investment cost | [5],[8],[10],[12],[14],[16],[18],[22] |  |  | 130,934 |  |  |  |  |  | 
| Investments, at fair value: | [8],[10],[12],[14],[16],[18],[22] |  |  | $ 128,326 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Redshift Bioanalytics, Inc., Senior Secured, January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [14] |  |  | 2026-01 |  |  |  | 2026-01 |  | 
| Investment, basis spread, variable rate | [7],[14] |  |  | 4.25% |  |  |  | 4.25% |  | 
| Investment, interest rate, floor | [7],[14] |  |  | 7.50% |  |  |  | 7.50% |  | 
| Investment exit fee | [7],[14] |  |  | 3.80% |  |  |  | 3.80% |  | 
| Principal amount | [14] |  |  | $ 5,000 |  |  |  |  |  | 
| Investment cost | [5],[14] |  |  | 5,047 |  |  |  |  |  | 
| Investments, at fair value: | [14] |  |  | $ 5,119 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Replimune Group, Inc., Senior Secured, October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[10],[16] |  |  | 2027-10 |  |  |  | 2027-10 |  | 
| Investment, basis spread, variable rate | [7],[8],[10],[16] |  |  | 1.75% |  |  |  | 1.75% |  | 
| Investment, interest rate, floor | [7],[8],[10],[16] |  |  | 7.25% |  |  |  | 7.25% |  | 
| Investment, interest rate, cap | [7],[8],[10],[16] |  |  | 9.00% |  |  |  | 9.00% |  | 
| Investment, interest rate, paid in kind | [7],[8],[10],[16] |  |  | 1.50% |  |  |  | 1.50% |  | 
| Investment exit fee | [7],[8],[10],[16] |  |  | 4.95% |  |  |  | 4.95% |  | 
| Principal amount | [8],[10],[16] |  |  | $ 31,416 |  |  |  |  |  | 
| Investment cost | [5],[8],[10],[16] |  |  | 31,450 |  |  |  |  |  | 
| Investments, at fair value: | [8],[10],[16] |  |  | $ 32,702 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and TG Therapeutics, Inc., Senior Secured, January 2026, Prime + 1.20%, Floor rate 8.95%, PIK Interest 2.25%, 5.69% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[10],[11],[16] |  |  | 2026-01 |  |  |  | 2026-01 |  | 
| Investment, basis spread, variable rate | [7],[8],[10],[11],[16] |  |  | 1.20% |  |  |  | 1.20% |  | 
| Investment, interest rate, floor | [7],[8],[10],[11],[16] |  |  | 8.95% |  |  |  | 8.95% |  | 
| Investment, interest rate, paid in kind | [7],[8],[10],[11],[16] |  |  | 2.25% |  |  |  | 2.25% |  | 
| Investment exit fee | [7],[8],[10],[11],[16] |  |  | 5.69% |  |  |  | 5.69% |  | 
| Principal amount | [8],[10],[11],[16] |  |  | $ 65,770 |  |  |  |  |  | 
| Investment cost | [5],[8],[10],[11],[16] |  |  | 66,439 |  |  |  |  |  | 
| Investments, at fair value: | [8],[10],[11],[16] |  |  | $ 67,610 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Senior Secured, February 2027, Prime + 4.45%, Floor rate 8.45%, Cap rate 11.45%, 4.75% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[12],[16] |  |  | 2027-02 |  |  |  | 2027-02 |  | 
| Investment, basis spread, variable rate | [7],[9],[12],[16] |  |  | 4.45% |  |  |  | 4.45% |  | 
| Investment, interest rate, floor | [7],[9],[12],[16] |  |  | 8.45% |  |  |  | 8.45% |  | 
| Investment, interest rate, cap | [7],[9],[12],[16] |  |  | 11.45% |  |  |  | 11.45% |  | 
| Investment exit fee | [7],[9],[12],[16] |  |  | 4.75% |  |  |  | 4.75% |  | 
| Principal amount | [9],[12],[16] |  |  | $ 12,375 |  |  |  |  |  | 
| Investment cost | [5],[9],[12],[16] |  |  | 12,488 |  |  |  |  |  | 
| Investments, at fair value: | [9],[12],[16] |  |  | $ 12,916 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Valo Health, LLC, Senior Secured, May 2024, Prime + 6.45%, Floor rate 9.70%, 3.85% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[11] |  |  | 2024-05 |  |  |  | 2024-05 |  | 
| Investment, basis spread, variable rate | [7],[9],[11] |  |  | 6.45% |  |  |  | 6.45% |  | 
| Investment, interest rate, floor | [7],[9],[11] |  |  | 9.70% |  |  |  | 9.70% |  | 
| Investment exit fee | [7],[9],[11] |  |  | 3.85% |  |  |  | 3.85% |  | 
| Principal amount | [9],[11] |  |  | $ 2,396 |  |  |  |  |  | 
| Investment cost | [5],[9],[11] |  |  | 2,808 |  |  |  |  |  | 
| Investments, at fair value: | [9],[11] |  |  | $ 2,808 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Verona Pharma, Inc., Senior Secured, December 2028, 1-month SOFR + 5.85%, Floor rate 11.19%, Cap rate 13.19%, 3.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [15],[16] |  |  | 2028-12 |  |  |  | 2028-12 |  | 
| Investment, basis spread, variable rate | [7],[15],[16] |  |  | 5.85% |  |  |  | 5.85% |  | 
| Investment, interest rate, floor | [7],[15],[16] |  |  | 11.19% |  |  |  | 11.19% |  | 
| Investment, interest rate, cap | [7],[15],[16] |  |  | 13.19% |  |  |  | 13.19% |  | 
| Investment exit fee | [7],[15],[16] |  |  | 3.50% |  |  |  | 3.50% |  | 
| Principal amount | [15],[16] |  |  | $ 15,750 |  |  |  |  |  | 
| Investment cost | [5],[15],[16] |  |  | 15,646 |  |  |  |  |  | 
| Investments, at fair value: | [15],[16] |  |  | $ 15,646 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and Viridian Therapeutics, Inc., Senior Secured, October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[16] |  |  | 2026-10 |  |  |  | 2026-10 |  | 
| Investment, basis spread, variable rate | [7],[9],[16] |  |  | 4.20% |  |  |  | 4.20% |  | 
| Investment, interest rate, floor | [7],[9],[16] |  |  | 7.45% |  |  |  | 7.45% |  | 
| Investment, interest rate, cap | [7],[9],[16] |  |  | 8.95% |  |  |  | 8.95% |  | 
| Investment exit fee | [7],[9],[16] |  |  | 6.00% |  |  |  | 6.00% |  | 
| Principal amount | [9],[16] |  |  | $ 8,000 |  |  |  |  |  | 
| Investment cost | [5],[9],[16] |  |  | 8,057 |  |  |  |  |  | 
| Investments, at fair value: | [9],[16] |  |  | $ 8,023 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and X4 Pharmaceuticals, Inc., Senior Secured, October 2026, Prime + 3.15%, Floor rate 10.15%, 3.80% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[10],[11] |  |  | 2026-10 |  |  |  | 2026-10 |  | 
| Investment, basis spread, variable rate | [7],[9],[10],[11] |  |  | 3.15% |  |  |  | 3.15% |  | 
| Investment, interest rate, floor | [7],[9],[10],[11] |  |  | 10.15% |  |  |  | 10.15% |  | 
| Investment exit fee | [7],[9],[10],[11] |  |  | 3.80% |  |  |  | 3.80% |  | 
| Principal amount | [9],[10],[11] |  |  | $ 55,000 |  |  |  |  |  | 
| Investment cost | [5],[9],[10],[11] |  |  | 54,680 |  |  |  |  |  | 
| Investments, at fair value: | [9],[10],[11] |  |  | $ 55,417 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and enGene, Inc., Senior Secured, July 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [15],[16] |  |  | 2028-01 |  |  |  | 2028-01 |  | 
| Investment, basis spread, variable rate | [7],[15],[16] |  |  | 0.75% |  |  |  | 0.75% |  | 
| Investment, interest rate, floor | [7],[15],[16] |  |  | 9.25% |  |  |  | 9.25% |  | 
| Investment, interest rate, cap | [7],[15],[16] |  |  | 9.75% |  |  |  | 9.75% |  | 
| Investment, interest rate, paid in kind | [7],[15],[16] |  |  | 1.15% |  |  |  | 1.15% |  | 
| Investment exit fee | [7],[15],[16] |  |  | 5.50% |  |  |  | 5.50% |  | 
| Principal amount | [15],[16] |  |  | $ 15,750 |  |  |  |  |  | 
| Investment cost | [5],[15],[16] |  |  | 15,550 |  |  |  |  |  | 
| Investments, at fair value: | [15],[16] |  |  | $ 15,550 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Drug Discovery & Development and uniQure B.V., Senior Secured, January 2027, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [10],[11],[15],[16] |  |  | 2027-01 |  |  |  | 2027-01 |  | 
| Investment, basis spread, variable rate | [7],[10],[11],[15],[16] |  |  | 4.70% |  |  |  | 4.70% |  | 
| Investment, interest rate, floor | [7],[10],[11],[15],[16] |  |  | 7.95% |  |  |  | 7.95% |  | 
| Investment exit fee | [7],[10],[11],[15],[16] |  |  | 6.10% |  |  |  | 6.10% |  | 
| Principal amount | [10],[11],[15],[16] |  |  | $ 70,000 |  |  |  |  |  | 
| Investment cost | [5],[10],[11],[15],[16] |  |  | 71,157 |  |  |  |  |  | 
| Investments, at fair value: | [10],[11],[15],[16] |  |  | $ 73,318 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other (16.56%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 16.56% |  |  |  | 16.56% |  | 
| Investment cost | [5] |  |  | $ 301,164 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 298,523 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Better Therapeutics, Inc., Senior Secured, August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [14] |  |  | 2025-08 |  |  |  | 2025-08 |  | 
| Investment, basis spread, variable rate | [7],[14] |  |  | 5.70% |  |  |  | 5.70% |  | 
| Investment, interest rate, floor | [7],[14] |  |  | 8.95% |  |  |  | 8.95% |  | 
| Investment exit fee | [7],[14] |  |  | 5.95% |  |  |  | 5.95% |  | 
| Principal amount | [14] |  |  | $ 10,865 |  |  |  |  |  | 
| Investment cost | [5],[14] |  |  | 11,285 |  |  |  |  |  | 
| Investments, at fair value: | [14] |  |  | $ 8,455 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Blue Sprig Pediatrics, Inc., Senior Secured, November 2026, 1-month SOFR + 5.11% , Floor rate 6.00%, PIK Interest 4.45% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[9],[11] |  |  | 2026-11 |  |  |  | 2026-11 |  | 
| Investment, basis spread, variable rate | [7] |  |  | 5.11% |  |  |  | 5.11% |  | 
| Investment, interest rate, floor | [7],[8],[9],[11] |  |  | 6.00% |  |  |  | 6.00% |  | 
| Investment, interest rate, paid in kind | [7],[8],[9],[11] |  |  | 4.45% |  |  |  | 4.45% |  | 
| Principal amount | [8],[9],[11] |  |  | $ 69,032 |  |  |  |  |  | 
| Investment cost | [5],[8],[9],[11] |  |  | 68,277 |  |  |  |  |  | 
| Investments, at fair value: | [8],[9],[11] |  |  | $ 68,393 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Carbon Health Technologies, Inc., Senior Secured, March 2025, Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[11] |  |  | 2025-03 |  |  |  | 2025-03 |  | 
| Investment, basis spread, variable rate | [7],[9],[11] |  |  | 5.60% |  |  |  | 5.60% |  | 
| Investment, interest rate, floor | [7],[9],[11] |  |  | 8.85% |  |  |  | 8.85% |  | 
| Investment exit fee | [7],[9],[11] |  |  | 4.61% |  |  |  | 4.61% |  | 
| Principal amount | [9],[11] |  |  | $ 46,125 |  |  |  |  |  | 
| Investment cost | [5],[9],[11] |  |  | 47,193 |  |  |  |  |  | 
| Investments, at fair value: | [9],[11] |  |  | $ 46,242 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Equality Health, LLC, Senior Secured, February 2026, Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[10],[11] |  |  | 2026-02 |  |  |  | 2026-02 |  | 
| Investment, basis spread, variable rate | [7],[8],[10],[11] |  |  | 6.25% |  |  |  | 6.25% |  | 
| Investment, interest rate, floor | [7],[8],[10],[11] |  |  | 9.50% |  |  |  | 9.50% |  | 
| Investment, interest rate, paid in kind | [7],[8],[10],[11] |  |  | 1.55% |  |  |  | 1.55% |  | 
| Principal amount | [8],[10],[11] |  |  | $ 54,425 |  |  |  |  |  | 
| Investment cost | [5],[8],[10],[11] |  |  | 54,142 |  |  |  |  |  | 
| Investments, at fair value: | [8],[10],[11] |  |  | $ 54,697 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Main Street Rural, Inc., Senior Secured, July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[14] |  |  | 2027-07 |  |  |  | 2027-07 |  | 
| Investment, basis spread, variable rate | [7],[12],[14] |  |  | 1.95% |  |  |  | 1.95% |  | 
| Investment, interest rate, floor | [7],[12],[14] |  |  | 9.95% |  |  |  | 9.95% |  | 
| Investment exit fee | [7],[12],[14] |  |  | 6.85% |  |  |  | 6.85% |  | 
| Principal amount | [12],[14] |  |  | $ 24,500 |  |  |  |  |  | 
| Investment cost | [5],[12],[14] |  |  | 24,476 |  |  |  |  |  | 
| Investments, at fair value: | [12],[14] |  |  | $ 24,929 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Modern Life, Inc., Senior Secured, February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[12] |  |  | 2027-02 |  |  |  | 2027-02 |  | 
| Investment, basis spread, variable rate | [7],[9],[12] |  |  | 2.75% |  |  |  | 2.75% |  | 
| Investment, interest rate, floor | [7],[9],[12] |  |  | 8.75% |  |  |  | 8.75% |  | 
| Investment exit fee | [7],[9],[12] |  |  | 5.00% |  |  |  | 5.00% |  | 
| Principal amount | [9],[12] |  |  | $ 13,000 |  |  |  |  |  | 
| Investment cost | [5],[9],[12] |  |  | 12,888 |  |  |  |  |  | 
| Investments, at fair value: | [9],[12] |  |  | $ 13,111 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Recover Together, Inc., Senior Secured, July 2027, Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date |  |  |  | 2027-07 |  |  |  | 2027-07 |  | 
| Investment, basis spread, variable rate | [7] |  |  | 1.90% |  |  |  | 1.90% |  | 
| Investment, interest rate, floor | [7] |  |  | 10.15% |  |  |  | 10.15% |  | 
| Investment exit fee | [7] |  |  | 7.50% |  |  |  | 7.50% |  | 
| Principal amount |  |  |  | $ 35,000 |  |  |  |  |  | 
| Investment cost | [5] |  |  | 34,683 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 34,683 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [14] |  |  | 2027-09 |  |  |  | 2027-09 |  | 
| Investment, basis spread, variable rate | [7],[14] |  |  | 0.70% |  |  |  | 0.70% |  | 
| Investment, interest rate, floor | [7],[14] |  |  | 9.20% |  |  |  | 9.20% |  | 
| Investment exit fee | [7],[14] |  |  | 5.95% |  |  |  | 5.95% |  | 
| Principal amount | [14] |  |  | $ 12,000 |  |  |  |  |  | 
| Investment cost | [5],[14] |  |  | 11,868 |  |  |  |  |  | 
| Investments, at fair value: | [14] |  |  | $ 11,868 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Healthcare Services, Other and Vida Health, Inc., Senior Secured, March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [11] |  |  | 2026-03 |  |  |  | 2026-03 |  | 
| Investment, basis spread, variable rate | [7],[11] |  |  | 3.25% |  |  |  | 3.25% |  | 
| Investment, interest rate, floor | [7],[11] |  |  | 9.20% |  |  |  | 9.20% |  | 
| Investment, interest rate, cap | [7],[11] |  |  | 10.20% |  |  |  | 10.20% |  | 
| Investment, interest rate, paid in kind | [7],[11] |  |  | 1.00% |  |  |  | 1.00% |  | 
| Investment exit fee | [7],[11] |  |  | 4.95% |  |  |  | 4.95% |  | 
| Principal amount | [11] |  |  | $ 36,500 |  |  |  |  |  | 
| Investment cost | [5],[11] |  |  | 36,352 |  |  |  |  |  | 
| Investments, at fair value: | [11] |  |  | $ 36,145 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Information Services (6.65%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 6.65% |  |  |  | 6.65% |  | 
| Investment cost | [5] |  |  | $ 117,099 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 119,876 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Information Services and Capella Space Corp., Senior Secured, November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[14] |  |  | 2025-11 |  |  |  | 2025-11 |  | 
| Investment, basis spread, variable rate | [7],[8],[14] |  |  | 5.00% |  |  |  | 5.00% |  | 
| Investment, interest rate, floor | [7],[8],[14] |  |  | 8.25% |  |  |  | 8.25% |  | 
| Investment, interest rate, paid in kind | [7],[8],[14] |  |  | 1.10% |  |  |  | 1.10% |  | 
| Investment exit fee | [7],[8],[14] |  |  | 7.00% |  |  |  | 7.00% |  | 
| Principal amount | [8],[14] |  |  | $ 20,477 |  |  |  |  |  | 
| Investment cost | [5],[8],[14] |  |  | 21,166 |  |  |  |  |  | 
| Investments, at fair value: | [8],[14] |  |  | $ 21,351 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Information Services and Checkr Group, Inc., Senior Secured, August 2028, Prime + 1.45%, Floor rate 8.00%, PIK Interest 2.00%, 2.75% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[12] |  |  | 2028-08 |  |  |  | 2028-08 |  | 
| Investment, basis spread, variable rate | [7],[8],[12] |  |  | 1.45% |  |  |  | 1.45% |  | 
| Investment, interest rate, floor | [7],[8],[12] |  |  | 8.00% |  |  |  | 8.00% |  | 
| Investment, interest rate, paid in kind | [7],[8],[12] |  |  | 2.00% |  |  |  | 2.00% |  | 
| Investment exit fee | [7],[8],[12] |  |  | 2.75% |  |  |  | 2.75% |  | 
| Principal amount | [8],[12] |  |  | $ 47,621 |  |  |  |  |  | 
| Investment cost | [5],[8],[12] |  |  | 47,460 |  |  |  |  |  | 
| Investments, at fair value: | [8],[12] |  |  | $ 49,382 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Information Services and Saama Technologies, LLC, Senior Secured, July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[12] |  |  | 2027-07 |  |  |  | 2027-07 |  | 
| Investment, basis spread, variable rate | [7],[8],[12] |  |  | 0.70% |  |  |  | 0.70% |  | 
| Investment, interest rate, floor | [7],[8],[12] |  |  | 8.95% |  |  |  | 8.95% |  | 
| Investment, interest rate, paid in kind | [7],[8],[12] |  |  | 2.00% |  |  |  | 2.00% |  | 
| Investment exit fee | [7],[8],[12] |  |  | 2.95% |  |  |  | 2.95% |  | 
| Principal amount | [8],[12] |  |  | $ 11,725 |  |  |  |  |  | 
| Investment cost | [5],[8],[12] |  |  | 11,627 |  |  |  |  |  | 
| Investments, at fair value: | [8],[12] |  |  | $ 11,876 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Information Services and Signal Media Limited, Senior Secured, June 2025, Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [15],[16] |  |  | 2025-06 |  |  |  | 2025-06 |  | 
| Investment, basis spread, variable rate | [7],[15],[16] |  |  | 5.50% |  |  |  | 5.50% |  | 
| Investment, interest rate, floor | [7],[15],[16] |  |  | 9.00% |  |  |  | 9.00% |  | 
| Investment, interest rate, cap | [7],[15],[16] |  |  | 12.00% |  |  |  | 12.00% |  | 
| Investment exit fee | [7],[15],[16] |  |  | 3.45% |  |  |  | 3.45% |  | 
| Principal amount | [15],[16] |  |  | $ 5,400 |  |  |  |  |  | 
| Investment cost | [5],[15],[16] |  |  | 5,364 |  |  |  |  |  | 
| Investments, at fair value: | [15],[16] |  |  | $ 5,392 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Information Services and Yipit, LLC, Senior Secured, September 2026, 1-month SOFR + 8.45%, Floor rate 9.35% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[13] |  |  | 2026-09 |  |  |  | 2026-09 |  | 
| Investment, basis spread, variable rate | [7],[12],[13] |  |  | 8.45% |  |  |  | 8.45% |  | 
| Investment, interest rate, floor | [7],[12],[13] |  |  | 9.35% |  |  |  | 9.35% |  | 
| Principal amount | [12],[13] |  |  | $ 31,875 |  |  |  |  |  | 
| Investment cost | [5],[12],[13] |  |  | 31,482 |  |  |  |  |  | 
| Investments, at fair value: | [12],[13] |  |  | $ 31,875 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Manufacturing Technology and Bright Machines, Inc., Senior Secured, May 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9] |  |  | 2025-05 |  |  |  | 2025-05 |  | 
| Investment, basis spread, variable rate | [7],[9] |  |  | 4.00% |  |  |  | 4.00% |  | 
| Investment, interest rate, floor | [7],[9] |  |  | 9.50% |  |  |  | 9.50% |  | 
| Investment exit fee | [7],[9] |  |  | 5.00% |  |  |  | 5.00% |  | 
| Principal amount | [9] |  |  | $ 7,827 |  |  |  |  |  | 
| Investment cost | [5],[9] |  |  | 8,064 |  |  |  |  |  | 
| Investments, at fair value: | [9] |  |  | $ 8,006 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Media/Content/Info (0.69%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.69% |  |  |  | 0.69% |  | 
| Investment cost | [5] |  |  | $ 12,340 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 12,469 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, December 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6] |  |  | 2025-12 |  |  |  | 2025-12 |  | 
| Investment, basis spread, variable rate | [6],[7] |  |  | 3.50% |  |  |  | 3.50% |  | 
| Investment, interest rate, floor | [6],[7] |  |  | 9.00% |  |  |  | 9.00% |  | 
| Investment exit fee | [6],[7] |  |  | 3.00% |  |  |  | 3.00% |  | 
| Principal amount | [6] |  |  | $ 1,333 |  |  |  |  |  | 
| Investment cost | [5],[6] |  |  | 1,342 |  |  |  |  |  | 
| Investments, at fair value: | [6] |  |  | $ 1,351 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, June 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6] |  |  | 2026-06 |  |  |  | 2026-06 |  | 
| Investment, basis spread, variable rate | [6],[7] |  |  | 3.50% |  |  |  | 3.50% |  | 
| Investment, interest rate, floor | [6],[7] |  |  | 9.00% |  |  |  | 9.00% |  | 
| Investment exit fee | [6],[7] |  |  | 3.00% |  |  |  | 3.00% |  | 
| Principal amount | [6] |  |  | $ 1,667 |  |  |  |  |  | 
| Investment cost | [5],[6] |  |  | 1,647 |  |  |  |  |  | 
| Investments, at fair value: | [6] |  |  | $ 1,653 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, March 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6] |  |  | 2026-03 |  |  |  | 2026-03 |  | 
| Investment, basis spread, variable rate | [6],[7] |  |  | 3.50% |  |  |  | 3.50% |  | 
| Investment, interest rate, floor | [6],[7] |  |  | 9.00% |  |  |  | 9.00% |  | 
| Investment exit fee | [6],[7] |  |  | 3.00% |  |  |  | 3.00% |  | 
| Principal amount | [6] |  |  | $ 1,500 |  |  |  |  |  | 
| Investment cost | [5],[6] |  |  | 1,501 |  |  |  |  |  | 
| Investments, at fair value: | [6] |  |  | $ 1,509 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, September 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6] |  |  | 2025-09 |  |  |  | 2025-09 |  | 
| Investment, basis spread, variable rate | [6],[7] |  |  | 3.50% |  |  |  | 3.50% |  | 
| Investment, interest rate, floor | [6],[7] |  |  | 9.00% |  |  |  | 9.00% |  | 
| Investment exit fee | [6],[7] |  |  | 3.00% |  |  |  | 3.00% |  | 
| Principal amount | [6] |  |  | $ 1,167 |  |  |  |  |  | 
| Investment cost | [5],[6] |  |  | 1,178 |  |  |  |  |  | 
| Investments, at fair value: | [6] |  |  | $ 1,188 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Media/Content/Info and Fever Labs, Inc., Senior Secured, September 2026, Prime + 3.50%, Floor rate 9.00%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6] |  |  | 2026-09 |  |  |  | 2026-09 |  | 
| Investment, basis spread, variable rate | [6],[7] |  |  | 3.50% |  |  |  | 3.50% |  | 
| Investment, interest rate, floor | [6],[7] |  |  | 9.00% |  |  |  | 9.00% |  | 
| Investment exit fee | [6],[7] |  |  | 4.00% |  |  |  | 4.00% |  | 
| Principal amount | [6] |  |  | $ 6,667 |  |  |  |  |  | 
| Investment cost | [5],[6] |  |  | 6,672 |  |  |  |  |  | 
| Investments, at fair value: | [6] |  |  | 6,768 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Media/Content/Info and Total Fever Labs, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  |  |  | 12,334 |  |  |  |  |  | 
| Investment cost | [5] |  |  | 12,340 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 12,469 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Medical Devices & Equipment and Senseonics Holdings, Inc., Senior Secured, September 2027, Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12] |  |  | 2027-09 |  |  |  | 2027-09 |  | 
| Investment, basis spread, variable rate | [7],[12] |  |  | 1.40% |  |  |  | 1.40% |  | 
| Investment, interest rate, floor | [7],[12] |  |  | 9.90% |  |  |  | 9.90% |  | 
| Investment exit fee | [7],[12] |  |  | 6.95% |  |  |  | 6.95% |  | 
| Principal amount | [12] |  |  | $ 21,875 |  |  |  |  |  | 
| Investment cost | [5],[12] |  |  | 21,572 |  |  |  |  |  | 
| Investments, at fair value: | [12] |  |  | $ 21,572 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software (40.39%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 40.39% |  |  |  | 40.39% |  | 
| Investment cost | [5] |  |  | $ 751,108 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 728,139 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Total Cybermaxx Intermediate Holdings, Inc., |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  |  |  | 10,501 |  |  |  |  |  | 
| Investment cost | [5] |  |  | 10,324 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 10,334 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and 3GTMS, LLC, Senior Secured, February 2025, 3-month SOFR + 6.88%, Floor rate 7.78% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[13] |  |  | 2025-02 |  |  |  | 2025-02 |  | 
| Investment, basis spread, variable rate | [7],[12] |  |  | 6.88% |  |  |  | 6.88% |  | 
| Investment, interest rate, floor | [7],[12],[13] |  |  | 7.78% |  |  |  | 7.78% |  | 
| Principal amount | [12],[13] |  |  | $ 1,990 |  |  |  |  |  | 
| Investment cost | [5],[12],[13] |  |  | 1,988 |  |  |  |  |  | 
| Investments, at fair value: | [12],[13] |  |  | $ 1,986 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and 3GTMS, LLC, Senior Secured, February 2025, 3-month SOFR + 9.70%, Floor rate 10.60% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [11],[12],[13] |  |  | 2025-02 |  |  |  | 2025-02 |  | 
| Investment, basis spread, variable rate | [7],[11],[12],[13] |  |  | 9.70% |  |  |  | 9.70% |  | 
| Investment, interest rate, floor | [7],[11],[12],[13] |  |  | 10.60% |  |  |  | 10.60% |  | 
| Principal amount | [11],[12],[13] |  |  | $ 13,110 |  |  |  |  |  | 
| Investment cost | [5],[11],[12],[13] |  |  | 13,029 |  |  |  |  |  | 
| Investments, at fair value: | [11],[12],[13] |  |  | $ 13,103 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Agilence, Inc., Senior Secured, October 2026, 1-month BSBY + 9.00%, Floor rate 10.00% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [10],[12],[13] |  |  | 2026-10 |  |  |  | 2026-10 |  | 
| Investment, basis spread, variable rate | [7],[10],[12],[13] |  |  | 9.00% |  |  |  | 9.00% |  | 
| Investment, interest rate, floor | [7],[10],[12],[13] |  |  | 10.00% |  |  |  | 10.00% |  | 
| Principal amount | [10],[12],[13] |  |  | $ 9,212 |  |  |  |  |  | 
| Investment cost | [5],[10],[12],[13] |  |  | 9,040 |  |  |  |  |  | 
| Investments, at fair value: | [10],[12],[13] |  |  | $ 9,212 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Alchemer LLC, Senior Secured, May 2028, 1-month SOFR + 8.14%, Floor rate 9.14% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[12],[13] |  |  | 2028-05 |  |  |  | 2028-05 |  | 
| Investment, basis spread, variable rate | [7],[9],[12],[13] |  |  | 8.14% |  |  |  | 8.14% |  | 
| Investment, interest rate, floor | [7],[9],[12],[13] |  |  | 9.14% |  |  |  | 9.14% |  | 
| Principal amount | [9],[12],[13] |  |  | $ 20,908 |  |  |  |  |  | 
| Investment cost | [5],[9],[12],[13] |  |  | 20,508 |  |  |  |  |  | 
| Investments, at fair value: | [9],[12],[13] |  |  | $ 21,297 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Allvue Systems, LLC, Senior Secured, September 2029, 6-month SOFR + 7.25%, Floor rate 8.25% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12] |  |  | 2029-09 |  |  |  | 2029-09 |  | 
| Investment, basis spread, variable rate | [7],[12] |  |  | 7.25% |  |  |  | 7.25% |  | 
| Investment, interest rate, floor | [7],[12] |  |  | 8.25% |  |  |  | 8.25% |  | 
| Principal amount | [12] |  |  | $ 36,410 |  |  |  |  |  | 
| Investment cost | [5],[12] |  |  | 35,530 |  |  |  |  |  | 
| Investments, at fair value: | [12] |  |  | $ 35,530 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Annex Cloud, Senior Secured, February 2027, 1-month BSBY + 9.41%, Floor rate 10.41% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[12] |  |  | 2027-02 |  |  |  | 2027-02 |  | 
| Investment, basis spread, variable rate | [7],[9],[12] |  |  | 9.41% |  |  |  | 9.41% |  | 
| Investment, interest rate, floor | [7],[9],[12] |  |  | 10.41% |  |  |  | 10.41% |  | 
| Principal amount | [9],[12] |  |  | $ 9,823 |  |  |  |  |  | 
| Investment cost | [5],[9],[12] |  |  | 9,649 |  |  |  |  |  | 
| Investments, at fair value: | [9],[12] |  |  | $ 9,761 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Automation Anywhere, Inc., Senior Secured, September 2027, Prime + 4.25%, Floor rate 9.00%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6],[11],[12] |  |  | 2027-09 |  |  |  | 2027-09 |  | 
| Investment, basis spread, variable rate | [6],[7],[11],[12] |  |  | 4.25% |  |  |  | 4.25% |  | 
| Investment, interest rate, floor | [6],[7],[11],[12] |  |  | 9.00% |  |  |  | 9.00% |  | 
| Investment exit fee | [6],[7],[11],[12] |  |  | 4.50% |  |  |  | 4.50% |  | 
| Principal amount | [6],[11],[12] |  |  | $ 19,600 |  |  |  |  |  | 
| Investment cost | [5],[6],[11],[12] |  |  | 19,345 |  |  |  |  |  | 
| Investments, at fair value: | [6],[11],[12] |  |  | $ 20,269 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Babel Street, Senior Secured, December 2027, 3-month SOFR + 7.89%, Floor rate 8.89% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[13],[14] |  |  | 2027-12 |  |  |  | 2027-12 |  | 
| Investment, basis spread, variable rate | [7],[12],[13],[14] |  |  | 7.89% |  |  |  | 7.89% |  | 
| Investment, interest rate, floor | [7],[12],[13],[14] |  |  | 8.89% |  |  |  | 8.89% |  | 
| Principal amount | [12],[13],[14] |  |  | $ 45,000 |  |  |  |  |  | 
| Investment cost | [5],[12],[13],[14] |  |  | 43,983 |  |  |  |  |  | 
| Investments, at fair value: | [12],[13],[14] |  |  | $ 44,928 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Brain Corporation, Senior Secured, April 2026, Prime + 3.70%, Floor rate 9.20%, PIK Interest 1.00%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[9],[12],[14] |  |  | 2026-04 |  |  |  | 2026-04 |  | 
| Investment, basis spread, variable rate | [7],[8],[9],[12],[14] |  |  | 3.70% |  |  |  | 3.70% |  | 
| Investment, interest rate, floor | [7],[8],[9],[12],[14] |  |  | 9.20% |  |  |  | 9.20% |  | 
| Investment, interest rate, paid in kind | [7],[8],[9],[12],[14] |  |  | 1.00% |  |  |  | 1.00% |  | 
| Investment exit fee | [7],[8],[9],[12],[14] |  |  | 3.95% |  |  |  | 3.95% |  | 
| Principal amount | [8],[9],[12],[14] |  |  | $ 30,415 |  |  |  |  |  | 
| Investment cost | [5],[8],[9],[12],[14] |  |  | 30,678 |  |  |  |  |  | 
| Investments, at fair value: | [8],[9],[12],[14] |  |  | $ 30,989 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Campaign Monitor Limited, Senior Secured, November 2025, 3-month SOFR + 9.05%, Floor rate 9.90% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6],[9] |  |  | 2025-11 |  |  |  | 2025-11 |  | 
| Investment, basis spread, variable rate | [6],[7],[9] |  |  | 9.05% |  |  |  | 9.05% |  | 
| Investment, interest rate, floor | [6],[7],[9] |  |  | 9.90% |  |  |  | 9.90% |  | 
| Principal amount | [6],[9] |  |  | $ 33,000 |  |  |  |  |  | 
| Investment cost | [5],[6],[9] |  |  | 32,706 |  |  |  |  |  | 
| Investments, at fair value: | [6],[9] |  |  | $ 33,000 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Catchpoint Systems, Inc., Senior Secured, November 2025, 3-month SOFR + 9.41%, Floor rate 11.81% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [13] |  |  | 2025-11 |  |  |  | 2025-11 |  | 
| Investment, basis spread, variable rate | [7],[13] |  |  | 9.41% |  |  |  | 9.41% |  | 
| Investment, interest rate, floor | [7],[13] |  |  | 11.81% |  |  |  | 11.81% |  | 
| Principal amount | [13] |  |  | $ 10,073 |  |  |  |  |  | 
| Investment cost | [5],[13] |  |  | 9,931 |  |  |  |  |  | 
| Investments, at fair value: | [13] |  |  | $ 9,940 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Ceros, Inc., Senior Secured, September 2026, 6-month SOFR + 8.99%, Floor rate 9.89% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[13] |  |  | 2026-09 |  |  |  | 2026-09 |  | 
| Investment, basis spread, variable rate | [7] |  |  | 8.99% |  |  |  | 8.99% |  | 
| Investment, interest rate, floor | [7],[12],[13] |  |  | 9.89% |  |  |  | 9.89% |  | 
| Principal amount | [12],[13] |  |  | $ 22,867 |  |  |  |  |  | 
| Investment cost | [5],[12],[13] |  |  | 22,498 |  |  |  |  |  | 
| Investments, at fair value: | [12],[13] |  |  | $ 23,075 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Constructor.io Corporation, Senior Secured, July 2027, 1-month SOFR + 8.44%, Floor rate 9.44% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[12],[13] |  |  | 2027-07 |  |  |  | 2027-07 |  | 
| Investment, basis spread, variable rate | [7],[9],[12],[13] |  |  | 8.44% |  |  |  | 8.44% |  | 
| Investment, interest rate, floor | [7],[9],[12],[13] |  |  | 9.44% |  |  |  | 9.44% |  | 
| Principal amount | [9],[12],[13] |  |  | $ 4,688 |  |  |  |  |  | 
| Investment cost | [5],[9],[12],[13] |  |  | 4,592 |  |  |  |  |  | 
| Investments, at fair value: | [9],[12],[13] |  |  | $ 4,790 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Convoy, Inc., Senior Secured, March 2026, Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6],[8],[23] |  |  | 2026-03 |  |  |  | 2026-03 |  | 
| Investment, basis spread, variable rate | [6],[7],[8],[23] |  |  | 3.20% |  |  |  | 3.20% |  | 
| Investment, interest rate, floor | [6],[7],[8],[23] |  |  | 6.45% |  |  |  | 6.45% |  | 
| Investment, interest rate, paid in kind | [6],[7],[8],[23] |  |  | 1.95% |  |  |  | 1.95% |  | 
| Investment exit fee | [6],[7],[8],[23] |  |  | 4.55% |  |  |  | 4.55% |  | 
| Principal amount | [6],[8],[23] |  |  | $ 31,049 |  |  |  |  |  | 
| Investment cost | [5],[6],[8],[23] |  |  | 30,916 |  |  |  |  |  | 
| Investments, at fair value: | [6],[8],[23] |  |  | $ 0 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Copper CRM, Inc, Senior Secured, March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 3.96% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[11] |  |  | 2025-03 |  |  |  | 2025-03 |  | 
| Investment, basis spread, variable rate | [7],[8],[11] |  |  | 4.50% |  |  |  | 4.50% |  | 
| Investment, interest rate, floor | [7],[8],[11] |  |  | 8.25% |  |  |  | 8.25% |  | 
| Investment, interest rate, cap | [7],[8],[11] |  |  | 10.25% |  |  |  | 10.25% |  | 
| Investment, interest rate, paid in kind | [7],[8],[11] |  |  | 1.95% |  |  |  | 1.95% |  | 
| Investment exit fee | [7],[8],[11] |  |  | 3.96% |  |  |  | 3.96% |  | 
| Principal amount | [8],[11] |  |  | $ 9,141 |  |  |  |  |  | 
| Investment cost | [5],[8],[11] |  |  | 9,307 |  |  |  |  |  | 
| Investments, at fair value: | [8],[11] |  |  | $ 9,153 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Cutover, Inc., Senior Secured, October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [10],[12],[15],[16] |  |  | 2025-10 |  |  |  | 2025-10 |  | 
| Investment, basis spread, variable rate | [7],[10],[12],[15],[16] |  |  | 5.20% |  |  |  | 5.20% |  | 
| Investment, interest rate, floor | [7],[10],[12],[15],[16] |  |  | 9.95% |  |  |  | 9.95% |  | 
| Investment exit fee | [7],[10],[12],[15],[16] |  |  | 4.95% |  |  |  | 4.95% |  | 
| Principal amount | [10],[12],[15],[16] |  |  | $ 5,500 |  |  |  |  |  | 
| Investment cost | [5],[10],[12],[15],[16] |  |  | 5,544 |  |  |  |  |  | 
| Investments, at fair value: | [10],[12],[15],[16] |  |  | $ 5,715 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, August 2026, 6-month SOFR + 12.36%, Floor rate 13.11% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12] |  |  | 2026-08 |  |  |  | 2026-08 |  | 
| Investment, basis spread, variable rate | [7],[12] |  |  | 12.36% |  |  |  | 12.36% |  | 
| Investment, interest rate, floor | [7],[12] |  |  | 13.11% |  |  |  | 13.11% |  | 
| Principal amount | [12] |  |  | $ 2,546 |  |  |  |  |  | 
| Investment cost | [5],[12] |  |  | 2,494 |  |  |  |  |  | 
| Investments, at fair value: | [12] |  |  | $ 2,556 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, August 2026, 6-month SOFR + 8.63%, Floor rate 9.38% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[12] |  |  | 2026-08 |  |  |  | 2026-08 |  | 
| Investment, basis spread, variable rate | [7],[9],[12] |  |  | 8.63% |  |  |  | 8.63% |  | 
| Investment, interest rate, floor | [7],[9],[12] |  |  | 9.38% |  |  |  | 9.38% |  | 
| Principal amount | [9],[12] |  |  | $ 7,955 |  |  |  |  |  | 
| Investment cost | [5],[9],[12] |  |  | 7,830 |  |  |  |  |  | 
| Investments, at fair value: | [9],[12] |  |  | $ 7,778 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Dashlane, Inc., Senior Secured, December 2027, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 7.26% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6],[9],[11],[12] |  |  | 2027-12 |  |  |  | 2027-12 |  | 
| Investment, basis spread, variable rate | [6],[7],[9],[11],[12] |  |  | 3.05% |  |  |  | 3.05% |  | 
| Investment, interest rate, floor | [6],[7],[9],[11],[12] |  |  | 11.55% |  |  |  | 11.55% |  | 
| Investment, interest rate, paid in kind | [6],[7],[9],[11],[12] |  |  | 1.10% |  |  |  | 1.10% |  | 
| Investment exit fee | [6],[7],[9],[11],[12] |  |  | 7.26% |  |  |  | 7.26% |  | 
| Principal amount | [6],[9],[11],[12] |  |  | $ 42,863 |  |  |  |  |  | 
| Investment cost | [5],[6],[9],[11],[12] |  |  | 43,087 |  |  |  |  |  | 
| Investments, at fair value: | [6],[9],[11],[12] |  |  | $ 43,087 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Dispatch Technologies, Inc., Senior Secured, April 2028, 3-month SOFR + 8.01%, Floor rate 8.76% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[13] |  |  | 2028-04 |  |  |  | 2028-04 |  | 
| Investment, basis spread, variable rate | [7],[12],[13] |  |  | 8.01% |  |  |  | 8.01% |  | 
| Investment, interest rate, floor | [7],[12],[13] |  |  | 8.76% |  |  |  | 8.76% |  | 
| Principal amount | [12],[13] |  |  | $ 8,125 |  |  |  |  |  | 
| Investment cost | [5],[12],[13] |  |  | 7,949 |  |  |  |  |  | 
| Investments, at fair value: | [12],[13] |  |  | $ 8,127 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and DroneDeploy, Inc., Senior Secured, July 2026, Prime + 4.50%, Floor rate 8.75%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12] |  |  | 2026-07 |  |  |  | 2026-07 |  | 
| Investment, basis spread, variable rate | [7],[12] |  |  | 4.50% |  |  |  | 4.50% |  | 
| Investment, interest rate, floor | [7],[12] |  |  | 8.75% |  |  |  | 8.75% |  | 
| Investment exit fee | [7],[12] |  |  | 4.00% |  |  |  | 4.00% |  | 
| Principal amount | [12] |  |  | $ 6,250 |  |  |  |  |  | 
| Investment cost | [5],[12] |  |  | 6,083 |  |  |  |  |  | 
| Investments, at fair value: | [12] |  |  | $ 6,153 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Eigen Technologies Ltd., Senior Secured, April 2025, Prime + 5.10%, Floor rate 8.35%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [15],[16] |  |  | 2025-04 |  |  |  | 2025-04 |  | 
| Investment, basis spread, variable rate | [7],[15],[16] |  |  | 5.10% |  |  |  | 5.10% |  | 
| Investment, interest rate, floor | [7],[15],[16] |  |  | 8.35% |  |  |  | 8.35% |  | 
| Investment exit fee | [7],[15],[16] |  |  | 2.95% |  |  |  | 2.95% |  | 
| Principal amount | [15],[16] |  |  | $ 3,750 |  |  |  |  |  | 
| Investment cost | [5],[15],[16] |  |  | 3,801 |  |  |  |  |  | 
| Investments, at fair value: | [15],[16] |  |  | $ 3,730 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Elation Health, Inc., Senior Secured, March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6],[8],[12] |  |  | 2026-03 |  |  |  | 2026-03 |  | 
| Investment, basis spread, variable rate | [6],[7],[8],[12] |  |  | 4.25% |  |  |  | 4.25% |  | 
| Investment, interest rate, floor | [6],[7],[8],[12] |  |  | 9.00% |  |  |  | 9.00% |  | 
| Investment, interest rate, paid in kind | [6],[7],[8],[12] |  |  | 1.95% |  |  |  | 1.95% |  | 
| Investment exit fee | [6],[7],[8],[12] |  |  | 3.95% |  |  |  | 3.95% |  | 
| Principal amount | [6],[8],[12] |  |  | $ 12,629 |  |  |  |  |  | 
| Investment cost | [5],[6],[8],[12] |  |  | 12,253 |  |  |  |  |  | 
| Investments, at fair value: | [6],[8],[12] |  |  | $ 12,692 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Enmark Systems, Inc., Senior Secured, September 2026, 3-month SOFR + 6.73%, Floor rate 7.73%, PIK Interest 2.13% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[11],[12],[13] |  |  | 2026-09 |  |  |  | 2026-09 |  | 
| Investment, basis spread, variable rate | [7],[8],[11],[13] |  |  | 6.73% |  |  |  | 6.73% |  | 
| Investment, interest rate, floor | [7],[8],[11],[12],[13] |  |  | 7.73% |  |  |  | 7.73% |  | 
| Investment, interest rate, paid in kind | [7],[8],[11],[12],[13] |  |  | 2.13% |  |  |  | 2.13% |  | 
| Principal amount | [8],[11],[12],[13] |  |  | $ 8,363 |  |  |  |  |  | 
| Investment cost | [5],[8],[11],[12],[13] |  |  | 8,230 |  |  |  |  |  | 
| Investments, at fair value: | [8],[11],[12],[13] |  |  | $ 8,363 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Flight Schedule Pro, LLC, Senior Secured, October 2027, 1-month SOFR + 7.80%, Floor rate 8.70% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[13] |  |  | 2027-10 |  |  |  | 2027-10 |  | 
| Investment, basis spread, variable rate | [7],[12],[13] |  |  | 7.80% |  |  |  | 7.80% |  | 
| Investment, interest rate, floor | [7],[12],[13] |  |  | 8.70% |  |  |  | 8.70% |  | 
| Principal amount | [12],[13] |  |  | $ 6,587 |  |  |  |  |  | 
| Investment cost | [5],[12],[13] |  |  | 6,420 |  |  |  |  |  | 
| Investments, at fair value: | [12],[13] |  |  | $ 6,553 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Fortified Health Security, Senior Secured, December 2027, 1-month SOFR + 7.64%, Floor rate 8.54% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [11],[12],[13] |  |  | 2027-12 |  |  |  | 2027-12 |  | 
| Investment, basis spread, variable rate | [7],[11],[12],[13] |  |  | 7.64% |  |  |  | 7.64% |  | 
| Investment, interest rate, floor | [7],[11],[12],[13] |  |  | 8.54% |  |  |  | 8.54% |  | 
| Principal amount | [11],[12],[13] |  |  | $ 7,000 |  |  |  |  |  | 
| Investment cost | [5],[11],[12],[13] |  |  | 6,851 |  |  |  |  |  | 
| Investments, at fair value: | [11],[12],[13] |  |  | $ 6,910 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Ikon Science Limited, Senior Secured, October 2024, 3-month SOFR + 9.26%, Floor rate 10.00% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[13],[15],[16] |  |  | 2024-10 |  |  |  | 2024-10 |  | 
| Investment, basis spread, variable rate | [7],[12],[13],[15],[16] |  |  | 9.26% |  |  |  | 9.26% |  | 
| Investment, interest rate, floor | [7],[12],[13],[15],[16] |  |  | 10.00% |  |  |  | 10.00% |  | 
| Principal amount | [12],[13],[15],[16] |  |  | $ 6,213 |  |  |  |  |  | 
| Investment cost | [5],[12],[13],[15],[16] |  |  | 6,148 |  |  |  |  |  | 
| Investments, at fair value: | [12],[13],[15],[16] |  |  | $ 6,148 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Khoros (p.k.a Lithium Technologies), Senior Secured, January 2025, 3-month SOFR + 4.50%, Floor rate 5.50%, PIK Interest 4.50% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8] |  |  | 2025-01 |  |  |  | 2025-01 |  | 
| Investment, basis spread, variable rate | [7],[8] |  |  | 4.50% |  |  |  | 4.50% |  | 
| Investment, interest rate, floor | [7],[8] |  |  | 5.50% |  |  |  | 5.50% |  | 
| Investment, interest rate, paid in kind | [7],[8] |  |  | 4.50% |  |  |  | 4.50% |  | 
| Principal amount | [8] |  |  | $ 57,770 |  |  |  |  |  | 
| Investment cost | [5],[8] |  |  | 57,730 |  |  |  |  |  | 
| Investments, at fair value: | [8] |  |  | $ 56,293 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Leapwork ApS, Senior Secured, February 2026, Prime + 0.25%, Floor rate 7.25%, PIK Interest 1.95%, 2.70% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[10],[12],[15],[16] |  |  | 2026-02 |  |  |  | 2026-02 |  | 
| Investment, basis spread, variable rate | [7],[8],[10],[12],[15],[16] |  |  | 0.25% |  |  |  | 0.25% |  | 
| Investment, interest rate, floor | [7],[8],[10],[12],[15],[16] |  |  | 7.25% |  |  |  | 7.25% |  | 
| Investment, interest rate, paid in kind | [7],[8],[10],[12],[15],[16] |  |  | 1.95% |  |  |  | 1.95% |  | 
| Investment exit fee | [7],[8],[10],[12],[15],[16] |  |  | 2.70% |  |  |  | 2.70% |  | 
| Principal amount | [8],[10],[12],[15],[16] |  |  | $ 3,813 |  |  |  |  |  | 
| Investment cost | [5],[8],[10],[12],[15],[16] |  |  | 3,810 |  |  |  |  |  | 
| Investments, at fair value: | [8],[10],[12],[15],[16] |  |  | $ 3,907 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and LinenMaster, LLC, Senior Secured, August 2028, 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[12] |  |  | 2028-08 |  |  |  | 2028-08 |  | 
| Investment, basis spread, variable rate | [7],[8],[12] |  |  | 6.25% |  |  |  | 6.25% |  | 
| Investment, interest rate, floor | [7],[8],[12] |  |  | 7.25% |  |  |  | 7.25% |  | 
| Investment, interest rate, paid in kind | [7],[8],[12] |  |  | 2.15% |  |  |  | 2.15% |  | 
| Principal amount | [8],[12] |  |  | $ 15,083 |  |  |  |  |  | 
| Investment cost | [5],[8],[12] |  |  | 14,799 |  |  |  |  |  | 
| Investments, at fair value: | [8],[12] |  |  | $ 14,799 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Loftware, Inc., Senior Secured, March 2028, 3-month SOFR + 7.88%, Floor rate 8.88% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[13] |  |  | 2028-03 |  |  |  | 2028-03 |  | 
| Investment, basis spread, variable rate | [7],[12],[13] |  |  | 7.88% |  |  |  | 7.88% |  | 
| Investment, interest rate, floor | [7],[12],[13] |  |  | 8.88% |  |  |  | 8.88% |  | 
| Principal amount | [12],[13] |  |  | $ 26,469 |  |  |  |  |  | 
| Investment cost | [5],[12],[13] |  |  | 25,897 |  |  |  |  |  | 
| Investments, at fair value: | [12],[13] |  |  | $ 26,566 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and LogicSource, Senior Secured, July 2027, 3-month SOFR + 8.93%, Floor rate 9.93% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[13] |  |  | 2027-07 |  |  |  | 2027-07 |  | 
| Investment, basis spread, variable rate | [7],[12],[13] |  |  | 8.93% |  |  |  | 8.93% |  | 
| Investment, interest rate, floor | [7],[12],[13] |  |  | 9.93% |  |  |  | 9.93% |  | 
| Principal amount | [12],[13] |  |  | $ 13,300 |  |  |  |  |  | 
| Investment cost | [5],[12],[13] |  |  | 13,074 |  |  |  |  |  | 
| Investments, at fair value: | [12],[13] |  |  | $ 13,493 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Mobile Solutions Services, Senior Secured, December 2025, 6-month SOFR + 9.31%, Floor rate 10.06% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [13] |  |  | 2025-12 |  |  |  | 2025-12 |  | 
| Investment, basis spread, variable rate | [7],[13] |  |  | 9.31% |  |  |  | 9.31% |  | 
| Investment, interest rate, floor | [7],[13] |  |  | 10.06% |  |  |  | 10.06% |  | 
| Principal amount | [13] |  |  | $ 18,366 |  |  |  |  |  | 
| Investment cost | [5],[13] |  |  | 18,116 |  |  |  |  |  | 
| Investments, at fair value: | [13] |  |  | $ 18,176 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and New Relic, Inc., Senior Secured, November 2030, 3-month SOFR + 6.75%, Floor rate 7.75% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12] |  |  | 2030-11 |  |  |  | 2030-11 |  | 
| Investment, basis spread, variable rate | [7],[12] |  |  | 6.75% |  |  |  | 6.75% |  | 
| Investment, interest rate, floor | [7],[12] |  |  | 7.75% |  |  |  | 7.75% |  | 
| Principal amount | [12] |  |  | $ 20,890 |  |  |  |  |  | 
| Investment cost | [5],[12] |  |  | 20,375 |  |  |  |  |  | 
| Investments, at fair value: | [12] |  |  | $ 20,375 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Omeda Holdings, LLC, Senior Secured, July 2027, 3-month SOFR + 8.05%, Floor rate 9.05% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [11],[12],[13] |  |  | 2027-07 |  |  |  | 2027-07 |  | 
| Investment, basis spread, variable rate | [7],[11],[12],[13] |  |  | 8.05% |  |  |  | 8.05% |  | 
| Investment, interest rate, floor | [7],[11],[12],[13] |  |  | 9.05% |  |  |  | 9.05% |  | 
| Principal amount | [11],[12],[13] |  |  | $ 7,706 |  |  |  |  |  | 
| Investment cost | [5],[11],[12],[13] |  |  | 7,508 |  |  |  |  |  | 
| Investments, at fair value: | [11],[12],[13] |  |  | $ 7,702 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Onna Technologies, Inc., Senior Secured, March 2026, Prime + 1.35%, Floor rate 8.85%, PIK Interest 1.75%, 4.45% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8] |  |  | 2026-03 |  |  |  | 2026-03 |  | 
| Investment, basis spread, variable rate | [7],[8] |  |  | 1.35% |  |  |  | 1.35% |  | 
| Investment, interest rate, floor | [7],[8] |  |  | 8.85% |  |  |  | 8.85% |  | 
| Investment, interest rate, paid in kind | [7],[8] |  |  | 1.75% |  |  |  | 1.75% |  | 
| Investment exit fee | [7],[8] |  |  | 4.45% |  |  |  | 4.45% |  | 
| Principal amount | [8] |  |  | $ 3,853 |  |  |  |  |  | 
| Investment cost | [5],[8] |  |  | 3,814 |  |  |  |  |  | 
| Investments, at fair value: | [8] |  |  | $ 3,810 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Salary.com, LLC, Senior Secured, September 2027, 3-month SOFR + 8.00%, Floor rate 9.00% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [13] |  |  | 2027-09 |  |  |  | 2027-09 |  | 
| Investment, basis spread, variable rate | [7],[13] |  |  | 8.00% |  |  |  | 8.00% |  | 
| Investment, interest rate, floor | [7],[13] |  |  | 9.00% |  |  |  | 9.00% |  | 
| Principal amount | [13] |  |  | $ 22,185 |  |  |  |  |  | 
| Investment cost | [5],[13] |  |  | 21,814 |  |  |  |  |  | 
| Investments, at fair value: | [13] |  |  | $ 22,048 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and ShadowDragon, LLC, Senior Secured, December 2026, 1-month SOFR + 9.01%, Floor rate 9.91% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[13] |  |  | 2026-12 |  |  |  | 2026-12 |  | 
| Investment, basis spread, variable rate | [7],[12],[13] |  |  | 9.01% |  |  |  | 9.01% |  | 
| Investment, interest rate, floor | [7],[12],[13] |  |  | 9.91% |  |  |  | 9.91% |  | 
| Principal amount | [12],[13] |  |  | $ 6,000 |  |  |  |  |  | 
| Investment cost | [5],[12],[13] |  |  | 5,883 |  |  |  |  |  | 
| Investments, at fair value: | [12],[13] |  |  | $ 5,921 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Simon Data, Inc., Senior Secured, March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.92% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[10] |  |  | 2027-03 |  |  |  | 2027-03 |  | 
| Investment, basis spread, variable rate | [7],[8],[10] |  |  | 1.00% |  |  |  | 1.00% |  | 
| Investment, interest rate, floor | [7],[8],[10] |  |  | 8.75% |  |  |  | 8.75% |  | 
| Investment, interest rate, paid in kind | [7],[8],[10] |  |  | 1.95% |  |  |  | 1.95% |  | 
| Investment exit fee | [7],[8],[10] |  |  | 2.92% |  |  |  | 2.92% |  | 
| Principal amount | [8],[10] |  |  | $ 15,065 |  |  |  |  |  | 
| Investment cost | [5],[8],[10] |  |  | 14,982 |  |  |  |  |  | 
| Investments, at fair value: | [8],[10] |  |  | $ 15,037 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Sisense Ltd., Senior Secured, July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[15],[16] |  |  | 2027-07 |  |  |  | 2027-07 |  | 
| Investment, basis spread, variable rate | [7],[8],[15],[16] |  |  | 1.50% |  |  |  | 1.50% |  | 
| Investment, interest rate, floor | [7],[8],[15],[16] |  |  | 9.50% |  |  |  | 9.50% |  | 
| Investment, interest rate, paid in kind | [7],[8],[15],[16] |  |  | 1.95% |  |  |  | 1.95% |  | 
| Investment exit fee | [7],[8],[15],[16] |  |  | 5.95% |  |  |  | 5.95% |  | 
| Principal amount | [8],[15],[16] |  |  | $ 34,830 |  |  |  |  |  | 
| Investment cost | [5],[8],[15],[16] |  |  | 34,584 |  |  |  |  |  | 
| Investments, at fair value: | [8],[15],[16] |  |  | $ 34,881 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Streamline Healthcare Solutions, Senior Secured, March 2028, 3-month SOFR + 7.25%, Floor rate 8.25% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[13] |  |  | 2028-03 |  |  |  | 2028-03 |  | 
| Investment, basis spread, variable rate | [7],[12],[13] |  |  | 7.25% |  |  |  | 7.25% |  | 
| Investment, interest rate, floor | [7],[12],[13] |  |  | 8.25% |  |  |  | 8.25% |  | 
| Principal amount | [12],[13] |  |  | $ 13,200 |  |  |  |  |  | 
| Investment cost | [5],[12],[13] |  |  | 12,953 |  |  |  |  |  | 
| Investments, at fair value: | [12],[13] |  |  | $ 13,327 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Sumo Logic, Inc., Senior Secured, May 2030, 3-month SOFR + 6.50%, Floor rate 7.50% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12] |  |  | 2030-05 |  |  |  | 2030-05 |  | 
| Investment, basis spread, variable rate | [7],[12] |  |  | 6.50% |  |  |  | 6.50% |  | 
| Investment, interest rate, floor | [7],[12] |  |  | 7.50% |  |  |  | 7.50% |  | 
| Principal amount | [12] |  |  | $ 23,000 |  |  |  |  |  | 
| Investment cost | [5],[12] |  |  | 22,460 |  |  |  |  |  | 
| Investments, at fair value: | [12] |  |  | $ 23,105 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Suzy, Inc., Senior Secured, August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[12],[14] |  |  | 2027-08 |  |  |  | 2027-08 |  | 
| Investment, basis spread, variable rate | [7],[8],[12],[14] |  |  | 1.75% |  |  |  | 1.75% |  | 
| Investment, interest rate, floor | [7],[8],[12],[14] |  |  | 10.00% |  |  |  | 10.00% |  | 
| Investment, interest rate, paid in kind | [7],[8],[12],[14] |  |  | 1.95% |  |  |  | 1.95% |  | 
| Investment exit fee | [7],[8],[12],[14] |  |  | 3.45% |  |  |  | 3.45% |  | 
| Principal amount | [8],[12],[14] |  |  | $ 12,064 |  |  |  |  |  | 
| Investment cost | [5],[8],[12],[14] |  |  | 11,837 |  |  |  |  |  | 
| Investments, at fair value: | [8],[12],[14] |  |  | $ 11,837 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and ThreatConnect, Inc., Senior Secured, May 2026, 6-month SOFR + 9.25%, Floor rate 10.00% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[13] |  |  | 2026-05 |  |  |  | 2026-05 |  | 
| Investment, basis spread, variable rate | [7],[12],[13] |  |  | 9.25% |  |  |  | 9.25% |  | 
| Investment, interest rate, floor | [7],[12],[13] |  |  | 10.00% |  |  |  | 10.00% |  | 
| Principal amount | [12],[13] |  |  | $ 10,920 |  |  |  |  |  | 
| Investment cost | [5],[12],[13] |  |  | 10,730 |  |  |  |  |  | 
| Investments, at fair value: | [12],[13] |  |  | $ 10,920 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Tipalti Solutions Ltd., Senior Secured, April 2027, Prime + 0.45%, Floor rate 7.95%, PIK Interest 2.00%, 3.75% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[12],[15],[16] |  |  | 2027-04 |  |  |  | 2027-04 |  | 
| Investment, basis spread, variable rate | [7],[8],[12],[15],[16] |  |  | 0.45% |  |  |  | 0.45% |  | 
| Investment, interest rate, floor | [7],[8],[12],[15],[16] |  |  | 7.95% |  |  |  | 7.95% |  | 
| Investment, interest rate, paid in kind | [7],[8],[12],[15],[16] |  |  | 2.00% |  |  |  | 2.00% |  | 
| Investment exit fee | [7],[8],[12],[15],[16] |  |  | 3.75% |  |  |  | 3.75% |  | 
| Principal amount | [8],[12],[15],[16] |  |  | $ 10,649 |  |  |  |  |  | 
| Investment cost | [5],[8],[12],[15],[16] |  |  | 10,578 |  |  |  |  |  | 
| Investments, at fair value: | [8],[12],[15],[16] |  |  | 10,835 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Total 3GTMS, LLC |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  |  |  | 15,100 |  |  |  |  |  | 
| Investment cost | [5] |  |  | 15,017 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 15,089 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Zappi, Inc., Senior Secured, December 2027, 3-month SOFR + 8.03%, Floor rate 9.03% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [9],[12],[13],[15],[16] |  |  | 2027-12 |  |  |  | 2027-12 |  | 
| Investment, basis spread, variable rate | [7],[9],[12],[13],[15],[16] |  |  | 8.03% |  |  |  | 8.03% |  | 
| Investment, interest rate, floor | [7],[9],[12],[13],[15],[16] |  |  | 9.03% |  |  |  | 9.03% |  | 
| Principal amount | [9],[12],[13],[15],[16] |  |  | $ 9,000 |  |  |  |  |  | 
| Investment cost | [5],[9],[12],[13],[15],[16] |  |  | 8,816 |  |  |  |  |  | 
| Investments, at fair value: | [9],[12],[13],[15],[16] |  |  | $ 8,967 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and Zimperium, Inc., Senior Secured, May 2027, 3-month SOFR + 8.31%, Floor rate 9.31% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [12],[13] |  |  | 2027-05 |  |  |  | 2027-05 |  | 
| Investment, basis spread, variable rate | [7],[12],[13] |  |  | 8.31% |  |  |  | 8.31% |  | 
| Investment, interest rate, floor | [7],[12],[13] |  |  | 9.31% |  |  |  | 9.31% |  | 
| Principal amount | [12],[13] |  |  | $ 16,313 |  |  |  |  |  | 
| Investment cost | [5],[12],[13] |  |  | 16,057 |  |  |  |  |  | 
| Investments, at fair value: | [12],[13] |  |  | $ 16,394 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Software and iGrafx, LLC, Senior Secured, May 2027, 1-month SOFR + 8.66%, Floor rate 9.56% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [13] |  |  | 2027-05 |  |  |  | 2027-05 |  | 
| Investment, basis spread, variable rate | [7],[13] |  |  | 8.66% |  |  |  | 8.66% |  | 
| Investment, interest rate, floor | [7],[13] |  |  | 9.56% |  |  |  | 9.56% |  | 
| Principal amount | [13] |  |  | $ 5,000 |  |  |  |  |  | 
| Investment cost | [5],[13] |  |  | 4,901 |  |  |  |  |  | 
| Investments, at fair value: | [13] |  |  | $ 4,901 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Sustainable and Renewable Technology (0.31%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.31% |  |  |  | 0.31% |  | 
| Investment cost | [5] |  |  | $ 5,634 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 5,617 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.78% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [8],[9] |  |  | 2025-05 |  |  |  | 2025-05 |  | 
| Investment, basis spread, variable rate | [7],[8],[9] |  |  | 4.70% |  |  |  | 4.70% |  | 
| Investment, interest rate, floor | [7],[8],[9] |  |  | 7.95% |  |  |  | 7.95% |  | 
| Investment, interest rate, paid in kind | [7],[8],[9] |  |  | 1.45% |  |  |  | 1.45% |  | 
| Investment exit fee | [7],[8],[9] |  |  | 3.78% |  |  |  | 3.78% |  | 
| Principal amount | [8],[9] |  |  | $ 3,926 |  |  |  |  |  | 
| Investment cost | [5],[8],[9] |  |  | 3,952 |  |  |  |  |  | 
| Investments, at fair value: | [8],[9] |  |  | $ 3,939 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investment Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, June 2027, FIXED 10.00% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [6] |  |  | 2027-06 |  |  |  | 2027-06 |  | 
| Investment, interest rate, paid in cash | [6],[7] |  |  | 10.00% |  |  |  | 10.00% |  | 
| Principal amount | [6] |  |  | $ 1,682 |  |  |  |  |  | 
| Investment cost | [5],[6] |  |  | 1,682 |  |  |  |  |  | 
| Investments, at fair value: | [6] |  |  | $ 1,678 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments (179.38%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 179.38% |  |  |  | 179.38% |  |  |  | 
| Investment cost | [2] | $ 3,383,664 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 3,382,970 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (2.57%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 2.57% |  |  |  | 2.57% |  |  |  | 
| Investment cost | [2] | $ 47,367 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 48,521 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and Alamar Biosciences, Inc. Senior Secured, Maturity Date June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[26],[27] | 2026-06 |  |  |  | 2026-06 |  |  |  | 
| Investment, basis spread, variable rate | [25],[26],[27],[28] | 3.00% |  |  |  | 3.00% |  |  |  | 
| Investment, interest rate, floor | [25],[26],[27],[28] | 6.50% |  |  |  | 6.50% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[26],[27],[28] | 1.00% |  |  |  | 1.00% |  |  |  | 
| Investment exit fee | [25],[26],[27],[28] | 5.95% |  |  |  | 5.95% |  |  |  | 
| Principal amount | [25],[26],[27] | $ 15,087 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[26],[27] | 15,223 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[26],[27] | $ 15,714 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, Maturity Date January 2027, Prime + 2.15%, Floor rate 9.15%, 7.85% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [27] | 2027-01 |  |  |  | 2027-01 |  |  |  | 
| Investment, basis spread, variable rate | [27],[28] | 2.15% |  |  |  | 2.15% |  |  |  | 
| Investment, interest rate, floor | [27],[28] | 9.15% |  |  |  | 9.15% |  |  |  | 
| Investment exit fee | [27],[28] | 7.85% |  |  |  | 7.85% |  |  |  | 
| Principal amount | [27] | $ 32,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[27] | 32,144 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [27] | $ 32,807 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Communications & Networking (1.56%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 1.56% |  |  |  | 1.56% |  |  |  | 
| Investment cost | [2] | $ 28,334 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 29,350 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Communications & Networking and Aryaka Networks, Inc. Senior Secured, Maturity Date July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[27],[29] | 2026-07 |  |  |  | 2026-07 |  |  |  | 
| Investment, basis spread, variable rate | [25],[27],[28],[29] | 3.25% |  |  |  | 3.25% |  |  |  | 
| Investment, interest rate, floor | [25],[27],[28],[29] | 6.75% |  |  |  | 6.75% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[27],[28],[29] | 1.05% |  |  |  | 1.05% |  |  |  | 
| Investment exit fee | [25],[27],[28],[29] | 3.55% |  |  |  | 3.55% |  |  |  | 
| Principal amount | [25],[27],[29] | $ 25,215 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[27],[29] | 25,097 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[27],[29] | $ 26,113 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Communications & Networking and Cytracom Holdings LLC Senior Secured, Maturity Date February 2025, 3-month SOFR + 10.50%, Floor rate 11.40% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [30],[31],[32] | 2025-02 |  |  |  | 2025-02 |  |  |  | 
| Investment, basis spread, variable rate | [28],[30],[31],[32] | 10.50% |  |  |  | 10.50% |  |  |  | 
| Investment, interest rate, floor | [28],[30],[31],[32] | 11.40% |  |  |  | 11.40% |  |  |  | 
| Principal amount | [30],[31],[32] | $ 3,260 |  |  |  |  |  |  |  | 
| Investment cost | [2],[30],[31],[32] | 3,237 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [30],[31],[32] | $ 3,237 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services (27.71%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 27.71% |  |  |  | 27.71% |  |  |  | 
| Investment cost | [2] | $ 518,659 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 522,600 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Altumint, Inc. Senior Secured, Maturity Date December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[31] | 2027-12 |  |  |  | 2027-12 |  |  |  | 
| Investment, basis spread, variable rate | [1],[28],[31] | 3.65% |  |  |  | 3.65% |  |  |  | 
| Investment, interest rate, floor | [1],[28],[31] | 12.15% |  |  |  | 12.15% |  |  |  | 
| Investment exit fee | [1],[28],[31] | 2.50% |  |  |  | 2.50% |  |  |  | 
| Principal amount | [1],[31] | $ 10,000 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[31] | 9,921 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[31] | $ 9,921 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and AppDirect, Inc. Senior Secured, Maturity Date April 2026, Prime + 5.50%, Floor rate 8.75%, 7.12% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [27] | 2026-04 |  |  |  | 2026-04 |  |  |  | 
| Investment, basis spread, variable rate | [27],[28] | 5.50% |  |  |  | 5.50% |  |  |  | 
| Investment, interest rate, floor | [27],[28] | 8.75% |  |  |  | 8.75% |  |  |  | 
| Investment exit fee | [27],[28] | 7.12% |  |  |  | 7.12% |  |  |  | 
| Principal amount | [27] | $ 55,790 |  |  |  |  |  |  |  | 
| Investment cost | [2],[27] | 57,914 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [27] | $ 60,132 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Carwow LTD Senior Secured, Maturity Date December 2027, Prime + 4.70%, Floor rate 11.45%, PIK Interest 1.45%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[33],[34] | 2027-12 |  |  |  | 2027-12 |  |  |  | 
| Investment, basis spread, variable rate | [25],[28],[33],[34] | 4.70% |  |  |  | 4.70% |  |  |  | 
| Investment, interest rate, floor | [25],[28],[33],[34] | 11.45% |  |  |  | 11.45% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[28],[33],[34] | 1.45% |  |  |  | 1.45% |  |  |  | 
| Investment exit fee | [25],[28],[33],[34] | 4.95% |  |  |  | 4.95% |  |  |  | 
| Principal amount | £ | [25],[33],[34] |  |  |  |  | £ 20,137 |  |  |  | 
| Investment cost | [2],[25],[33],[34] | $ 27,388 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[33],[34] | $ 25,426 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 8.50% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[35] | 2028-05 |  |  |  | 2028-05 |  |  |  | 
| Investment, interest rate, paid in kind | [25],[28],[35] | 8.50% |  |  |  | 8.50% |  |  |  | 
| Principal amount | [25],[35] | $ 23,841 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[35] | 23,841 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[35] | $ 24,227 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date February 2025, 1-month SOFR + 8.86, Floor rate 9.75%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [33],[34] | 2025-02 |  |  |  | 2025-02 |  |  |  | 
| Investment, basis spread, variable rate | [28],[33],[34] | 8.86% |  |  |  | 8.86% |  |  |  | 
| Investment, interest rate, floor | [28],[33],[34] | 9.75% |  |  |  | 9.75% |  |  |  | 
| Investment exit fee | [28],[33],[34] | 3.00% |  |  |  | 3.00% |  |  |  | 
| Principal amount | [33],[34] | $ 14,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[33],[34] | 14,161 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [33],[34] | $ 14,161 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Plentific Ltd. Senior Secured, Maturity Date October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[33],[34] | 2026-10 |  |  |  | 2026-10 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[33],[34] | 2.55% |  |  |  | 2.55% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[33],[34] | 11.05% |  |  |  | 11.05% |  |  |  | 
| Investment exit fee | [28],[31],[33],[34] | 2.95% |  |  |  | 2.95% |  |  |  | 
| Principal amount | [31],[33],[34] | $ 875 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[33],[34] | 857 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[33],[34] | $ 863 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Provi, Senior Secured, Maturity Date December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1] | 2026-12 |  |  |  | 2026-12 |  |  |  | 
| Investment, basis spread, variable rate | [1],[28] | 4.40% |  |  |  | 4.40% |  |  |  | 
| Investment, interest rate, floor | [1],[28] | 10.65% |  |  |  | 10.65% |  |  |  | 
| Investment exit fee | [1],[28] | 2.95% |  |  |  | 2.95% |  |  |  | 
| Principal amount | [1] | $ 15,000 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2] | 14,948 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1] | $ 15,228 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, Maturity Date December 2026, 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[25],[26] | 2026-12 |  |  |  | 2026-12 |  |  |  | 
| Investment, basis spread, variable rate | [1],[25],[26],[28] | 5.50% |  |  |  | 5.50% |  |  |  | 
| Investment, interest rate, floor | [1],[25],[26],[28] | 6.50% |  |  |  | 6.50% |  |  |  | 
| Investment, interest rate, paid in kind | [1],[25],[26],[28] | 4.00% |  |  |  | 4.00% |  |  |  | 
| Principal amount | [1],[25],[26] | $ 29,169 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[25],[26] | 28,742 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[25],[26] | $ 29,299 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Rhino Labs, Inc. Senior Secured, Maturity Date June 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[25] | 2024-06 |  |  |  | 2024-06 |  |  |  | 
| Investment, basis spread, variable rate | [1],[25],[28] | 5.50% |  |  |  | 5.50% |  |  |  | 
| Investment, interest rate, floor | [1],[25],[28] | 8.75% |  |  |  | 8.75% |  |  |  | 
| Investment, interest rate, paid in kind | [1],[25],[28] | 2.25% |  |  |  | 2.25% |  |  |  | 
| Principal amount | [1],[25] | $ 3,019 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[25] | 3,017 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[25] | $ 3,025 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Riviera Partners LLC. Senior Secured, Maturity Date April 2027, 3-month SOFR + 8.26%, Floor rate 9.26% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[32] | 2027-04 |  |  |  | 2027-04 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[32] | 8.26% |  |  |  | 8.26% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[32] | 9.26% |  |  |  | 9.26% |  |  |  | 
| Principal amount | [31],[32] | $ 36,775 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[32] | 36,279 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[32] | $ 34,500 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[27],[36] | 2026-07 |  |  |  | 2026-07 |  |  |  | 
| Investment, basis spread, variable rate | [25],[27],[28],[36] | 2.50% |  |  |  | 2.50% |  |  |  | 
| Investment, interest rate, floor | [25],[27],[28],[36] | 10.75% |  |  |  | 10.75% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[27],[28],[36] | 0.50% |  |  |  | 0.50% |  |  |  | 
| Investment exit fee | [25],[27],[28],[36] | 3.00% |  |  |  | 3.00% |  |  |  | 
| Principal amount | [25],[27],[36] | $ 77,740 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[27],[36] | 77,309 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[27],[36] | $ 80,073 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc., Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[30],[36] | 2026-05 |  |  |  | 2026-05 |  |  |  | 
| Investment, basis spread, variable rate | [25],[28],[30],[36] | 7.00% |  |  |  | 7.00% |  |  |  | 
| Investment, interest rate, floor | [25],[28],[30],[36] | 10.50% |  |  |  | 10.50% |  |  |  | 
| Investment, interest rate, cap | [25],[28],[30],[36] | 0.50% |  |  |  | 0.50% |  |  |  | 
| Investment exit fee | [25],[28],[30],[36] | 4.00% |  |  |  | 4.00% |  |  |  | 
| Principal amount | [25],[30],[36] | $ 25,230 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[30],[36] | 25,187 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[30],[36] | $ 26,237 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Skyword, Inc. Senior Secured, Maturity Date November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[26] | 2026-11 |  |  |  | 2026-11 |  |  |  | 
| Investment, basis spread, variable rate | [25],[26],[28] | 2.75% |  |  |  | 2.75% |  |  |  | 
| Investment, interest rate, floor | [25],[26],[28] | 9.25% |  |  |  | 9.25% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[26],[28] | 1.75% |  |  |  | 1.75% |  |  |  | 
| Investment exit fee | [25],[26],[28] | 3.00% |  |  |  | 3.00% |  |  |  | 
| Principal amount | [25],[26] | $ 8,555 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[26] | 8,604 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[26] | $ 8,770 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024, FIXED 8.25% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [37] | 2024-07 |  |  |  | 2024-07 |  |  |  | 
| Investment, interest rate, paid in cash | [28] | 8.25% |  |  |  | 8.25% |  |  |  | 
| Principal amount | [37] | $ 8,250 |  |  |  |  |  |  |  | 
| Investment cost | [2],[37] | 8,250 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [37] | $ 8,250 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Thumbtack, Inc. Senior Secured, Maturity Date March 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.50% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31] | 2028-03 |  |  |  | 2028-03 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31] | 2.45% |  |  |  | 2.45% |  |  |  | 
| Investment, interest rate, floor | [28],[31] | 10.95% |  |  |  | 10.95% |  |  |  | 
| Investment, interest rate, paid in kind | [28],[31] | 1.50% |  |  |  | 1.50% |  |  |  | 
| Principal amount | [31] | $ 20,704 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31] | 20,284 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31] | 20,284 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Total SeatGeek, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  | 102,970 |  |  |  |  |  |  |  | 
| Investment cost | [2] | 102,496 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 106,310 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Total Worldremit Group Limited |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  | 97,761 |  |  |  |  |  |  |  | 
| Investment cost | [2] | 97,057 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 97,304 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Udacity, Inc. Senior Secured, Maturity Date September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[27] | 2024-09 |  |  |  | 2024-09 |  |  |  | 
| Investment, basis spread, variable rate | [25],[27],[28] | 4.50% |  |  |  | 4.50% |  |  |  | 
| Investment, interest rate, floor | [25],[27],[28] | 7.75% |  |  |  | 7.75% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[27],[28] | 2.00% |  |  |  | 2.00% |  |  |  | 
| Investment exit fee | [25],[27],[28] | 3.00% |  |  |  | 3.00% |  |  |  | 
| Principal amount | [25],[27] | $ 53,268 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[27] | 54,440 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[27] | $ 54,440 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[26] | 2025-03 |  |  |  | 2025-03 |  |  |  | 
| Investment, basis spread, variable rate | [25],[26],[28] | 4.00% |  |  |  | 4.00% |  |  |  | 
| Investment, interest rate, floor | [25],[26],[28] | 7.25% |  |  |  | 7.25% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[26],[28] | 1.25% |  |  |  | 1.25% |  |  |  | 
| Investment exit fee | [25],[26],[28] | 4.50% |  |  |  | 4.50% |  |  |  | 
| Principal amount | [25],[26] | $ 5,123 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[26] | 5,223 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[26] | $ 5,223 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[27] | 2025-03 |  |  |  | 2025-03 |  |  |  | 
| Investment, basis spread, variable rate | [25],[27],[28] | 4.70% |  |  |  | 4.70% |  |  |  | 
| Investment, interest rate, floor | [25],[27],[28] | 7.95% |  |  |  | 7.95% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[27],[28] | 1.50% |  |  |  | 1.50% |  |  |  | 
| Investment exit fee | [25],[27],[28] | 4.50% |  |  |  | 4.50% |  |  |  | 
| Principal amount | [25],[27] | $ 5,129 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[27] | 5,237 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[27] | $ 5,237 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2026, 1-month SOFR + 9.35%, Floor rate 10.25% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [29],[33],[34],[36] | 2026-02 |  |  |  | 2026-02 |  |  |  | 
| Investment, basis spread, variable rate | [28],[29],[33],[34],[36] | 9.35% |  |  |  | 9.35% |  |  |  | 
| Investment, interest rate, floor | [28],[29],[33],[34],[36] | 10.25% |  |  |  | 10.25% |  |  |  | 
| Principal amount | [29],[33],[34],[36] | $ 6,466 |  |  |  |  |  |  |  | 
| Investment cost | [2],[29],[33],[34],[36] | 6,411 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [29],[33],[34],[36] | $ 6,429 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2026, 3-month SOFR + 9.40%, Floor rate 10.25% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [27],[29],[30],[33],[34],[36] | 2026-02 |  |  |  | 2026-02 |  |  |  | 
| Investment, basis spread, variable rate | [27],[28],[29],[30],[33],[34],[36] | 9.40% |  |  |  | 9.40% |  |  |  | 
| Investment, interest rate, floor | [27],[28],[29],[30],[33],[34],[36] | 10.25% |  |  |  | 10.25% |  |  |  | 
| Principal amount | [27],[29],[30],[33],[34],[36] | $ 91,295 |  |  |  |  |  |  |  | 
| Investment cost | [2],[27],[29],[30],[33],[34],[36] | 90,646 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [27],[29],[30],[33],[34],[36] | 90,875 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, and Total Veem, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  | 10,252 |  |  |  |  |  |  |  | 
| Investment cost | [2] | 10,460 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 10,460 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Diversified Financial Services (3.04%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 3.04% |  |  |  | 3.04% |  |  |  | 
| Investment cost | [2] | $ 56,958 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 57,285 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), UnSecured, Maturity Date September 2026, Fixed + 11.95% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [37],[38] | 2026-09 |  |  |  | 2026-09 |  |  |  | 
| Investment, interest rate, paid in cash | [28],[37],[38] | 11.95% |  |  |  | 11.95% |  |  |  | 
| Principal amount | [37],[38] | $ 10,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[37],[38] | 9,830 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [37],[38] | $ 9,829 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, Maturity Date September 2026, FIXED 11.50% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [37],[38] | 2026-09 |  |  |  | 2026-09 |  |  |  | 
| Investment, interest rate, paid in cash | [28],[37],[38] | 11.50% |  |  |  | 11.50% |  |  |  | 
| Principal amount | [37],[38] | $ 25,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[37],[38] | 24,689 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [37],[38] | $ 24,689 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Hercules Adviser LLC, Unsecured, Maturity Date June 2025, FIXED 5.00% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [37],[39] | 2025-06 |  |  |  | 2025-06 |  |  |  | 
| Investment, interest rate, paid in cash | [28],[37],[39] | 5.00% |  |  |  | 5.00% |  |  |  | 
| Principal amount | [37],[39] | $ 12,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[37],[39] | 12,000 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [37],[39] | $ 12,000 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Next Insurance, Inc, Senior Secured, Maturity Date February 2028, Prime -(1.50%), Floor rate 4.75%, PIK Interest 5.50% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[26],[29],[31] | 2028-02 |  |  |  | 2028-02 |  |  |  | 
| Investment, basis spread, variable rate | [25],[26],[28],[29],[31] | (1.50%) |  |  |  | (1.50%) |  |  |  | 
| Investment, interest rate, floor | [25],[26],[28],[29],[31] | 4.75% |  |  |  | 4.75% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[26],[28],[29],[31] | 5.50% |  |  |  | 5.50% |  |  |  | 
| Principal amount | [25],[26],[29],[31] | $ 10,616 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[26],[29],[31] | 10,439 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[26],[29],[31] | 10,767 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Total Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  | 35,000 |  |  |  |  |  |  |  | 
| Investment cost | [2] | 34,519 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 34,518 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (61.36%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 61.36% |  |  |  | 61.36% |  |  |  | 
| Investment cost | [2] | $ 1,138,523 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 1,157,172 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and ATAI Life Sciences N.V. Senior Secured, Maturity Date August 2026, Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[33],[34] | 2026-08 |  |  |  | 2026-08 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[33],[34] | 4.55% |  |  |  | 4.55% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[33],[34] | 8.55% |  |  |  | 8.55% |  |  |  | 
| Investment exit fee | [28],[31],[33],[34] | 6.95% |  |  |  | 6.95% |  |  |  | 
| Principal amount | [31],[33],[34] | $ 10,500 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[33],[34] | 10,749 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[33],[34] | $ 10,934 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Akero Therapeutics, Inc. Senior Secured, Maturity Date March 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[33] | 2027-03 |  |  |  | 2027-03 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28],[33] | 3.65% |  |  |  | 3.65% |  |  |  | 
| Investment, interest rate, floor | [26],[28],[33] | 7.65% |  |  |  | 7.65% |  |  |  | 
| Investment exit fee | [26],[28],[33] | 5.85% |  |  |  | 5.85% |  |  |  | 
| Principal amount | [26],[33] | $ 17,500 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[33] | 17,412 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[33] | $ 17,703 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [30] | 2024-10 |  |  |  | 2024-10 |  |  |  | 
| Investment, basis spread, variable rate | [28],[30] | 3.10% |  |  |  | 3.10% |  |  |  | 
| Investment, interest rate, floor | [28],[30] | 8.60% |  |  |  | 8.60% |  |  |  | 
| Investment exit fee | [28],[30] | 8.90% |  |  |  | 8.90% |  |  |  | 
| Principal amount | [30] | $ 15,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[30] | 15,212 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [30] | $ 15,212 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1] | 2027-01 |  |  |  | 2027-01 |  |  |  | 
| Investment, basis spread, variable rate | [1],[28] | 2.50% |  |  |  | 2.50% |  |  |  | 
| Investment, interest rate, floor | [1],[28] | 9.50% |  |  |  | 9.50% |  |  |  | 
| Investment, interest rate, cap | [1],[28] | 10.75% |  |  |  | 10.75% |  |  |  | 
| Investment exit fee | [1],[28] | 5.85% |  |  |  | 5.85% |  |  |  | 
| Principal amount | [1] | $ 24,000 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2] | 24,243 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1] | $ 24,584 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date January 2028 Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [27],[30],[31],[33],[36] | 2028-01 |  |  |  | 2028-01 |  |  |  | 
| Investment, basis spread, variable rate | [27],[28],[30],[31],[33],[36] | 2.20% |  |  |  | 2.20% |  |  |  | 
| Investment, interest rate, floor | [27],[28],[30],[31],[33],[36] | 9.95% |  |  |  | 9.95% |  |  |  | 
| Investment, interest rate, cap | [27],[28],[30],[31],[33],[36] | 10.70% |  |  |  | 10.70% |  |  |  | 
| Investment exit fee | [27],[28],[30],[31],[33],[36] | 5.78% |  |  |  | 5.78% |  |  |  | 
| Principal amount | [27],[30],[31],[33],[36] | $ 143,350 |  |  |  |  |  |  |  | 
| Investment cost | [2],[27],[30],[31],[33],[36] | 144,074 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [27],[30],[31],[33],[36] | $ 150,228 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Senior Secured, Maturity Date July 2025, Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [27],[30],[33],[34] | 2025-07 |  |  |  | 2025-07 |  |  |  | 
| Investment, basis spread, variable rate | [27],[28],[30],[33],[34] | 4.55% |  |  |  | 4.55% |  |  |  | 
| Investment, interest rate, floor | [27],[28],[30],[33],[34] | 8.05% |  |  |  | 8.05% |  |  |  | 
| Investment, interest rate, cap | [27],[28],[30],[33],[34] | 9.05% |  |  |  | 9.05% |  |  |  | 
| Investment exit fee | [27],[28],[30],[33],[34] | 5.00% |  |  |  | 5.00% |  |  |  | 
| Principal amount | [27],[30],[33],[34] | $ 11,500 |  |  |  |  |  |  |  | 
| Investment cost | [2],[27],[30],[33],[34] | 11,912 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [27],[30],[33],[34] | $ 11,857 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25] | 2028-10 |  |  |  | 2028-10 |  |  |  | 
| Investment, basis spread, variable rate | [25],[28] | 2.45% |  |  |  | 2.45% |  |  |  | 
| Investment, interest rate, floor | [25],[28] | 10.95% |  |  |  | 10.95% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[28] | 1.10% |  |  |  | 1.10% |  |  |  | 
| Investment exit fee | [25],[28] | 5.45% |  |  |  | 5.45% |  |  |  | 
| Principal amount | [25] | $ 52,748 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25] | 52,477 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25] | $ 53,544 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and COMPASS Pathways plc Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[33],[34] | 2027-07 |  |  |  | 2027-07 |  |  |  | 
| Investment, basis spread, variable rate | [25],[28],[33],[34] | 1.50% |  |  |  | 1.50% |  |  |  | 
| Investment, interest rate, floor | [25],[28],[33],[34] | 9.75% |  |  |  | 9.75% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[28],[33],[34] | 1.40% |  |  |  | 1.40% |  |  |  | 
| Investment exit fee | [25],[28],[33],[34] | 4.75% |  |  |  | 4.75% |  |  |  | 
| Principal amount | [25],[33],[34] | $ 24,230 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[33],[34] | 23,993 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[33],[34] | $ 24,837 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Corium, Inc. Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[36] | 2026-09 |  |  |  | 2026-09 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28],[36] | 5.70% |  |  |  | 5.70% |  |  |  | 
| Investment, interest rate, floor | [26],[28],[36] | 8.95% |  |  |  | 8.95% |  |  |  | 
| Investment exit fee | [26],[28],[36] | 7.75% |  |  |  | 7.75% |  |  |  | 
| Principal amount | [26],[36] | $ 105,225 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[36] | 108,105 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[36] | $ 109,343 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Curevo, Inc. Senior Secured, Maturity Date June 2027 Prime + 1.70%, Floor rate 9.70%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[31] | 2027-06 |  |  |  | 2027-06 |  |  |  | 
| Investment, basis spread, variable rate | [1],[28],[31] | 1.70% |  |  |  | 1.70% |  |  |  | 
| Investment, interest rate, floor | [1],[28],[31] | 9.70% |  |  |  | 9.70% |  |  |  | 
| Investment exit fee | [1],[28],[31] | 6.95% |  |  |  | 6.95% |  |  |  | 
| Principal amount | [1],[31] | $ 10,000 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[31] | 9,892 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[31] | $ 9,825 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Eloxx Pharmaceuticals, Inc. Senior Secured, Maturity Date April 2025, Prime + 6.25%, Floor rate 9.50%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1] | 2025-04 |  |  |  | 2025-04 |  |  |  | 
| Investment, basis spread, variable rate | [1],[28] | 6.25% |  |  |  | 6.25% |  |  |  | 
| Investment, interest rate, floor | [1],[28] | 9.50% |  |  |  | 9.50% |  |  |  | 
| Investment exit fee | [1],[28] | 4.00% |  |  |  | 4.00% |  |  |  | 
| Principal amount | [1] | $ 530 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2] | 1,028 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1] | $ 950 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc. Senior Secured, Maturity Date November 2026, Prime + 5.65%, Floor rate 9.15%, 10.31% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[27],[30] | 2026-11 |  |  |  | 2026-11 |  |  |  | 
| Investment, basis spread, variable rate | [1],[27],[28],[30] | 5.65% |  |  |  | 5.65% |  |  |  | 
| Investment, interest rate, floor | [1],[27],[28],[30] | 9.15% |  |  |  | 9.15% |  |  |  | 
| Investment exit fee | [1],[27],[28],[30] | 10.31% |  |  |  | 10.31% |  |  |  | 
| Principal amount | [1],[27],[30] | $ 32,399 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[27],[30] | 33,304 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[27],[30] | $ 33,841 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date April 2025, Prime + 4.50%, Floor rate 9.00%, 6.55% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[27],[33] | 2025-04 |  |  |  | 2025-04 |  |  |  | 
| Investment, basis spread, variable rate | [26],[27],[28],[33] | 4.50% |  |  |  | 4.50% |  |  |  | 
| Investment, interest rate, floor | [26],[27],[28],[33] | 9.00% |  |  |  | 9.00% |  |  |  | 
| Investment exit fee | [26],[27],[28],[33] | 6.55% |  |  |  | 6.55% |  |  |  | 
| Principal amount | [26],[27],[33] | $ 30,200 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[27],[33] | 31,287 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[27],[33] | $ 31,473 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Gritstone Bio, Inc. Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[26] | 2027-07 |  |  |  | 2027-07 |  |  |  | 
| Investment, basis spread, variable rate | [25],[26],[28] | 3.15% |  |  |  | 3.15% |  |  |  | 
| Investment, interest rate, floor | [25],[26],[28] | 7.15% |  |  |  | 7.15% |  |  |  | 
| Investment, interest rate, cap | [25],[26],[28] | 8.65% |  |  |  | 8.65% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[26],[28] | 2.00% |  |  |  | 2.00% |  |  |  | 
| Investment exit fee | [25],[26],[28] | 5.75% |  |  |  | 5.75% |  |  |  | 
| Principal amount | [25],[26] | $ 30,680 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[26] | 30,975 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[26] | $ 30,415 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc.. Senior Secured, Maturity Date February 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[25],[31] | 2026-02 |  |  |  | 2026-02 |  |  |  | 
| Investment, basis spread, variable rate | [1],[25],[28],[31] | 1.70% |  |  |  | 1.70% |  |  |  | 
| Investment, interest rate, floor | [1],[25],[28],[31] | 9.95% |  |  |  | 9.95% |  |  |  | 
| Investment, interest rate, paid in kind | [1],[25],[28],[31] | 1.50% |  |  |  | 1.50% |  |  |  | 
| Investment exit fee | [1],[25],[28],[31] | 3.00% |  |  |  | 3.00% |  |  |  | 
| Principal amount | [1],[25],[31] | $ 20,171 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[25],[31] | 19,955 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[25],[31] | $ 20,397 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Hibercell, Inc. Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[26] | 2025-05 |  |  |  | 2025-05 |  |  |  | 
| Investment, basis spread, variable rate | [1],[26],[28] | 5.40% |  |  |  | 5.40% |  |  |  | 
| Investment, interest rate, floor | [1],[26],[28] | 8.65% |  |  |  | 8.65% |  |  |  | 
| Investment exit fee | [1],[26],[28] | 4.95% |  |  |  | 4.95% |  |  |  | 
| Principal amount | [1],[26] | $ 10,505 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[26] | 11,147 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[26] | $ 11,032 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and HilleVax, Inc. Senior Secured, Maturity Date May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[25],[31] | 2027-05 |  |  |  | 2027-05 |  |  |  | 
| Investment, basis spread, variable rate | [1],[25],[28],[31] | 1.05% |  |  |  | 1.05% |  |  |  | 
| Investment, interest rate, floor | [1],[25],[28],[31] | 4.55% |  |  |  | 4.55% |  |  |  | 
| Investment, interest rate, cap | [1],[25],[28],[31] | 6.05% |  |  |  | 6.05% |  |  |  | 
| Investment, interest rate, paid in kind | [1],[25],[28],[31] | 2.85% |  |  |  | 2.85% |  |  |  | 
| Investment exit fee | [1],[25],[28],[31] | 7.15% |  |  |  | 7.15% |  |  |  | 
| Principal amount | [1],[25],[31] | $ 20,672 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[25],[31] | 20,932 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[25],[31] | $ 20,701 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[33] | 2027-11 |  |  |  | 2027-11 |  |  |  | 
| Investment, basis spread, variable rate | [1],[28],[33] | 2.40% |  |  |  | 2.40% |  |  |  | 
| Investment, interest rate, floor | [1],[28],[33] | 8.65% |  |  |  | 8.65% |  |  |  | 
| Investment exit fee | [1],[28],[33] | 15.13% |  |  |  | 15.13% |  |  |  | 
| Principal amount | [1],[33] | $ 5,500 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[33] | 5,554 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[33] | $ 5,777 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Locus Biosciences, Inc. Senior Secured, Maturity Date July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1] | 2025-07 |  |  |  | 2025-07 |  |  |  | 
| Investment, basis spread, variable rate | [1],[28] | 6.10% |  |  |  | 6.10% |  |  |  | 
| Investment, interest rate, floor | [1],[28] | 9.35% |  |  |  | 9.35% |  |  |  | 
| Investment exit fee | [1],[28] | 4.95% |  |  |  | 4.95% |  |  |  | 
| Principal amount | [1] | $ 4,630 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2] | 4,912 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1] | $ 4,936 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2027, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[31],[33] | 2027-05 |  |  |  | 2027-05 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28],[31],[33] | 2.45% |  |  |  | 2.45% |  |  |  | 
| Investment, interest rate, floor | [26],[28],[31],[33] | 8.25% |  |  |  | 8.25% |  |  |  | 
| Investment exit fee | [26],[28],[31],[33] | 5.35% |  |  |  | 5.35% |  |  |  | 
| Principal amount | [26],[31],[33] | $ 78,200 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[31],[33] | 79,108 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[31],[33] | $ 82,663 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc. Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.15%, 7.06% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[25],[27],[31],[33],[36],[40] | 2027-12 |  |  |  | 2027-12 |  |  |  | 
| Investment, basis spread, variable rate | [1],[25],[27],[28],[31],[33],[36],[40] | 1.35% |  |  |  | 1.35% |  |  |  | 
| Investment, interest rate, floor | [1],[25],[27],[28],[31],[33],[36],[40] | 9.85% |  |  |  | 9.85% |  |  |  | 
| Investment, interest rate, paid in kind | [1],[25],[27],[28],[31],[33],[36],[40] | 2.15% |  |  |  | 2.15% |  |  |  | 
| Investment exit fee | [1],[25],[27],[28],[31],[33],[36],[40] | 7.06% |  |  |  | 7.06% |  |  |  | 
| Principal amount | [1],[25],[27],[31],[33],[36],[40] | $ 136,480 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[25],[27],[31],[33],[36],[40] | 137,990 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[25],[27],[31],[33],[36],[40] | $ 135,839 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Redshift Bioanalytics, Inc. Senior Secured, Maturity Date January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1] | 2026-01 |  |  |  | 2026-01 |  |  |  | 
| Investment, basis spread, variable rate | [1],[28] | 4.25% |  |  |  | 4.25% |  |  |  | 
| Investment, interest rate, floor | [1],[28] | 7.50% |  |  |  | 7.50% |  |  |  | 
| Investment exit fee | [1],[28] | 3.80% |  |  |  | 3.80% |  |  |  | 
| Principal amount | [1] | $ 5,000 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2] | 5,072 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1] | $ 5,148 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc. Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[26],[27],[33] | 2027-10 |  |  |  | 2027-10 |  |  |  | 
| Investment, basis spread, variable rate | [25],[26],[27],[28],[33] | 1.75% |  |  |  | 1.75% |  |  |  | 
| Investment, interest rate, floor | [25],[26],[27],[28],[33] | 7.25% |  |  |  | 7.25% |  |  |  | 
| Investment, interest rate, cap | [25],[26],[27],[28],[33] | 9.00% |  |  |  | 9.00% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[26],[27],[28],[33] | 1.50% |  |  |  | 1.50% |  |  |  | 
| Investment exit fee | [25],[26],[27],[28],[33] | 4.95% |  |  |  | 4.95% |  |  |  | 
| Principal amount | [25],[26],[27],[33] | $ 31,526 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[26],[27],[33] | 31,648 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[26],[27],[33] | $ 33,011 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and TG Therapeutics, Inc. Senior Secured, Maturity Date January 2026, Prime + 1.20%, Floor rate 8.95%, PIK Interest 2.25%, 5.69% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[27],[30],[31],[33] | 2026-01 |  |  |  | 2026-01 |  |  |  | 
| Investment, basis spread, variable rate | [25],[27],[28],[30],[31],[33] | 1.20% |  |  |  | 1.20% |  |  |  | 
| Investment, interest rate, floor | [25],[27],[28],[30],[31],[33] | 8.95% |  |  |  | 8.95% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[27],[28],[30],[31],[33] | 2.25% |  |  |  | 2.25% |  |  |  | 
| Investment exit fee | [25],[27],[28],[30],[31],[33] | 5.69% |  |  |  | 5.69% |  |  |  | 
| Principal amount | [25],[27],[30],[31],[33] | $ 66,145 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[27],[30],[31],[33] | 67,153 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[27],[30],[31],[33] | $ 68,838 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc. Senior Secured, Maturity Date February 2027, Prime + 4.45%, Floor rate 8.45%, Cap rate 11.45%, 4.75% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[33] | 2027-02 |  |  |  | 2027-02 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28],[33] | 4.45% |  |  |  | 4.45% |  |  |  | 
| Investment, interest rate, floor | [26],[28],[33] | 8.45% |  |  |  | 8.45% |  |  |  | 
| Investment, interest rate, cap | [26],[28],[33] | 11.45% |  |  |  | 11.45% |  |  |  | 
| Investment exit fee | [26],[28],[33] | 4.75% |  |  |  | 4.75% |  |  |  | 
| Principal amount | [26],[33] | $ 12,375 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[33] | 12,524 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[33] | $ 13,148 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Verona Pharma, Inc. Senior Secured, Maturity Date December 2028, 1-month SOFR + 5.85%, Floor rate 11.19%, Cap rate 13.19%, 3.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [33],[34] | 2028-12 |  |  |  | 2028-12 |  |  |  | 
| Investment, basis spread, variable rate | [28],[33],[34] | 5.85% |  |  |  | 5.85% |  |  |  | 
| Investment, interest rate, floor | [28],[33],[34] | 11.19% |  |  |  | 11.19% |  |  |  | 
| Investment, interest rate, cap | [28],[33],[34] | 13.19% |  |  |  | 13.19% |  |  |  | 
| Investment exit fee | [28],[33],[34] | 3.50% |  |  |  | 3.50% |  |  |  | 
| Principal amount | [33],[34] | $ 15,750 |  |  |  |  |  |  |  | 
| Investment cost | [2],[33],[34] | 15,672 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [33],[34] | $ 15,672 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[33] | 2026-10 |  |  |  | 2026-10 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28],[33] | 4.20% |  |  |  | 4.20% |  |  |  | 
| Investment, interest rate, floor | [26],[28],[33] | 7.45% |  |  |  | 7.45% |  |  |  | 
| Investment, interest rate, cap | [26],[28],[33] | 8.95% |  |  |  | 8.95% |  |  |  | 
| Investment exit fee | [26],[28],[33] | 6.00% |  |  |  | 6.00% |  |  |  | 
| Principal amount | [26],[33] | $ 8,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[33] | 8,100 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[33] | $ 8,057 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date October 2026, Prime + 3.15%, Floor rate 10.15%, 3.80% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[27],[30] | 2026-10 |  |  |  | 2026-10 |  |  |  | 
| Investment, basis spread, variable rate | [26],[27],[28],[30] | 3.15% |  |  |  | 3.15% |  |  |  | 
| Investment, interest rate, floor | [26],[27],[28],[30] | 10.15% |  |  |  | 10.15% |  |  |  | 
| Investment exit fee | [26],[27],[28],[30] | 3.80% |  |  |  | 3.80% |  |  |  | 
| Principal amount | [26],[27],[30] | $ 55,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[27],[30] | 54,921 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[27],[30] | $ 55,753 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and bluebird bio, Inc. Senior Secured, Maturity Date April 2029, Prime + 1.45%, Floor rate 9.95%, PIK Interest 2.45%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date |  | 2029-04 |  |  |  | 2029-04 |  |  |  | 
| Investment, basis spread, variable rate | [28] | 1.45% |  |  |  | 1.45% |  |  |  | 
| Investment, interest rate, floor | [28] | 9.95% |  |  |  | 9.95% |  |  |  | 
| Investment, interest rate, paid in kind | [28] | 2.45% |  |  |  | 2.45% |  |  |  | 
| Investment exit fee | [28] | 4.95% |  |  |  | 4.95% |  |  |  | 
| Principal amount |  | $ 64,500 |  |  |  |  |  |  |  | 
| Investment cost | [2] | 62,111 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 62,111 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[33],[34] | 2028-01 |  |  |  | 2028-01 |  |  |  | 
| Investment, basis spread, variable rate | [25],[28],[33],[34] | 0.75% |  |  |  | 0.75% |  |  |  | 
| Investment, interest rate, floor | [25],[28],[33],[34] | 9.25% |  |  |  | 9.25% |  |  |  | 
| Investment, interest rate, cap | [25],[28],[33],[34] | 9.75% |  |  |  | 9.75% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[28],[33],[34] | 1.15% |  |  |  | 1.15% |  |  |  | 
| Investment exit fee | [25],[28],[33],[34] | 5.50% |  |  |  | 5.50% |  |  |  | 
| Principal amount | [25],[33],[34] | $ 15,785 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[33],[34] | 15,656 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[33],[34] | $ 15,970 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V. Senior Secured, Maturity Date January 2027, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [27],[30],[33],[34] | 2027-01 |  |  |  | 2027-01 |  |  |  | 
| Investment, basis spread, variable rate | [27],[28],[30],[33],[34] | 4.70% |  |  |  | 4.70% |  |  |  | 
| Investment, interest rate, floor | [27],[28],[30],[33],[34] | 7.95% |  |  |  | 7.95% |  |  |  | 
| Investment exit fee | [27],[28],[30],[33],[34] | 6.10% |  |  |  | 6.10% |  |  |  | 
| Principal amount | [27],[30],[33],[34] | $ 70,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[27],[30],[33],[34] | 71,405 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [27],[30],[33],[34] | $ 73,373 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (3.97%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 3.97% |  |  |  | 3.97% |  |  |  | 
| Investment cost | [2] | $ 74,166 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 74,884 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Locus Robotics Corp. Senior Secured, Maturity Date June 2026, Prime + 4.50%, Floor rate 8.00%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [29] | 2026-06 |  |  |  | 2026-06 |  |  |  | 
| Investment, basis spread, variable rate | [28],[29] | 4.50% |  |  |  | 4.50% |  |  |  | 
| Investment, interest rate, floor | [28],[29] | 8.00% |  |  |  | 8.00% |  |  |  | 
| Investment exit fee | [28],[29] | 4.00% |  |  |  | 4.00% |  |  |  | 
| Principal amount | [29] | $ 18,281 |  |  |  |  |  |  |  | 
| Investment cost | [2],[29] | 18,396 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [29] | $ 19,114 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Shield AI, Inc. Senior Secured, Maturity Date February 2029, Prime + 0.85%, Floor rate 6.85%, Cap rate 9.60%, PIK Interest 2.50%, 2.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[31] | 2029-02 |  |  |  | 2029-02 |  |  |  | 
| Investment, basis spread, variable rate | [25],[28],[31] | 0.85% |  |  |  | 0.85% |  |  |  | 
| Investment, interest rate, floor | [25],[28],[31] | 6.85% |  |  |  | 6.85% |  |  |  | 
| Investment, interest rate, cap | [25],[28],[31] | 9.60% |  |  |  | 9.60% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[28],[31] | 2.50% |  |  |  | 2.50% |  |  |  | 
| Investment exit fee | [25],[28],[31] | 2.50% |  |  |  | 2.50% |  |  |  | 
| Principal amount | [25],[31] | $ 56,316 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[31] | 55,770 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[31] | $ 55,770 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (25.39%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 25.39% |  |  |  | 25.39% |  |  |  | 
| Investment cost | [2] | $ 485,173 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 478,893 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Better Therapeutics, Inc. Senior Secured, Maturity Date August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[41] | 2025-08 |  |  |  | 2025-08 |  |  |  | 
| Investment, basis spread, variable rate | [1],[28],[41] | 5.70% |  |  |  | 5.70% |  |  |  | 
| Investment, interest rate, floor | [1],[28],[41] | 8.95% |  |  |  | 8.95% |  |  |  | 
| Investment exit fee | [1],[28],[41] | 5.95% |  |  |  | 5.95% |  |  |  | 
| Principal amount | [1],[41] | $ 10,838 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[41] | 11,296 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[41] | $ 5,215 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 1-month SOFR + 5.11%, Floor rate 6.00%, PIK Interest 4.45% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[26],[27],[30] | 2026-11 |  |  |  | 2026-11 |  |  |  | 
| Investment, basis spread, variable rate | [25],[26],[27],[28],[30] | 5.11% |  |  |  | 5.11% |  |  |  | 
| Investment, interest rate, floor | [25],[26],[27],[28],[30] | 6.00% |  |  |  | 6.00% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[26],[27],[28],[30] | 4.45% |  |  |  | 4.45% |  |  |  | 
| Principal amount | [25],[26],[27],[30] | $ 69,811 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[26],[27],[30] | 69,105 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[26],[27],[30] | $ 68,322 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc. Senior Secured, Maturity Date March 2026, Prime - (1.50%), Floor rate 7.00%, PIK Interest 7.00%, 5.64% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[26],[30] | 2026-03 |  |  |  | 2026-03 |  |  |  | 
| Investment, basis spread, variable rate | [25],[26],[28],[30] | (1.50%) |  |  |  | (1.50%) |  |  |  | 
| Investment, interest rate, floor | [25],[26],[28],[30] | 7.00% |  |  |  | 7.00% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[26],[28],[30] | 7.00% |  |  |  | 7.00% |  |  |  | 
| Investment exit fee | [25],[26],[28],[30] | 5.64% |  |  |  | 5.64% |  |  |  | 
| Principal amount | [25],[26],[30] | $ 47,789 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[26],[30] | 49,026 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[26],[30] | $ 47,835 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Curana Health Holdings, LLC Senior Secured, Maturity Date January 2028, Prime + 1.45%, Floor rate 9.20%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [29],[31] | 2028-01 |  |  |  | 2028-01 |  |  |  | 
| Investment, basis spread, variable rate | [28],[29],[31] | 1.45% |  |  |  | 1.45% |  |  |  | 
| Investment, interest rate, floor | [28],[29],[31] | 9.20% |  |  |  | 9.20% |  |  |  | 
| Investment exit fee | [28],[29],[31] | 4.95% |  |  |  | 4.95% |  |  |  | 
| Principal amount | [29],[31] | $ 20,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[29],[31] | 19,998 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [29],[31] | $ 20,053 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[27],[30] | 2026-02 |  |  |  | 2026-02 |  |  |  | 
| Investment, basis spread, variable rate | [25],[27],[28],[30] | 6.25% |  |  |  | 6.25% |  |  |  | 
| Investment, interest rate, floor | [25],[27],[28],[30] | 9.50% |  |  |  | 9.50% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[27],[28],[30] | 1.55% |  |  |  | 1.55% |  |  |  | 
| Principal amount | [25],[27],[30] | $ 53,762 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[27],[30] | 53,514 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[27],[30] | $ 54,031 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Main Street Rural, Inc. Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[31] | 2027-07 |  |  |  | 2027-07 |  |  |  | 
| Investment, basis spread, variable rate | [1],[28],[31] | 1.95% |  |  |  | 1.95% |  |  |  | 
| Investment, interest rate, floor | [1],[28],[31] | 9.95% |  |  |  | 9.95% |  |  |  | 
| Investment exit fee | [1],[28],[31] | 6.85% |  |  |  | 6.85% |  |  |  | 
| Principal amount | [1],[31] | $ 28,000 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[31] | 28,071 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[31] | $ 28,172 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Marathon Health, LLC Senior Secured, Maturity Date February 2029,Prime - (0.90%), Floor rate 7.10%, PIK Interest 4.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[31],[36] | 2029-02 |  |  |  | 2029-02 |  |  |  | 
| Investment, basis spread, variable rate | [25],[28],[31],[36] | (0.90%) |  |  |  | (0.90%) |  |  |  | 
| Investment, interest rate, floor | [25],[28],[31],[36] | 7.10% |  |  |  | 7.10% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[28],[31],[36] | 4.00% |  |  |  | 4.00% |  |  |  | 
| Investment exit fee | [25],[28],[31],[36] | 3.00% |  |  |  | 3.00% |  |  |  | 
| Principal amount | [25],[31],[36] | $ 154,394 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[31],[36] | 152,970 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[31],[36] | $ 152,970 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Modern Life, Inc. Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[31] | 2027-02 |  |  |  | 2027-02 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28],[31] | 2.75% |  |  |  | 2.75% |  |  |  | 
| Investment, interest rate, floor | [26],[28],[31] | 8.75% |  |  |  | 8.75% |  |  |  | 
| Investment exit fee | [26],[28],[31] | 5.00% |  |  |  | 5.00% |  |  |  | 
| Principal amount | [26],[31] | $ 13,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[31] | 12,952 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[31] | $ 13,287 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Recover Together, Inc. Senior Secured, Maturity Date July 2027 Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date |  | 2027-07 |  |  |  | 2027-07 |  |  |  | 
| Investment, basis spread, variable rate | [28] | 1.90% |  |  |  | 1.90% |  |  |  | 
| Investment, interest rate, floor | [28] | 10.15% |  |  |  | 10.15% |  |  |  | 
| Investment exit fee | [28] | 7.50% |  |  |  | 7.50% |  |  |  | 
| Principal amount |  | $ 40,000 |  |  |  |  |  |  |  | 
| Investment cost | [2] | 39,782 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 40,880 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Strive Health Holdings, LLC Senior Secured, Maturity Date September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[31] | 2027-09 |  |  |  | 2027-09 |  |  |  | 
| Investment, basis spread, variable rate | [1],[28],[31] | 0.70% |  |  |  | 0.70% |  |  |  | 
| Investment, interest rate, floor | [1],[28],[31] | 9.20% |  |  |  | 9.20% |  |  |  | 
| Investment exit fee | [1],[28],[31] | 5.95% |  |  |  | 5.95% |  |  |  | 
| Principal amount | [1],[31] | $ 12,000 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[31] | 11,915 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[31] | $ 12,126 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc. Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [30] | 2026-03 |  |  |  | 2026-03 |  |  |  | 
| Investment, basis spread, variable rate | [28] | 3.25% |  |  |  | 3.25% |  |  |  | 
| Investment, interest rate, floor | [28],[30] | 9.20% |  |  |  | 9.20% |  |  |  | 
| Investment, interest rate, cap | [28],[30] | 10.20% |  |  |  | 10.20% |  |  |  | 
| Investment exit fee | [28],[30] | 4.95% |  |  |  | 4.95% |  |  |  | 
| Principal amount | [30] | $ 36,500 |  |  |  |  |  |  |  | 
| Investment cost | [2],[30] | 36,544 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [30] | $ 36,002 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc. Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee | Minimum |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment, basis spread, variable rate | [28],[30] | 1.00% |  |  |  | 1.00% |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Information Services (6.49%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 6.49% |  |  |  | 6.49% |  |  |  | 
| Investment cost | [2] | $ 118,457 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 122,304 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Information Services and Capella Space Corp. Senior Secured, Maturity Date November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[25] | 2025-11 |  |  |  | 2025-11 |  |  |  | 
| Investment, basis spread, variable rate | [1],[25],[28] | 5.00% |  |  |  | 5.00% |  |  |  | 
| Investment, interest rate, floor | [1],[25],[28] | 8.25% |  |  |  | 8.25% |  |  |  | 
| Investment, interest rate, paid in kind | [1],[25],[28] | 1.10% |  |  |  | 1.10% |  |  |  | 
| Investment exit fee | [1],[25],[28] | 7.00% |  |  |  | 7.00% |  |  |  | 
| Principal amount | [1],[25] | $ 20,534 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[25] | 21,342 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[25] | $ 21,541 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Information Services and Checkr Group, Inc. Senior Secured, Maturity Date August 2028, Prime + 1.45%, Floor rate 8.00%, PIK Interest 2.00%, 2.75% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[27],[31] | 2028-08 |  |  |  | 2028-08 |  |  |  | 
| Investment, basis spread, variable rate | [25],[27],[28],[31] | 1.45% |  |  |  | 1.45% |  |  |  | 
| Investment, interest rate, floor | [25],[27],[28],[31] | 8.00% |  |  |  | 8.00% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[27],[28],[31] | 2.00% |  |  |  | 2.00% |  |  |  | 
| Investment exit fee | [25],[27],[28],[31] | 2.75% |  |  |  | 2.75% |  |  |  | 
| Principal amount | [25],[27],[31] | $ 47,862 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[27],[31] | 47,758 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[27],[31] | $ 50,549 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Information Services and Saama Technologies, LLC Senior Secured, Maturity Date July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[27],[31] | 2027-07 |  |  |  | 2027-07 |  |  |  | 
| Investment, basis spread, variable rate | [25],[27],[28],[31] | 0.70% |  |  |  | 0.70% |  |  |  | 
| Investment, interest rate, floor | [25],[27],[28],[31] | 8.95% |  |  |  | 8.95% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[27],[28],[31] | 2.00% |  |  |  | 2.00% |  |  |  | 
| Investment exit fee | [25],[27],[28],[31] | 2.95% |  |  |  | 2.95% |  |  |  | 
| Principal amount | [25],[27],[31] | $ 11,784 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[27],[31] | 11,711 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[27],[31] | $ 12,127 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Information Services and Signal Media Limited, Senior Secured, Maturity Date June 2025, Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [33],[34] | 2025-06 |  |  |  | 2025-06 |  |  |  | 
| Investment, basis spread, variable rate | [28],[33],[34] | 5.50% |  |  |  | 5.50% |  |  |  | 
| Investment, interest rate, floor | [28],[33],[34] | 9.00% |  |  |  | 9.00% |  |  |  | 
| Investment, interest rate, cap | [28],[33],[34] | 12.00% |  |  |  | 12.00% |  |  |  | 
| Investment exit fee | [28],[33],[34] | 3.45% |  |  |  | 3.45% |  |  |  | 
| Principal amount | [33],[34] | $ 6,150 |  |  |  |  |  |  |  | 
| Investment cost | [2],[33],[34] | 6,134 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [33],[34] | $ 6,212 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 8.42%, Floor rate 9.32% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[32] | 2026-09 |  |  |  | 2026-09 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[32] | 8.42% |  |  |  | 8.42% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[32] | 9.32% |  |  |  | 9.32% |  |  |  | 
| Principal amount | [31],[32] | $ 31,875 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[32] | 31,512 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[32] | $ 31,875 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Manufacturing Technology (0.38%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.38% |  |  |  | 0.38% |  |  |  | 
| Investment cost | [2] | $ 6,767 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 7,219 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and Bright Machines, Inc. Senior Secured, Maturity Date May 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26] | 2025-05 |  |  |  | 2025-05 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28] | 4.00% |  |  |  | 4.00% |  |  |  | 
| Investment, interest rate, floor | [26],[28] | 9.50% |  |  |  | 9.50% |  |  |  | 
| Investment exit fee | [26],[28] | 5.00% |  |  |  | 5.00% |  |  |  | 
| Principal amount | [26] | $ 6,446 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26] | 6,767 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26] | $ 7,219 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Media/Content/Info (0.63%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.63% |  |  |  | 0.63% |  |  |  | 
| Investment cost | [2] | $ 11,736 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 11,856 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. , Senior Secured, Maturity Date June 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [29] | 2026-06 |  |  |  | 2026-06 |  |  |  | 
| Investment, basis spread, variable rate | [28],[29] | 3.50% |  |  |  | 3.50% |  |  |  | 
| Investment, interest rate, floor | [28],[29] | 9.00% |  |  |  | 9.00% |  |  |  | 
| Investment exit fee | [28],[29] | 3.00% |  |  |  | 3.00% |  |  |  | 
| Principal amount | [29] | $ 1,500 |  |  |  |  |  |  |  | 
| Investment cost | [2],[29] | 1,491 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [29] | $ 1,498 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date December 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [29] | 2025-12 |  |  |  | 2025-12 |  |  |  | 
| Investment, basis spread, variable rate | [28],[29] | 3.50% |  |  |  | 3.50% |  |  |  | 
| Investment, interest rate, floor | [28],[29] | 9.00% |  |  |  | 9.00% |  |  |  | 
| Investment exit fee | [28],[29] | 3.00% |  |  |  | 3.00% |  |  |  | 
| Principal amount | [29] | $ 1,167 |  |  |  |  |  |  |  | 
| Investment cost | [2],[29] | 1,183 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [29] | $ 1,191 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date March 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [29] | 2026-03 |  |  |  | 2026-03 |  |  |  | 
| Investment, basis spread, variable rate | [28],[29] | 3.50% |  |  |  | 3.50% |  |  |  | 
| Investment, interest rate, floor | [28],[29] | 9.00% |  |  |  | 9.00% |  |  |  | 
| Investment exit fee | [28],[29] | 3.00% |  |  |  | 3.00% |  |  |  | 
| Principal amount | [29] | $ 1,333 |  |  |  |  |  |  |  | 
| Investment cost | [2],[29] | 1,343 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [29] | $ 1,350 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date September 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [29] | 2025-09 |  |  |  | 2025-09 |  |  |  | 
| Investment, basis spread, variable rate | [28],[29] | 3.50% |  |  |  | 3.50% |  |  |  | 
| Investment, interest rate, floor | [28],[29] | 9.00% |  |  |  | 9.00% |  |  |  | 
| Investment exit fee | [28],[29] | 3.00% |  |  |  | 3.00% |  |  |  | 
| Principal amount | [29] | $ 1,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[29] | 1,019 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [29] | $ 1,027 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc. Senior Secured, Maturity Date September 2026, Prime + 3.50%, Floor rate 9.00%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [29] | 2026-09 |  |  |  | 2026-09 |  |  |  | 
| Investment, basis spread, variable rate | [28],[29] | 3.50% |  |  |  | 3.50% |  |  |  | 
| Investment, interest rate, floor | [28],[29] | 9.00% |  |  |  | 9.00% |  |  |  | 
| Investment exit fee | [28],[29] | 4.00% |  |  |  | 4.00% |  |  |  | 
| Principal amount | [29] | $ 6,667 |  |  |  |  |  |  |  | 
| Investment cost | [2],[29] | 6,700 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [29] | 6,790 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Total Fever Labs, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  | 11,667 |  |  |  |  |  |  |  | 
| Investment cost | [2] | 11,736 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 11,856 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment (2.89%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 2.89% |  |  |  | 2.89% |  |  |  | 
| Investment cost | [2] | $ 54,365 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 54,535 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc. Senior Secured, Maturity Date September 2027 Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [30] | 2027-09 |  |  |  | 2027-09 |  |  |  | 
| Investment, basis spread, variable rate | [28],[30] | 1.40% |  |  |  | 1.40% |  |  |  | 
| Investment, interest rate, floor | [28],[30] | 9.90% |  |  |  | 9.90% |  |  |  | 
| Investment exit fee | [28],[30] | 6.95% |  |  |  | 6.95% |  |  |  | 
| Principal amount | [30] | $ 30,625 |  |  |  |  |  |  |  | 
| Investment cost | [2],[30] | 30,310 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [30] | $ 30,480 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Sight Sciences, Inc. Senior Secured, Maturity Date July 2028 Prime + 2.35%, Floor rate 10.35%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31] | 2028-07 |  |  |  | 2028-07 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31] | 2.35% |  |  |  | 2.35% |  |  |  | 
| Investment, interest rate, floor | [28],[31] | 10.35% |  |  |  | 10.35% |  |  |  | 
| Investment exit fee | [28],[31] | 5.95% |  |  |  | 5.95% |  |  |  | 
| Principal amount | [31] | $ 24,500 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31] | 24,055 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31] | $ 24,055 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software (42.47%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 42.47% |  |  |  | 42.47% |  |  |  | 
| Investment cost | [2] | $ 825,673 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 800,904 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software , Total Streamline Healthcare Solutions |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  | 17,600 |  |  |  |  |  |  |  | 
| Investment cost | [2] | 17,273 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 17,890 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Reveleer, Senior Secured, Maturity Date February 2027, Prime + 0.65%, Floor rate 9.15%, PIK Interest 2.00%, 5.05% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[25],[31] | 2027-02 |  |  |  | 2027-02 |  |  |  | 
| Investment, basis spread, variable rate | [1],[25],[28],[31] | 0.65% |  |  |  | 0.65% |  |  |  | 
| Investment, interest rate, floor | [1],[25],[28],[31] | 9.15% |  |  |  | 9.15% |  |  |  | 
| Investment, interest rate, paid in kind | [1],[25],[28],[31] | 2.00% |  |  |  | 2.00% |  |  |  | 
| Investment exit fee | [1],[25],[28],[31] | 5.05% |  |  |  | 5.05% |  |  |  | 
| Principal amount | [1],[25],[31] | $ 16,027 |  |  |  |  |  |  |  | 
| Investment cost | [1],[25],[31] | 15,932 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[25],[31] | $ 15,932 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 6.96%, Floor rate 7.86% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[32] | 2025-02 |  |  |  | 2025-02 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[32] | 6.96% |  |  |  | 6.96% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[32] | 7.86% |  |  |  | 7.86% |  |  |  | 
| Principal amount | [31],[32] | $ 2,983 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[32] | 2,973 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[32] | $ 2,973 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 9.86%, Floor rate 10.76% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [30],[31],[32] | 2025-02 |  |  |  | 2025-02 |  |  |  | 
| Investment, basis spread, variable rate | [28],[30],[31],[32] | 9.86% |  |  |  | 9.86% |  |  |  | 
| Investment, interest rate, floor | [28],[30],[31],[32] | 10.76% |  |  |  | 10.76% |  |  |  | 
| Principal amount | [30],[31],[32] | $ 13,562 |  |  |  |  |  |  |  | 
| Investment cost | [2],[30],[31],[32] | 13,498 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [30],[31],[32] | $ 13,498 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Agilence, Inc. Senior Secured, Maturity Date October 2026, 1-month BSBY + 9.00%, Floor rate 10.00% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [27],[31],[32] | 2026-10 |  |  |  | 2026-10 |  |  |  | 
| Investment, basis spread, variable rate | [27],[28],[31],[32] | 9.00% |  |  |  | 9.00% |  |  |  | 
| Investment, interest rate, floor | [27],[28],[31],[32] | 10.00% |  |  |  | 10.00% |  |  |  | 
| Principal amount | [27],[31],[32] | $ 9,189 |  |  |  |  |  |  |  | 
| Investment cost | [2],[27],[31],[32] | 9,029 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [27],[31],[32] | $ 9,212 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 8.14%, Floor rate 9.14% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[32] | 2028-05 |  |  |  | 2028-05 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28],[32] | 8.14% |  |  |  | 8.14% |  |  |  | 
| Investment, interest rate, floor | [26],[28],[32] | 9.14% |  |  |  | 9.14% |  |  |  | 
| Principal amount | [26],[32] | $ 21,353 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[32] | 20,970 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[32] | $ 21,879 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Allvue Systems, LLC, Senior Secured, Maturity Date September 2029, 3-month SOFR + 7.25%, Floor rate 8.25% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31] | 2029-09 |  |  |  | 2029-09 |  |  |  | 
| Investment, basis spread, variable rate |  | 7.25% |  |  |  | 7.25% |  |  |  | 
| Investment, interest rate, floor | [28],[31] | 8.25% |  |  |  | 8.25% |  |  |  | 
| Principal amount | [31] | $ 36,410 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31] | 35,556 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31] | $ 36,385 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 10.00%, Floor rate 11.00% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26] | 2027-02 |  |  |  | 2027-02 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28] | 10.00% |  |  |  | 10.00% |  |  |  | 
| Investment, interest rate, floor | [26],[28] | 11.00% |  |  |  | 11.00% |  |  |  | 
| Principal amount | [26] | $ 11,549 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26] | 11,375 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26] | $ 11,562 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Armis, Inc., Senior Secured, Maturity Date March 2028, Prime + 0.00%, Floor rate 7.50%, PIK Interest 2.00%, 2.25% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31] | 2028-03 |  |  |  | 2028-03 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31] | 0.00% |  |  |  | 0.00% |  |  |  | 
| Investment, interest rate, floor | [28],[31] | 7.50% |  |  |  | 7.50% |  |  |  | 
| Investment, interest rate, paid in kind | [28],[31] | 2.00% |  |  |  | 2.00% |  |  |  | 
| Investment exit fee | [28],[31] | 2.25% |  |  |  | 2.25% |  |  |  | 
| Principal amount | [31] | $ 40,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31] | 39,618 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31] | $ 39,618 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 4.50% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [29],[30],[31] | 2027-09 |  |  |  | 2027-09 |  |  |  | 
| Investment, basis spread, variable rate | [28],[29],[30],[31] | 4.25% |  |  |  | 4.25% |  |  |  | 
| Investment, interest rate, floor | [28],[29],[30],[31] | 9.00% |  |  |  | 9.00% |  |  |  | 
| Investment exit fee | [28],[29],[30],[31] | 4.50% |  |  |  | 4.50% |  |  |  | 
| Principal amount | [29],[30],[31] | $ 19,600 |  |  |  |  |  |  |  | 
| Investment cost | [2],[29],[30],[31] | 19,423 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [29],[30],[31] | $ 20,313 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 6-month SOFR + 8.01%, Floor rate 9.01% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[31],[32] | 2027-12 |  |  |  | 2027-12 |  |  |  | 
| Investment, basis spread, variable rate | [1],[28],[31],[32] | 8.01% |  |  |  | 8.01% |  |  |  | 
| Investment, interest rate, floor | [1],[28],[31],[32] | 9.01% |  |  |  | 9.01% |  |  |  | 
| Principal amount | [1],[31],[32] | $ 65,500 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[31],[32] | 63,975 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[31],[32] | $ 65,806 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2026, PRIME + 3.70%, Floor rate 9.20%, PIK Interest 1.00%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[25],[26],[31] | 2026-04 |  |  |  | 2026-04 |  |  |  | 
| Investment, basis spread, variable rate | [1],[25],[26],[28],[31] | 3.70% |  |  |  | 3.70% |  |  |  | 
| Investment, interest rate, floor | [1],[25],[26],[28],[31] | 9.20% |  |  |  | 9.20% |  |  |  | 
| Investment, interest rate, paid in kind | [1],[25],[26],[28],[31] | 1.00% |  |  |  | 1.00% |  |  |  | 
| Investment exit fee | [1],[25],[26],[28],[31] | 3.95% |  |  |  | 3.95% |  |  |  | 
| Principal amount | [1],[25],[26],[31] | $ 30,492 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[25],[26],[31] | 30,869 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[25],[26],[31] | $ 31,509 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Catchpoint Systems, Inc., Senior Secured, Maturity Date November 2025, 3-month SOFR + 9.41%, Floor rate 11.81% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [32] | 2025-11 |  |  |  | 2025-11 |  |  |  | 
| Investment, basis spread, variable rate | [28],[32] | 9.41% |  |  |  | 9.41% |  |  |  | 
| Investment, interest rate, floor | [28],[32] | 11.81% |  |  |  | 11.81% |  |  |  | 
| Principal amount | [32] | $ 10,047 |  |  |  |  |  |  |  | 
| Investment cost | [2],[32] | 9,922 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [32] | $ 9,993 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 3-month LIBOR + 8.99%, Floor rate 9.89% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[32] | 2026-09 |  |  |  | 2026-09 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[32] | 8.99% |  |  |  | 8.99% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[32] | 9.89% |  |  |  | 9.89% |  |  |  | 
| Principal amount | [31],[32] | $ 22,815 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[32] | 22,474 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[32] | $ 23,023 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Constructor io Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[31],[32] | 2027-07 |  |  |  | 2027-07 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28],[31],[32] | 8.44% |  |  |  | 8.44% |  |  |  | 
| Investment, interest rate, floor | [26],[28],[31],[32] | 9.44% |  |  |  | 9.44% |  |  |  | 
| Principal amount | [26],[31],[32] | $ 4,688 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[31],[32] | 4,596 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[31],[32] | $ 4,763 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Convoy, Inc., Senior Secured, Maturity Date March 2026, Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[29],[41] | 2026-03 |  |  |  | 2026-03 |  |  |  | 
| Investment, basis spread, variable rate | [25],[28],[29],[41] | 3.20% |  |  |  | 3.20% |  |  |  | 
| Investment, interest rate, floor | [25],[28],[29],[41] | 6.45% |  |  |  | 6.45% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[28],[29],[41] | 1.95% |  |  |  | 1.95% |  |  |  | 
| Investment exit fee | [25],[28],[29],[41] | 4.55% |  |  |  | 4.55% |  |  |  | 
| Principal amount | [25],[29],[41] | $ 31,049 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[29],[41] | 30,916 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[29],[41] | $ 0 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 3.77% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[30] | 2025-03 |  |  |  | 2025-03 |  |  |  | 
| Investment, basis spread, variable rate | [25],[28],[30] | 4.50% |  |  |  | 4.50% |  |  |  | 
| Investment, interest rate, floor | [25],[28],[30] | 8.25% |  |  |  | 8.25% |  |  |  | 
| Investment, interest rate, cap | [25],[28],[30] | 10.25% |  |  |  | 10.25% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[28],[30] | 1.95% |  |  |  | 1.95% |  |  |  | 
| Investment exit fee | [25],[28],[30] | 3.77% |  |  |  | 3.77% |  |  |  | 
| Principal amount | [25],[30] | $ 8,762 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[30] | 8,962 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[30] | $ 8,962 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee1 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [27],[31],[33],[34] | 2025-10 |  |  |  | 2025-10 |  |  |  | 
| Investment, basis spread, variable rate | [27],[28],[31],[33],[34] | 5.20% |  |  |  | 5.20% |  |  |  | 
| Investment, interest rate, floor | [27],[28],[31],[33],[34] | 9.95% |  |  |  | 9.95% |  |  |  | 
| Investment exit fee | [27],[28],[31],[33],[34] | 4.95% |  |  |  | 4.95% |  |  |  | 
| Principal amount | [27],[31],[33],[34] | $ 5,500 |  |  |  |  |  |  |  | 
| Investment cost | [2],[27],[31],[33],[34] | 5,573 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [27],[31],[33],[34] | $ 5,747 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee2 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [27],[31],[33],[34] | 2025-10 |  |  |  | 2025-10 |  |  |  | 
| Investment, basis spread, variable rate | [27],[28],[31],[33],[34] | 5.20% |  |  |  | 5.20% |  |  |  | 
| Investment, interest rate, floor | [27],[28],[31],[33],[34] | 9.95% |  |  |  | 9.95% |  |  |  | 
| Investment exit fee | [27],[28],[31],[33],[34] | 4.95% |  |  |  | 4.95% |  |  |  | 
| Principal amount | [27],[31],[33],[34] | $ 1,250 |  |  |  |  |  |  |  | 
| Investment cost | [2],[27],[31],[33],[34] | 1,569 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [27],[31],[33],[34] | $ 1,667 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 12.36%, Floor rate 13.11% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[31] | 2026-08 |  |  |  | 2026-08 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28],[31] | 12.36% |  |  |  | 12.36% |  |  |  | 
| Investment, interest rate, floor | [26],[28],[31] | 13.11% |  |  |  | 13.11% |  |  |  | 
| Principal amount | [26],[31] | $ 2,527 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[31] | 2,479 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[31] | $ 2,537 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 8.63%, Floor rate 9.38% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[31] | 2026-08 |  |  |  | 2026-08 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28],[31] | 8.63% |  |  |  | 8.63% |  |  |  | 
| Investment, interest rate, floor | [26],[28],[31] | 9.38% |  |  |  | 9.38% |  |  |  | 
| Principal amount | [26],[31] | $ 7,896 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[31] | 7,781 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[31] | $ 7,782 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date December 2027, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 6.35% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[26],[29],[30],[31] | 2027-12 |  |  |  | 2027-12 |  |  |  | 
| Investment, basis spread, variable rate | [25],[26],[28],[29],[30],[31] | 3.05% |  |  |  | 3.05% |  |  |  | 
| Investment, interest rate, floor | [25],[26],[28],[29],[30],[31] | 11.55% |  |  |  | 11.55% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[26],[28],[29],[30],[31] | 1.10% |  |  |  | 1.10% |  |  |  | 
| Investment exit fee | [25],[26],[28],[29],[30],[31] | 6.35% |  |  |  | 6.35% |  |  |  | 
| Principal amount | [25],[26],[29],[30],[31] | $ 42,967 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[26],[29],[30],[31] | 43,395 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[26],[29],[30],[31] | $ 43,395 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Dispatch Technologies, Inc., Senior Secured, Maturity Date April 2028, 3-month SOFR + 8.01%, Floor rate 8.76% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[32] | 2028-04 |  |  |  | 2028-04 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[32] | 8.01% |  |  |  | 8.01% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[32] | 8.76% |  |  |  | 8.76% |  |  |  | 
| Principal amount | [31],[32] | $ 8,125 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[32] | 7,956 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[32] | $ 7,876 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and DroneDeploy, Inc., Senior Secured, Maturity Date July 2026, Prime + 4.50%, Floor rate 8.75%, 4.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[31] | 2026-07 |  |  |  | 2026-07 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28],[31] | 4.50% |  |  |  | 4.50% |  |  |  | 
| Investment, interest rate, floor | [26],[28],[31] | 8.75% |  |  |  | 8.75% |  |  |  | 
| Investment exit fee | [26],[28],[31] | 4.00% |  |  |  | 4.00% |  |  |  | 
| Principal amount | [26],[31] | $ 6,250 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[31] | 6,125 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[31] | $ 6,239 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Eigen Technologies Ltd., Senior Secured, Maturity Date April 2025, Prime + 5.10%, Floor rate 8.35%, 2.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [33],[34] | 2025-04 |  |  |  | 2025-04 |  |  |  | 
| Investment, basis spread, variable rate | [28],[33],[34] | 5.10% |  |  |  | 5.10% |  |  |  | 
| Investment, interest rate, floor | [28],[33],[34] | 8.35% |  |  |  | 8.35% |  |  |  | 
| Investment exit fee | [28],[33],[34] | 2.95% |  |  |  | 2.95% |  |  |  | 
| Principal amount | [33],[34] | $ 3,750 |  |  |  |  |  |  |  | 
| Investment cost | [2],[33],[34] | 3,817 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [33],[34] | $ 2,991 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[29],[31] | 2026-03 |  |  |  | 2026-03 |  |  |  | 
| Investment, basis spread, variable rate | [25],[28],[29],[31] | 4.25% |  |  |  | 4.25% |  |  |  | 
| Investment, interest rate, floor | [25],[28],[29],[31] | 9.00% |  |  |  | 9.00% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[28],[29],[31] | 1.95% |  |  |  | 1.95% |  |  |  | 
| Investment exit fee | [25],[28],[29],[31] | 3.95% |  |  |  | 3.95% |  |  |  | 
| Principal amount | [25],[29],[31] | $ 12,688 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[29],[31] | 12,394 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[29],[31] | $ 12,867 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.80%, Floor rate 8.70% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[32] | 2027-10 |  |  |  | 2027-10 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[32] | 7.80% |  |  |  | 7.80% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[32] | 8.70% |  |  |  | 8.70% |  |  |  | 
| Principal amount | [31],[32] | $ 6,587 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[32] | 6,429 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[32] | $ 6,679 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 1-month SOFR + 7.64%, Floor rate 8.54% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [30],[31],[32] | 2027-12 |  |  |  | 2027-12 |  |  |  | 
| Investment, basis spread, variable rate | [28],[30],[31],[32] | 7.64% |  |  |  | 7.64% |  |  |  | 
| Investment, interest rate, floor | [28],[30],[31],[32] | 8.54% |  |  |  | 8.54% |  |  |  | 
| Principal amount | [30],[31],[32] | $ 7,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[30],[31],[32] | 6,858 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [30],[31],[32] | $ 7,012 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Harness, Inc., Senior Secured, Maturity Date March 2029, Prime - (2.25%), Floor rate 5.25%, Cap rate 6.50%, PIK Interest 6.25%, 1.00% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [29],[31] | 2029-03 |  |  |  | 2029-03 |  |  |  | 
| Investment, basis spread, variable rate | [28],[29],[31] | (2.25%) |  |  |  | (2.25%) |  |  |  | 
| Investment, interest rate, floor | [28],[29],[31] | 5.25% |  |  |  | 5.25% |  |  |  | 
| Investment, interest rate, cap | [28],[29],[31] | 6.50% |  |  |  | 6.50% |  |  |  | 
| Investment, interest rate, paid in kind | [28],[29],[31] | 6.25% |  |  |  | 6.25% |  |  |  | 
| Investment exit fee | [28],[29],[31] | 1.00% |  |  |  | 1.00% |  |  |  | 
| Principal amount | [29],[31] | $ 17,325 |  |  |  |  |  |  |  | 
| Investment cost | [2],[29],[31] | 17,101 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [29],[31] | $ 17,101 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Ikon Science Limited, Senior Secured, Maturity Date October 2024, 3-month SOFR + 9.26%, Floor rate 10.00% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[32],[33],[34] | 2024-10 |  |  |  | 2024-10 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[32],[33],[34] | 9.26% |  |  |  | 9.26% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[32],[33],[34] | 10.00% |  |  |  | 10.00% |  |  |  | 
| Principal amount | [31],[32],[33],[34] | $ 6,125 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[32],[33],[34] | 6,080 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[32],[33],[34] | $ 6,080 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Khoros (p.k.a Lithium Technologies), Senior Secured, Maturity Date January 2025, 3-month SOFR + 4.50%, Floor rate 5.50%, PIK Interest 4.50% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25] | 2025-01 |  |  |  | 2025-01 |  |  |  | 
| Investment, basis spread, variable rate | [25],[28] | 4.50% |  |  |  | 4.50% |  |  |  | 
| Investment, interest rate, floor | [25],[28] | 5.50% |  |  |  | 5.50% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[28] | 4.50% |  |  |  | 4.50% |  |  |  | 
| Principal amount | [25] | $ 58,449 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25] | 58,418 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25] | $ 51,846 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Leapwork ApS., Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.25%, PIK Interest 1.95%, 2.70% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[27],[31],[33],[34] | 2026-02 |  |  |  | 2026-02 |  |  |  | 
| Investment, basis spread, variable rate | [25],[27],[28],[31],[33],[34] | 0.25% |  |  |  | 0.25% |  |  |  | 
| Investment, interest rate, floor | [25],[27],[28],[31],[33],[34] | 7.25% |  |  |  | 7.25% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[27],[28],[31],[33],[34] | 1.95% |  |  |  | 1.95% |  |  |  | 
| Investment exit fee | [25],[27],[28],[31],[33],[34] | 2.70% |  |  |  | 2.70% |  |  |  | 
| Principal amount | [25],[27],[31],[33],[34] | $ 3,832 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[27],[31],[33],[34] | 3,840 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[27],[31],[33],[34] | $ 3,963 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and LinenMaster, LLC., Senior Secured, Maturity Date August 2028 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[27],[31] | 2028-08 |  |  |  | 2028-08 |  |  |  | 
| Investment, basis spread, variable rate | [25],[27],[28],[31] | 6.25% |  |  |  | 6.25% |  |  |  | 
| Investment, interest rate, floor | [25],[27],[28],[31] | 7.25% |  |  |  | 7.25% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[27],[28],[31] | 2.15% |  |  |  | 2.15% |  |  |  | 
| Principal amount | [25],[27],[31] | $ 15,170 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[27],[31] | 14,896 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[27],[31] | $ 15,416 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[32] | 2028-03 |  |  |  | 2028-03 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[32] | 7.88% |  |  |  | 7.88% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[32] | 8.88% |  |  |  | 8.88% |  |  |  | 
| Principal amount | [31],[32] | $ 26,913 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[32] | 26,355 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[32] | $ 27,412 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and LogicSource, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.93%, Floor rate 9.93% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[32] | 2027-07 |  |  |  | 2027-07 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[32] | 8.93% |  |  |  | 8.93% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[32] | 9.93% |  |  |  | 9.93% |  |  |  | 
| Principal amount | [31],[32] | $ 13,300 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[32] | 13,087 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[32] | $ 13,493 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Marigold Group, Inc. (p.k.a. Campaign Monitor Limited), Senior Secured, Maturity Date November 2025, 3-month SOFR + 9.05%, Floor rate 9.90% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[29] | 2025-11 |  |  |  | 2025-11 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28],[29] | 9.05% |  |  |  | 9.05% |  |  |  | 
| Investment, interest rate, floor | [26],[28],[29] | 9.90% |  |  |  | 9.90% |  |  |  | 
| Principal amount | [26],[29] | $ 33,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[29] | 32,741 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[29] | $ 32,732 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 6-month SOFR + 9.21%, Floor rate 10.06% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [32] | 2025-12 |  |  |  | 2025-12 |  |  |  | 
| Investment, basis spread, variable rate | [28],[32] | 9.31% |  |  |  | 9.31% |  |  |  | 
| Investment, interest rate, floor | [28],[32] | 10.06% |  |  |  | 10.06% |  |  |  | 
| Principal amount | [32] | $ 18,366 |  |  |  |  |  |  |  | 
| Investment cost | [2],[32] | 18,144 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [32] | $ 18,217 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and New Relic, Inc., Senior Secured, Maturity Date November 2030, 3-month SOFR + 6.75%, Floor rate 7.75% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31] | 2030-11 |  |  |  | 2030-11 |  |  |  | 
| Investment, basis spread, variable rate | [31] | 6.75% |  |  |  | 6.75% |  |  |  | 
| Investment, interest rate, floor | [31] | 7.75% |  |  |  | 7.75% |  |  |  | 
| Principal amount | [31] | $ 20,890 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31] | 20,387 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31] | $ 20,387 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Omeda Holdings, LLC, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.05%, Floor rate 9.05% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [30],[31],[32] | 2027-07 |  |  |  | 2027-07 |  |  |  | 
| Investment, basis spread, variable rate | [28],[30],[31],[32] | 8.05% |  |  |  | 8.05% |  |  |  | 
| Investment, interest rate, floor | [28],[30],[31],[32] | 9.05% |  |  |  | 9.05% |  |  |  | 
| Principal amount | [30],[31],[32] | $ 7,706 |  |  |  |  |  |  |  | 
| Investment cost | [2],[30],[31],[32] | 7,519 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [30],[31],[32] | $ 7,751 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Onna Technologies, Inc., Senior Secured, Maturity Date March 2026, Prime + 1.35%, Floor rate 8.85%, PIK Interest, 1.75%, 4.45% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25] | 2026-03 |  |  |  | 2026-03 |  |  |  | 
| Investment, basis spread, variable rate | [25],[28] | 1.35% |  |  |  | 1.35% |  |  |  | 
| Investment, interest rate, floor | [25],[28] | 8.85% |  |  |  | 8.85% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[28] | 1.75% |  |  |  | 1.75% |  |  |  | 
| Investment exit fee | [25],[28] | 4.45% |  |  |  | 4.45% |  |  |  | 
| Principal amount | [25] | $ 3,870 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25] | 3,865 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25] | $ 3,967 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 6-month SOFR + 8.98%, Floor rate 9.88% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[32] | 2026-12 |  |  |  | 2026-12 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[32] | 8.98% |  |  |  | 8.98% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[32] | 9.88% |  |  |  | 9.88% |  |  |  | 
| Principal amount | [31],[32] | $ 6,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[32] | 5,891 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[32] | $ 5,930 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Simon Data, Inc., Senior Secured, Maturity Date March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.48% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[27] | 2027-03 |  |  |  | 2027-03 |  |  |  | 
| Investment, basis spread, variable rate | [25],[27],[28] | 1.00% |  |  |  | 1.00% |  |  |  | 
| Investment, interest rate, floor | [25],[27],[28] | 8.75% |  |  |  | 8.75% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[27],[28] | 1.95% |  |  |  | 1.95% |  |  |  | 
| Investment exit fee | [25],[27],[28] | 2.48% |  |  |  | 2.48% |  |  |  | 
| Principal amount | [25],[27] | $ 12,893 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[27] | 12,855 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[27] | $ 12,922 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Sisense Ltd., Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[33],[34] | 2027-07 |  |  |  | 2027-07 |  |  |  | 
| Investment, basis spread, variable rate | [25],[28],[33],[34] | 1.50% |  |  |  | 1.50% |  |  |  | 
| Investment, interest rate, floor | [25],[28],[33],[34] | 9.50% |  |  |  | 9.50% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[28],[33],[34] | 1.95% |  |  |  | 1.95% |  |  |  | 
| Investment exit fee | [25],[28],[33],[34] | 5.95% |  |  |  | 5.95% |  |  |  | 
| Principal amount | [25],[33],[34] | $ 35,002 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[33],[34] | 34,898 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[33],[34] | $ 35,261 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.25%, Floor rate 8.25% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[32] | 2028-03 |  |  |  | 2028-03 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[32] | 7.25% |  |  |  | 7.25% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[32] | 8.25% |  |  |  | 8.25% |  |  |  | 
| Principal amount | [31],[32] | $ 13,200 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[32] | 12,965 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[32] | $ 13,422 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 6-month SOFR + 7.25%, Floor rate 8.25% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[32] | 2028-03 |  |  |  | 2028-03 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[32] | 7.25% |  |  |  | 7.25% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[32] | 8.25% |  |  |  | 8.25% |  |  |  | 
| Principal amount | [31],[32] | $ 4,400 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[32] | 4,308 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[32] | $ 4,468 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Sumo Logic, Inc., Senior Secured, Maturity Date May 2030, 3-month SOFR + 6.50%, Floor rate 7.50% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31] | 2030-05 |  |  |  | 2030-05 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31] | 6.50% |  |  |  | 6.50% |  |  |  | 
| Investment, interest rate, floor | [28],[31] | 7.50% |  |  |  | 7.50% |  |  |  | 
| Principal amount | [31] | $ 23,000 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31] | 22,474 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31] | $ 23,341 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Suzy, Inc.., Senior Secured, Maturity Date August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[25],[31] | 2027-08 |  |  |  | 2027-08 |  |  |  | 
| Investment, basis spread, variable rate | [1],[25],[28],[31] | 1.75% |  |  |  | 1.75% |  |  |  | 
| Investment, interest rate, floor | [1],[25],[28],[31] | 10.00% |  |  |  | 10.00% |  |  |  | 
| Investment, interest rate, paid in kind | [1],[25],[28],[31] | 1.95% |  |  |  | 1.95% |  |  |  | 
| Investment exit fee | [1],[25],[28],[31] | 3.45% |  |  |  | 3.45% |  |  |  | 
| Principal amount | [1],[25],[31] | $ 12,124 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[25],[31] | 11,931 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[25],[31] | $ 12,246 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 6-month SOFR + 9.25%, Floor rate 10.00% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[32] | 2026-05 |  |  |  | 2026-05 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[32] | 9.25% |  |  |  | 9.25% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[32] | 10.00% |  |  |  | 10.00% |  |  |  | 
| Principal amount | [31],[32] | $ 10,920 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[32] | 10,748 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[32] | $ 10,920 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2027, Prime + 0.45%, Floor rate 7.95%, PIK Interest 2.00%, 3.75% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[31],[33],[34] | 2027-04 |  |  |  | 2027-04 |  |  |  | 
| Investment, basis spread, variable rate | [25],[28],[31],[33],[34] | 0.45% |  |  |  | 0.45% |  |  |  | 
| Investment, interest rate, floor | [25],[28],[31],[33],[34] | 7.95% |  |  |  | 7.95% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[28],[31],[33],[34] | 2.00% |  |  |  | 2.00% |  |  |  | 
| Investment exit fee | [25],[28],[31],[33],[34] | 3.75% |  |  |  | 3.75% |  |  |  | 
| Principal amount | [25],[31],[33],[34] | $ 10,703 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[31],[33],[34] | 10,661 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[31],[33],[34] | 11,057 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Total 3GTMS, LLC |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  | 16,545 |  |  |  |  |  |  |  | 
| Investment cost | [2] | 16,471 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 16,471 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Total Cutover, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | 7,142 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 7,414 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Total Cybermaxx Intermediate Holdings, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Principal amount |  | 10,423 |  |  |  |  |  |  |  | 
| Investment cost | [2] | 10,260 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 10,319 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Zappi, Inc., Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.03%, Floor rate 9.03% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [26],[31],[32],[33],[34] | 2027-12 |  |  |  | 2027-12 |  |  |  | 
| Investment, basis spread, variable rate | [26],[28],[31],[32],[33],[34] | 8.03% |  |  |  | 8.03% |  |  |  | 
| Investment, interest rate, floor | [26],[28],[31],[32],[33],[34] | 9.03% |  |  |  | 9.03% |  |  |  | 
| Principal amount | [26],[31],[32],[33],[34] | $ 12,825 |  |  |  |  |  |  |  | 
| Investment cost | [2],[26],[31],[32],[33],[34] | 12,578 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [26],[31],[32],[33],[34] | $ 12,953 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and Zimperium, Inc., Senior Secured, Maturity Date May 2027, 3-month SOFR + 8.31%, Floor rate 9.31% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [31],[32] | 2027-05 |  |  |  | 2027-05 |  |  |  | 
| Investment, basis spread, variable rate | [28],[31],[32] | 8.31% |  |  |  | 8.31% |  |  |  | 
| Investment, interest rate, floor | [28],[31],[32] | 9.31% |  |  |  | 9.31% |  |  |  | 
| Principal amount | [31],[32] | $ 14,790 |  |  |  |  |  |  |  | 
| Investment cost | [2],[31],[32] | 14,573 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [31],[32] | $ 14,864 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Software and iGrafx, LLC, Senior Secured, Maturity Date May 2027, 1-month SOFR + 8.61%, Floor rate 9.51% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [32] | 2027-05 |  |  |  | 2027-05 |  |  |  | 
| Investment, basis spread, variable rate | [28],[32] | 8.61% |  |  |  | 8.61% |  |  |  | 
| Investment, interest rate, floor | [28],[32] | 9.51% |  |  |  | 9.51% |  |  |  | 
| Principal amount | [32] | $ 4,987 |  |  |  |  |  |  |  | 
| Investment cost | [2],[32] | 4,894 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [32] | $ 4,935 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology (0.93%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.93% |  |  |  | 0.93% |  |  |  | 
| Investment cost | [2] | $ 17,486 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 17,447 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.78% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [25],[26] | 2025-05 |  |  |  | 2025-05 |  |  |  | 
| Investment, basis spread, variable rate | [25],[26],[28] | 4.70% |  |  |  | 4.70% |  |  |  | 
| Investment, interest rate, floor | [25],[26],[28] | 7.95% |  |  |  | 7.95% |  |  |  | 
| Investment, interest rate, paid in kind | [25],[26],[28] | 1.45% |  |  |  | 1.45% |  |  |  | 
| Investment exit fee | [25],[26],[28] | 3.78% |  |  |  | 3.78% |  |  |  | 
| Principal amount | [25],[26] | $ 3,940 |  |  |  |  |  |  |  | 
| Investment cost | [2],[25],[26] | 3,988 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [25],[26] | $ 3,964 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Electric Hydrogen Co., Senior Secured, May 2028, Prime + 2.25%, Floor rate 10.75%, PIK Interest 1.25%, 4.25% Exit Fee |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [1],[29] | 2028-05 |  |  |  | 2028-05 |  |  |  | 
| Investment, basis spread, variable rate | [1],[28],[29] | 2.25% |  |  |  | 2.25% |  |  |  | 
| Investment, interest rate, floor | [1],[28],[29] | 10.75% |  |  |  | 10.75% |  |  |  | 
| Investment, interest rate, paid in kind | [1],[28],[29] | 1.25% |  |  |  | 1.25% |  |  |  | 
| Investment exit fee | [1],[28],[29] | 4.25% |  |  |  | 4.25% |  |  |  | 
| Principal amount | [1],[29] | $ 12,500 |  |  |  |  |  |  |  | 
| Investment cost | [1],[2],[29] | 11,917 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1],[29] | $ 11,917 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, Maturity Date June 2027, FIXED 10.00% |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Maturity Date | [29] | 2027-06 |  |  |  | 2027-06 |  |  |  | 
| Investment, interest rate, paid in kind | [28],[29] | 10.00% |  |  |  | 10.00% |  |  |  | 
| Principal amount | [29] | $ 1,581 |  |  |  |  |  |  |  | 
| Investment cost | [2],[29] | 1,581 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [29] | $ 1,566 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments (7.96%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 7.96% |  |  |  | 7.96% |  |  |  | 
| Investment cost | [2] | $ 155,783 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 150,199 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments (8.44%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 8.44% |  |  |  | 8.44% |  | 
| Investment cost | [5] |  |  | $ 155,226 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 152,170 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Biotechnology Tools (0.08%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.08% |  |  |  | 0.08% |  |  |  | 
| Investment cost | [2] | $ 1,500 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 1,504 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Biotechnology Tools Alamar Biosciences, Inc and Equity, Acquisition Date 2/21/2024, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | 1,500 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 1,504 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Feb. 21,  2024 |  |  |  |  |  |  |  | 
| Shares | shares |  | 503,778 |  |  |  | 503,778 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.12%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.12% |  |  |  | 0.12% |  |  |  | 
| Investment cost | [2] | $ 1,764 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 2,265 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.13%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.13% |  |  |  | 0.13% |  | 
| Investment cost | [5] |  |  | $ 1,764 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 2,264 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc. Equity, Acquisition Date 7/16/2013, Preferred Series B |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | 1,101 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 700 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Jul. 16,  2013 |  |  |  |  |  | 
| Shares | shares |  |  |  | 130,191 |  |  |  | 130,191 |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 128 | [2] | $ 128 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 109 |  | $ 96 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Apr. 30,  2010 | [3] | Apr. 30,  2010 | [42] |  |  |  |  | 
| Shares | shares |  | 42,989 |  | 42,989 |  | 42,989 |  | 42,989 |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 7/16/2013, Series Preferred Series B |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 1,101 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 686 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Jul. 16,  2013 |  |  |  |  |  |  |  | 
| Shares | shares |  | 130,191 |  |  |  | 130,191 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3] | $ 433 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3] | $ 20 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Apr. 30,  2021 |  |  |  |  |  |  |  | 
| Shares | shares | [3] | 12,260 |  |  |  | 12,260 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Equity, Acquisition Date 4/30/2021, Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[42] |  |  | $ 433 |  |  |  |  |  | 
| Investments, at fair value: | [42] |  |  | $ 21 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Apr. 30,  2021 |  |  |  |  |  | 
| Shares | shares | [42] |  |  | 12,260 |  |  |  | 12,260 |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 13 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 792 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Apr. 30,  2010 |  |  |  |  |  |  |  | 
| Shares | shares |  | 172,328 |  |  |  | 172,328 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Equity, Acquisition Date 4/30/2010, Class A Units |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 13 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 863 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Apr. 30,  2010 |  |  |  |  |  | 
| Shares | shares |  |  |  | 172,328 |  |  |  | 172,328 |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 89 | [2] | $ 89 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 658 |  | $ 584 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Apr. 30,  2010 | [3] | Apr. 30,  2010 | [42] |  |  |  |  | 
| Shares | shares |  | 173,180 |  | 173,180 |  | 173,180 |  | 173,180 |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Total Fabletics, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,229 | [2] | $ 1,229 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 795 |  | $ 796 |  |  |  |  |  | 
| Shares | shares |  | 173,180 |  | 173,180 |  | 173,180 |  | 173,180 |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.52%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.52% |  |  |  | 0.52% |  |  |  | 
| Investment cost | [2] | $ 25,684 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 9,778 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.70%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.70% |  |  |  | 0.70% |  | 
| Investment cost | [5] |  |  | $ 26,145 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 12,703 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-4 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 1,151 | [2],[33],[34] | 1,151 | [5],[15],[16] |  |  |  |  | 
| Investments, at fair value: |  | $ 580 | [33],[34] | $ 679 | [15],[16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec. 15,  2021 | [3],[33],[34] | Dec. 15,  2021 | [15],[16],[42] |  |  |  |  | 
| Shares | shares |  | 199,742 | [33],[34] | 199,742 | [15],[16] | 199,742 | [33],[34] | 199,742 | [15],[16] | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 196 | [2],[3] | $ 657 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 2,341 | [3] | $ 5,636 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec. 20,  2018 | [3] | Dec. 20,  2018 | [42] |  |  |  |  | 
| Shares | shares |  | 16,996 | [3] | 56,996 | [42] | 16,996 | [3] | 56,996 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 5,263 | [2],[3] | $ 5,263 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 1,949 | [3] | $ 1,510 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec. 26,  2018 | [3] | Dec. 26,  2018 | [42] |  |  |  |  | 
| Shares | shares |  | 100,738 | [3] | 100,738 | [42] | 100,738 | [3] | 100,738 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,000 | [2],[3] | $ 1,000 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 291 | [3] | $ 343 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep. 17,  2021 | [3] | Sep. 17,  2021 | [42] |  |  |  |  | 
| Shares | shares |  | 100,000 | [3] | 100,000 | [42] | 100,000 | [3] | 100,000 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,663 | [2] | $ 1,663 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 458 |  | $ 377 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Oct. 25,  2016 | [3] | Oct. 25,  2016 | [42] |  |  |  |  | 
| Shares | shares |  | 286,080 |  | 286,080 |  | 286,080 |  | 286,080 |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 632 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 174 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Oct. 25,  2016 |  |  |  |  |  |  |  | 
| Shares | shares |  | 108,710 |  |  |  | 108,710 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 577 | [2],[3] | $ 577 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 118 | [3] | $ 189 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 28,  2013 | [3] | Jun. 28,  2013 | [42] |  |  |  |  | 
| Shares | shares |  | 48,365 | [3] | 48,365 | [42] | 48,365 | [3] | 48,365 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 39 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Jul. 31,  2020 |  |  |  |  |  |  |  | 
| Shares | shares |  | 3,095 |  |  |  | 3,095 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,000 | [2] | $ 1,000 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 559 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jan. 24,  2022 | [3] | Jan. 24,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 7,063 |  | 7,063 |  | 7,063 |  | 7,063 |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 39 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Jul. 31,  2020 |  |  |  |  |  | 
| Shares | shares |  |  |  | 3,095 |  |  |  | 3,095 |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 13,263 | [2],[37] | $ 13,263 | [5],[19] |  |  |  |  | 
| Investments, at fair value: |  | $ 3,832 | [37] | $ 3,251 | [19] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec. 29,  2023 | [3],[37] | Dec. 29,  2023 | [19],[42] |  |  |  |  | 
| Shares | shares |  | 3,235,298 | [37] | 3,235,298 | [19] | 3,235,298 | [37] | 3,235,298 | [19] | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 900 | [2],[37] | $ 900 | [5],[19] |  |  |  |  | 
| Investments, at fair value: |  | $ 11 | [37] | $ 4 | [19] |  |  |  |  | 
| Investments Owned Acquisition Date |  | May 23,  2018 | [3],[37] | May 23,  2018 | [19],[42] |  |  |  |  | 
| Shares | shares |  | 414,994,863 | [37] | 414,994,863 | [19] | 414,994,863 | [37] | 414,994,863 | [19] | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 0 | [2],[37] | $ 0 | [5],[19] |  |  |  |  | 
| Investments, at fair value: |  | $ 24 | [37] | $ 12 | [19] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun.  06,  2016 | [3],[37] | Jun.  06,  2016 | [19],[42] |  |  |  |  | 
| Shares | shares |  | 1,000,000 | [37] | 1,000,000 | [19] | 1,000,000 | [37] | 1,000,000 | [19] | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total OfferUp, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 2,295 | [2] | $ 2,295 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 632 |  | $ 520 |  |  |  |  |  | 
| Shares | shares |  | 394,790 |  | 394,790 |  | 394,790 |  | 394,790 |  | 
| Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total Tectura Corporation |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 14,163 | [2] | $ 14,163 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 3,867 |  | $ 3,267 |  |  |  |  |  | 
| Shares | shares |  | 419,230,161 |  | 419,230,161 |  | 419,230,161 |  | 419,230,161 |  | 
| Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (2.84%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 2.84% |  |  |  | 2.84% |  |  |  | 
| Investment cost | [2] | $ 34,444 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 53,617 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (3.17%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 3.17% |  |  |  | 3.17% |  | 
| Investment cost | [5] |  |  | $ 34,444 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 57,072 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Equity, Acquisition Date 3/1/2018, Series Member Units |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 34,006 | [2],[37],[38] | 34,006 | [5],[19],[20] |  |  |  |  | 
| Investments, at fair value: |  | $ 23,413 | [37],[38] | $ 28,034 | [19],[20] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar.  01,  2018 | [3],[37],[38] | Mar.  01,  2018 | [19],[20],[42] |  |  |  |  | 
| Shares | shares |  | 1 | [37],[38] | 1 | [19],[20] | 1 | [37],[38] | 1 | [19],[20] | 
| Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 35 | [2],[37],[39] | $ 35 | [5],[19],[21] |  |  |  |  | 
| Investments, at fair value: |  | $ 29,884 | [37],[39] | $ 28,713 | [19],[21] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 26,  2021 | [3],[37],[39] | Mar. 26,  2021 | [19],[21],[42] |  |  |  |  | 
| Shares | shares |  | 1 | [37],[39] | 1 | [19],[21] | 1 | [37],[39] | 1 | [19],[21] | 
| Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 403 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 320 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Sep. 30,  2021 |  |  |  |  |  |  |  | 
| Shares | shares |  | 210,282 |  |  |  | 210,282 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Diversified Financial Services, Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 403 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 325 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Sep. 30,  2021 |  |  |  |  |  | 
| Shares | shares |  |  |  | 210,282 |  |  |  | 210,282 |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Delivery (0.00%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets |  | 0.00% |  | 0.00% | [4] | 0.00% |  | 0.00% | [4] | 
| Investment cost |  | $ 3,638 | [2] | $ 3,638 | [5] |  |  |  |  | 
| Investments, at fair value: |  | 21 |  | 21 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 1,500 | [2],[3] | 1,500 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 2 | [3] | $ 2 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 28,  2014 | [3] | Mar. 28,  2014 | [42] |  |  |  |  | 
| Shares | shares |  | 680 | [3] | 680 | [42] | 680 | [3] | 680 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 500 | [2] | $ 500 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec.  08,  2015 | [3] | Dec.  08,  2015 | [42] |  |  |  |  | 
| Shares | shares |  | 165,000 |  | 165,000 |  | 165,000 |  | 165,000 |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 309 | [2],[3] | $ 309 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 10 | [3] | $ 12 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Apr.  06,  2015 | [3] | Apr.  06,  2015 | [42] |  |  |  |  | 
| Shares | shares |  | 2,498 | [3] | 2,498 | [42] | 2,498 | [3] | 2,498 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Delivery and Talphera, Inc, Equity, Acquisition Date 12/10/2018, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3] | $ 1,329 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3] | $ 9 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Dec. 10,  2018 |  |  |  |  |  |  |  | 
| Shares | shares | [3] | 8,836 |  |  |  | 8,836 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Delivery and Talphera, Inc. (p.k.a. AcelRx Pharmaceuticals, Inc.), Equity, Acquisition Date 12/10/2018, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[42] |  |  | $ 1,329 |  |  |  |  |  | 
| Investments, at fair value: | [42] |  |  | $ 7 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Dec. 10,  2018 |  |  |  |  |  | 
| Shares | shares | [42] |  |  | 8,836 |  |  |  | 8,836 |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (2.47%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 2.47% |  |  |  | 2.47% |  | 
| Investment cost | [5] |  |  | $ 40,735 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 44,500 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (2.63%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 2.63% |  |  |  | 2.63% |  |  |  | 
| Investment cost | [2] | $ 41,728 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 49,676 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Akero Therapeutics, Inc., Equity, Acquisition Date 3/8/2024, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3],[33] | 1,000 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3],[33] | $ 871 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3],[33] | Mar.  08,  2024 |  |  |  |  |  |  |  | 
| Shares | shares | [3],[33] | 34,483 |  |  |  | 34,483 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,000 | [2],[3] | 1,000 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 1 | [3] | $ 0 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug. 19,  2014 | [3] | Aug. 19,  2014 | [42] |  |  |  |  | 
| Shares | shares |  | 42 | [3] | 42 | [42] | 42 | [3] | 42 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3],[33],[36] | $ 4,165 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3],[33],[36] | $ 10,136 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3],[33],[36] | May  09,  2022 |  |  |  |  |  |  |  | 
| Shares | shares | [3],[33],[36] | 127,021 |  |  |  | 127,021 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc.., Equity, Acquisition Date 5/9/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[16],[18],[42] |  |  | $ 4,165 |  |  |  |  |  | 
| Investments, at fair value: | [16],[18],[42] |  |  | $ 10,110 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [16],[18],[42] |  |  | May  09,  2022 |  |  |  |  |  | 
| Shares | shares | [16],[18],[42] |  |  | 127,021 |  |  |  | 127,021 |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/05/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[15],[16],[42] |  |  | $ 1,871 |  |  |  |  |  | 
| Investments, at fair value: | [15],[16],[42] |  |  | $ 1,774 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [15],[16],[42] |  |  | Oct.  05,  2020 |  |  |  |  |  | 
| Shares | shares | [15],[16],[42] |  |  | 98,100 |  |  |  | 98,100 |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/5/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3],[33],[34] | $ 1,871 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3],[33],[34] | $ 2,443 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3],[33],[34] | Oct.  05,  2020 |  |  |  |  |  |  |  | 
| Shares | shares | [3],[33],[34] | 98,100 |  |  |  | 98,100 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 2,255 | [2],[3] | $ 2,255 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 7,153 | [3] | $ 9,339 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 21,  2018 | [3] | Jun. 21,  2018 | [42] |  |  |  |  | 
| Shares | shares |  | 231,329 | [3] | 231,329 | [42] | 231,329 | [3] | 231,329 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc. (p.k.a. Applied Molecular Transport)., Equity, Acquisition Date 4/06/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[16],[42] |  |  | $ 42 |  |  |  |  |  | 
| Investments, at fair value: | [16],[42] |  |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [16],[42] |  |  | Apr.  06,  2021 |  |  |  |  |  | 
| Shares | shares | [16],[42] |  |  | 134 |  |  |  | 134 |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc., Equity, Acquisition Date 4/6/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3],[33] | $ 42 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3],[33] | $ 0 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3],[33] | Apr.  06,  2021 |  |  |  |  |  |  |  | 
| Shares | shares | [3],[33] | 134 |  |  |  | 134 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3] | $ 1,000 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3] | $ 7 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Jan.  08,  2015 |  |  |  |  |  |  |  | 
| Shares | shares | [3] | 13,550 |  |  |  | 13,550 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[42] |  |  | $ 1,000 |  |  |  |  |  | 
| Investments, at fair value: | [42] |  |  | $ 4 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Jan.  08,  2015 |  |  |  |  |  | 
| Shares | shares | [42] |  |  | 13,550 |  |  |  | 13,550 |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 550 | [2],[3],[33] | $ 550 | [5],[16],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 248 | [3],[33] | $ 280 | [16],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jul. 22,  2015 | [3],[33] | Jul. 22,  2015 | [16],[42] |  |  |  |  | 
| Shares | shares |  | 20,000 | [3],[33] | 20,000 | [16],[42] | 20,000 | [3],[33] | 20,000 | [16],[42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, Acquisition Date 10/26/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,000 | [2],[3] | $ 1,000 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 1,137 | [3] | $ 903 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Oct. 26,  2022 | [3] | Oct. 26,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 442,477 | [3] | 442,477 | [42] | 442,477 | [3] | 442,477 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, Acquisition Date 7/25/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 500 | [2],[3] | $ 500 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 1,011 | [3] | $ 620 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jul. 25,  2023 | [3] | Jul. 25,  2023 | [42] |  |  |  |  | 
| Shares | shares |  | 364,963 | [3] | 364,963 | [42] | 364,963 | [3] | 364,963 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 4,250 | [1],[2] | $ 4,250 | [5],[14] |  |  |  |  | 
| Investments, at fair value: |  | $ 2,292 | [1] | $ 1,834 | [14] |  |  |  |  | 
| Investments Owned Acquisition Date |  | May  07,  2021 | [1],[3] | May  07,  2021 | [14],[42] |  |  |  |  | 
| Shares | shares |  | 3,466,840 | [1] | 3,466,840 | [14] | 3,466,840 | [1] | 3,466,840 | [14] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and HilleVax, Inc, Equity, Acquisition Date 5/3/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3] | $ 4,000 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3] | $ 3,913 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | May  03,  2022 |  |  |  |  |  |  |  | 
| Shares | shares | [3] | 235,295 |  |  |  | 235,295 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and HilleVax, Inc., Equity, Acquisition Date 5/3/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[42] |  |  | $ 4,000 |  |  |  |  |  | 
| Investments, at fair value: | [42] |  |  | $ 3,777 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | May  03,  2022 |  |  |  |  |  | 
| Shares | shares | [42] |  |  | 235,295 |  |  |  | 235,295 |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, Acquisition Date 3/31/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 800 | [2],[3],[33] | $ 800 | [5],[16],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 | [3],[33] | $ 0 | [16],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 31,  2021 | [3],[33] | Mar. 31,  2021 | [16],[42] |  |  |  |  | 
| Shares | shares |  | 43,243 | [3],[33] | 43,243 | [16],[42] | 43,243 | [3],[33] | 43,243 | [16],[42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, Acquisition Date 6/16/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 550 | [2],[3],[33] | $ 550 | [5],[16],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 1,020 | [3],[33] | $ 688 | [16],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 16,  2023 | [3],[33] | Jun. 16,  2023 | [16],[42] |  |  |  |  | 
| Shares | shares |  | 47,826 | [3],[33] | 47,826 | [16],[42] | 47,826 | [3],[33] | 47,826 | [16],[42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Equity, Acquisition Date 9/29/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 774 | [2],[3],[33] | $ 773 | [5],[16],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 1,362 | [3],[33] | $ 1,180 | [16],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep. 29,  2023 | [3],[33] | Sep. 29,  2023 | [16],[42] |  |  |  |  | 
| Shares | shares |  | 5,100 | [3],[33] | 5,100 | [16],[42] | 5,100 | [3],[33] | 5,100 | [16],[42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 2,000 | [2],[33],[34] | $ 2,000 | [5],[15],[16] |  |  |  |  | 
| Investments, at fair value: |  | $ 1,113 | [33],[34] | $ 1,427 | [15],[16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec. 15,  2021 | [3],[33],[34] | Dec. 15,  2021 | [15],[16],[42] |  |  |  |  | 
| Shares | shares |  | 983 | [33],[34] | 983 | [15],[16] | 983 | [33],[34] | 983 | [15],[16] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, Acquisition Date 6/9/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,730 | [2],[3],[33],[36] | $ 1,730 | [5],[16],[18],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 1,564 | [3],[33],[36] | $ 1,344 | [16],[18],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun.  09,  2023 | [3],[33],[36] | Jun.  09,  2023 | [16],[18],[42] |  |  |  |  | 
| Shares | shares |  | 147,233 | [3],[33],[36] | 147,233 | [16],[18],[42] | 147,233 | [3],[33],[36] | 147,233 | [16],[18],[42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,500 | [2],[3] | $ 1,500 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 25 | [3] | $ 28 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug. 22,  2007 | [3] | Aug. 22,  2007 | [42] |  |  |  |  | 
| Shares | shares |  | 944 | [3] | 944 | [42] | 944 | [3] | 944 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 202 | [2],[3] | $ 203 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 55 | [3] | $ 52 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug. 11,  2015 | [3] | Aug. 11,  2015 | [42] |  |  |  |  | 
| Shares | shares |  | 11,119 | [3] | 11,119 | [42] | 11,119 | [3] | 11,119 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, Acquisition Date 2/2/2017, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,262 | [2] | $ 1,269 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 6 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Feb.  02,  2017 | [3] | Feb.  02,  2017 | [42] |  |  |  |  | 
| Shares | shares |  | 16,228 |  | 16,228 | [42] | 16,228 |  | 16,228 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, Acquisition Date 5/5/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 2,100 | [2],[3],[33] | $ 2,100 | [5],[16],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 5,654 | [3],[33] | $ 3,150 | [16],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | May  05,  2022 | [3],[33] | May  05,  2022 | [16],[42] |  |  |  |  | 
| Shares | shares |  | 155,555 | [3],[33] | 155,555 | [16],[42] | 155,555 | [3],[33] | 155,555 | [16],[42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Total Valo Health, LLC |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 4,000 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 4,098 |  |  |  |  |  | 
| Shares | shares |  |  |  | 680,410 |  |  |  | 680,410 |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,000 | [2] | $ 1,000 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 1,344 |  | $ 1,187 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Oct. 31,  2022 | [3] | Oct. 31,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 170,102 |  | 170,102 |  | 170,102 |  | 170,102 |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 3,000 | [2] | $ 3,000 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 3,372 |  | $ 2,911 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec. 11,  2020 | [3] | Dec. 11,  2020 | [42] |  |  |  |  | 
| Shares | shares |  | 510,308 |  | 510,308 |  | 510,308 |  | 510,308 |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, Acquisition Date 9/6/2023, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,500 | [2] | $ 1,500 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 2,123 |  | $ 1,753 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep.  06,  2023 | [3] | Sep.  06,  2023 | [42] |  |  |  |  | 
| Shares | shares |  | 208,588 |  | 208,588 |  | 208,588 |  | 208,588 |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc Equity, Acquisition Date 11/6/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3],[33] | $ 400 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3],[33] | $ 566 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3],[33] | Nov.  06,  2023 |  |  |  |  |  |  |  | 
| Shares | shares | [3],[33] | 32,310 |  |  |  | 32,310 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Equity, Acquisition Date 11/6/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[16],[42] |  |  | $ 400 |  |  |  |  |  | 
| Investments, at fair value: | [16],[42] |  |  | $ 704 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [16],[42] |  |  | Nov.  06,  2023 |  |  |  |  |  | 
| Shares | shares | [16],[42] |  |  | 32,310 |  |  |  | 32,310 |  | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 2,945 | [2],[3] | $ 2,945 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 2,177 | [3] | $ 1,313 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Nov. 26,  2019 | [3] | Nov. 26,  2019 | [42] |  |  |  |  | 
| Shares | shares |  | 1,566,064 | [3] | 1,566,064 | [42] | 1,566,064 | [3] | 1,566,064 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 332 | [2],[3],[33],[34] | $ 332 | [5],[15],[16],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 89 | [3],[33],[34] | $ 116 | [15],[16],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jan. 31,  2019 | [3],[33],[34] | Jan. 31,  2019 | [15],[16],[42] |  |  |  |  | 
| Shares | shares |  | 17,175 | [3],[33],[34] | 17,175 | [15],[16],[42] | 17,175 | [3],[33],[34] | 17,175 | [15],[16],[42] | 
| Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development, Total Valo Health LLC |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 4,000 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 4,716 |  |  |  |  |  |  |  | 
| Shares | shares |  | 680,410 |  |  |  | 680,410 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.04%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.04% |  |  |  | 0.04% |  |  |  | 
| Investment cost | [2] | $ 2,150 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 817 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.05%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.05% |  |  |  | 0.05% |  | 
| Investment cost | [5] |  |  | $ 2,150 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 951 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 650 | [2] | 650 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 332 |  | $ 407 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Nov. 17,  2022 | [3] | Nov. 17,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 15,116 |  | 15,116 |  | 15,116 |  | 15,116 |  | 
| Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,500 | [2] | $ 1,500 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 485 |  | $ 544 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar.  08,  2022 | [3] | Mar.  08,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 248,900 |  | 248,900 |  | 248,900 |  | 248,900 |  | 
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.03%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.03% |  |  |  | 0.03% |  |  |  | 
| Investment cost | [2] | $ 6,781 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 561 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.05%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.05% |  |  |  | 0.05% |  | 
| Investment cost | [5] |  |  | $ 6,782 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 960 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 5,094 | [2],[3] | 5,094 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 439 | [3] | $ 754 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 11,  2019 | [3] | Mar. 11,  2019 | [42] |  |  |  |  | 
| Shares | shares |  | 825,732 | [3] | 825,732 | [42] | 825,732 | [3] | 825,732 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,687 | [2] | $ 1,688 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 122 |  | $ 206 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 30,  2021 | [3] | Mar. 30,  2021 | [42] |  |  |  |  | 
| Shares | shares |  | 217,880 |  | 217,880 |  | 217,880 |  | 217,880 |  | 
| Investment, Identifier [Axis]: Equity Investments Information Services (0.31%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.31% |  |  |  | 0.31% |  |  |  | 
| Investment cost | [2] | $ 4,440 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 5,886 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Information Services (0.35%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.35% |  |  |  | 0.35% |  | 
| Investment cost | [5] |  |  | $ 4,440 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 6,243 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 615 | [2],[3] | 615 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 1,397 | [3] | $ 1,353 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 21,  2019 | [3] | Jun. 21,  2019 | [42] |  |  |  |  | 
| Shares | shares |  | 547,880 | [3] | 547,880 | [42] | 547,880 | [3] | 547,880 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 3,825 | [2] | $ 3,825 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 4,489 |  | $ 4,890 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec. 30,  2021 | [3] | Dec. 30,  2021 | [42] |  |  |  |  | 
| Shares | shares |  | 41,021 |  | 41,021 |  | 41,021 |  | 41,021 |  | 
| Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment (0.01%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.01% |  |  |  | 0.01% |  | 
| Investment cost | [5] |  |  | $ 250 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 262 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment (0.02%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.02% |  |  |  | 0.02% |  |  |  | 
| Investment cost | [2] | $ 250 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 283 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 0 | [2],[37] | 0 | [5],[19] |  |  |  |  | 
| Investments, at fair value: |  | $ 1 | [37] | $ 2 | [19] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Oct. 15,  2021 | [3],[37] | Oct. 15,  2021 | [19],[42] |  |  |  |  | 
| Shares | shares |  | 180,000 | [37] | 180,000 | [19] | 180,000 | [37] | 180,000 | [19] | 
| Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[37] | $ 250 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [37] | $ 282 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3],[37] | Oct. 15,  2021 |  |  |  |  |  |  |  | 
| Shares | shares | [37] | 5,000,000 |  |  |  | 5,000,000 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment, Coronado Aesthetics, LLC |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 250 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 262 |  |  |  |  |  | 
| Shares | shares |  |  |  | 5,180,000 |  |  |  | 5,180,000 |  | 
| Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment, Total Coronado Aesthetics, LLC |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 250 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 283 |  |  |  |  |  |  |  | 
| Shares | shares |  | 5,180,000 |  |  |  | 5,180,000 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Semiconductors (0.02%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets |  | 0.02% | [24] | 0.02% | [4] | 0.02% | [24] | 0.02% | [4] | 
| Investment cost |  | $ 160 | [2] | $ 160 | [5] |  |  |  |  | 
| Investments, at fair value: |  | 326 |  | 394 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 160 | [2] | 160 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 326 |  | $ 394 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jul.  01,  2011 | [3] | Jul.  01,  2011 | [42] |  |  |  |  | 
| Shares | shares |  | 277,995 |  | 277,995 |  | 277,995 |  | 277,995 |  | 
| Investment, Identifier [Axis]: Equity Investments Software (1.18%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 1.18% |  |  |  | 1.18% |  |  |  | 
| Investment cost | [2] | $ 22,278 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 22,343 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Software (1.27%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 1.27% |  |  |  | 1.27% |  | 
| Investment cost | [5] |  |  | $ 23,210 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 22,919 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 1,000 | [2] | 1,000 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 844 |  | $ 863 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug.  09,  2021 | [3] | Aug.  09,  2021 | [42] |  |  |  |  | 
| Shares | shares |  | 1,000,000 |  | 1,000,000 |  | 1,000,000 |  | 1,000,000 |  | 
| Investment, Identifier [Axis]: Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 2,406 | [2],[43] | $ 2,406 | [5],[44] |  |  |  |  | 
| Investments, at fair value: |  | $ 2,406 | [43] | $ 2,406 | [44] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 24,  2021 | [3],[43] | Mar. 24,  2021 | [42],[44] |  |  |  |  | 
| Shares | shares |  | 3 | [43] | 3 | [44] | 3 | [43] | 3 | [44] | 
| Investment, Identifier [Axis]: Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-3 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 51 | [2] | $ 51 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Oct. 26,  2012 | [3] | Oct. 26,  2012 | [42] |  |  |  |  | 
| Shares | shares |  | 53,614 |  | 53,614 |  | 53,614 |  | 53,614 |  | 
| Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 500 | [2],[33],[34] | $ 500 | [5],[15],[16] |  |  |  |  | 
| Investments, at fair value: |  | $ 857 | [33],[34] | $ 842 | [15],[16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Nov. 20,  2018 | [3],[33],[34] | Nov. 20,  2018 | [15],[16],[42] |  |  |  |  | 
| Shares | shares |  | 108,500 | [33],[34] | 108,500 | [15],[16] | 108,500 | [33],[34] | 108,500 | [15],[16] | 
| Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 138 | [2],[33],[34] | $ 138 | [5],[15],[16] |  |  |  |  | 
| Investments, at fair value: |  | $ 309 | [33],[34] | $ 303 | [15],[16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec. 22,  2020 | [3],[33],[34] | Dec. 22,  2020 | [15],[16],[42] |  |  |  |  | 
| Shares | shares |  | 41,000 | [33],[34] | 41,000 | [15],[16] | 41,000 | [33],[34] | 41,000 | [15],[16] | 
| Investment, Identifier [Axis]: Equity Investments Software and DNAnexus, Inc, Equity, Acquisition Date 3/21/2014, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 97 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 7 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Mar. 21,  2014 |  |  |  |  |  |  |  | 
| Shares | shares |  | 51,948 |  |  |  | 51,948 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 4,284 | [2] | $ 4,284 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 391 |  | $ 636 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Nov. 29,  2018 | [3] | Nov. 29,  2018 | [42] |  |  |  |  | 
| Shares | shares |  | 20,000 |  | 20,000 |  | 20,000 |  | 20,000 |  | 
| Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 2 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,000 | [2] | $ 1,000 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 2,607 |  | $ 2,752 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Oct. 22,  2015 | [3] | Oct. 22,  2015 | [42] |  |  |  |  | 
| Shares | shares |  | 458,841 |  | 458,841 |  | 458,841 |  | 458,841 |  | 
| Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 3 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 300 | [2] | $ 300 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 558 |  | $ 587 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug. 24,  2017 | [3] | Aug. 24,  2017 | [42] |  |  |  |  | 
| Shares | shares |  | 93,620 |  | 93,620 |  | 93,620 |  | 93,620 |  | 
| Investment, Identifier [Axis]: Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 307 | [2] | $ 307 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jan. 18,  2013 | [3] | Jan. 18,  2013 | [42] |  |  |  |  | 
| Shares | shares |  | 190 |  | 190 |  | 190 |  | 190 |  | 
| Investment, Identifier [Axis]: Equity Investments Software and Leapwork ApS, Equity, Acquisition Date 8/25/2023, Preferred Series B2 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[15],[16] |  |  | $ 250 |  |  |  |  |  | 
| Investments, at fair value: | [15],[16] |  |  | $ 231 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [15],[16],[42] |  |  | Aug. 25,  2023 |  |  |  |  |  | 
| Shares | shares | [15],[16] |  |  | 183,073 |  |  |  | 183,073 |  | 
| Investment, Identifier [Axis]: Equity Investments Software and Leapwork ApS., Equity, Acquisition Date 8/25/2023, Series Preferred Series B2 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[33],[34] | $ 250 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [33],[34] | $ 215 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3],[33],[34] | Aug. 25,  2023 |  |  |  |  |  |  |  | 
| Shares | shares | [33],[34] | 183,073 |  |  |  | 183,073 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 265 | [2] | $ 265 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 18 |  | $ 23 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec.  04,  2020 | [3] | Dec.  04,  2020 | [42] |  |  |  |  | 
| Shares | shares |  | 38,461 |  | 38,461 |  | 38,461 |  | 38,461 |  | 
| Investment, Identifier [Axis]: Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 4,854 | [2],[3] | $ 4,854 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 2,293 | [3] | $ 1,927 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug.  01,  2018 | [3] | Aug.  01,  2018 | [42] |  |  |  |  | 
| Shares | shares |  | 1,019,255 | [3] | 1,019,255 | [42] | 1,019,255 | [3] | 1,019,255 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 2,445 | [2],[3] | $ 3,474 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 9,204 | [3] | $ 9,758 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep. 23,  2020 | [3] | Sep. 23,  2020 | [42] |  |  |  |  | 
| Shares | shares |  | 400,000 | [3] | 568,337 | [42] | 400,000 | [3] | 568,337 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 2,000 | [2] | $ 2,000 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 1,711 |  | $ 1,721 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Nov. 25,  2020 | [3] | Nov. 25,  2020 | [42] |  |  |  |  | 
| Shares | shares |  | 580,983 |  | 580,983 |  | 580,983 |  | 580,983 |  | 
| Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 280 | [2] | $ 280 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 193 |  | $ 196 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug. 12,  2021 | [3] | Aug. 12,  2021 | [42] |  |  |  |  | 
| Shares | shares |  | 52,956 |  | 52,956 |  | 52,956 |  | 52,956 |  | 
| Investment, Identifier [Axis]: Equity Investments Software and Total Contentful Global, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 638 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 1,145 |  |  |  |  |  | 
| Shares | shares |  |  |  | 149,500 |  |  |  | 149,500 |  | 
| Investment, Identifier [Axis]: Equity Investments Software and Total Druva Holdings, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 1,300 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 3,339 |  |  |  |  |  | 
| Shares | shares |  |  |  | 552,461 |  |  |  | 552,461 |  | 
| Investment, Identifier [Axis]: Equity Investments Software and Total SingleStore, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 2,280 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 1,917 |  |  |  |  |  | 
| Shares | shares |  |  |  | 633,939 |  |  |  | 633,939 |  | 
| Investment, Identifier [Axis]: Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 2,000 | [2] | $ 2,000 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 405 |  | $ 422 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jul.  08,  2021 | [3] | Jul.  08,  2021 | [42] |  |  |  |  | 
| Shares | shares |  | 952,562 |  | 952,562 |  | 952,562 |  | 952,562 |  | 
| Investment, Identifier [Axis]: Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 101 | [2],[3] | $ 101 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 325 | [3] | $ 252 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | May  07,  2020 | [3] | May  07,  2020 | [42] |  |  |  |  | 
| Shares | shares |  | 289,992 | [3] | 289,992 | [42] | 289,992 | [3] | 289,992 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Software, Total Contentful Global, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 638 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 1,166 |  |  |  |  |  |  |  | 
| Shares | shares |  | 149,500 |  |  |  | 149,500 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Software, Total Druva Holdings, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 1,300 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 3,165 |  |  |  |  |  |  |  | 
| Shares | shares |  | 552,461 |  |  |  | 552,461 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Software, Total SingleStore, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 2,280 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 1,904 |  |  |  |  |  |  |  | 
| Shares | shares |  | 633,939 |  |  |  | 633,939 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.17%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.17% |  |  |  | 0.17% |  |  |  | 
| Investment cost | [2] | $ 10,966 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 3,122 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.22%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.22% |  |  |  | 0.22% |  | 
| Investment cost | [5] |  |  | $ 11,508 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 3,881 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-1 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 711 | [2] | 711 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 313 |  | $ 529 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep. 13,  2012 | [3] | Sep. 13,  2012 | [42] |  |  |  |  | 
| Shares | shares |  | 187,265 |  | 187,265 |  | 187,265 |  | 187,265 |  | 
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 3/10/2019, Series Preferred Series E-1 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 2,000 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 375 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | May 10,  2019 |  |  |  |  |  |  |  | 
| Shares | shares |  | 188,611 |  |  |  | 188,611 |  |  |  | 
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-1 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 2,000 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 479 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | May 10,  2019 |  |  |  |  |  | 
| Shares | shares |  |  |  | 188,611 |  |  |  | 188,611 |  | 
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 500 | [2] | $ 500 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun.  01,  2015 | [3] | Jun.  01,  2015 | [42] |  |  |  |  | 
| Shares | shares |  | 1,035 |  | 1,035 |  | 1,035 |  | 1,035 |  | 
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 102 | [2] | $ 102 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug. 31,  2013 | [3] | Aug. 31,  2013 | [42] |  |  |  |  | 
| Shares | shares |  | 59,665 |  | 59,665 |  | 59,665 |  | 59,665 |  | 
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 3,153 | [2],[3] | $ 3,153 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 21 | [3] | $ 180 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec. 10,  2020 | [3] | Dec. 10,  2020 | [42] |  |  |  |  | 
| Shares | shares |  | 304,487 | [3] | 304,487 | [42] | 304,487 | [3] | 304,487 | [42] | 
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 4,500 | [2] | $ 4,500 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 2,413 |  | $ 2,684 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 28,  2021 | [3] | Jun. 28,  2021 | [42] |  |  |  |  | 
| Shares | shares |  | 593,080 |  | 593,080 |  | 593,080 |  | 593,080 |  | 
| Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Proterra, Inc., Equity, Acquisition Date 5/28/2015, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[42] |  |  | $ 542 |  |  |  |  |  | 
| Investments, at fair value: | [42] |  |  | $ 9 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | May 28,  2015 |  |  |  |  |  | 
| Shares | shares | [42] |  |  | 457,841 |  |  |  | 457,841 |  | 
| Investment, Identifier [Axis]: Equity Investments and Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[19] |  |  | $ 250 |  |  |  |  |  | 
| Investments, at fair value: | [19] |  |  | $ 260 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [19],[42] |  |  | Oct. 15,  2021 |  |  |  |  |  | 
| Shares | shares | [19] |  |  | 5,000,000 |  |  |  | 5,000,000 |  | 
| Investment, Identifier [Axis]: Equity, Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date10/25/2016, Series Preferred Series A-1 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 632 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 143 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Oct. 25,  2016 |  |  |  |  |  | 
| Shares | shares |  |  |  | 108,710 |  |  |  | 108,710 |  | 
| Investment, Identifier [Axis]: Investment Fund After Cash & Cash Equivalents (183.28%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets |  |  |  | 183.28% |  |  |  | 183.28% |  | 
| Investment cost | [5] |  |  | $ 3,303,033 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 3,304,046 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Investment Fund Cash & Cash Equivalent and GS Financial Square Government Fund, Series FGTXX/38141W273 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | 56,000 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 56,000 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Investment Fund In Cash & Cash Equivalents (3.11%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets |  |  |  | 3.11% |  |  |  | 3.11% |  | 
| Investment cost | [5] |  |  | $ 56,000 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 56,000 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.26%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.26% |  |  |  | 0.26% |  | 
| Investment cost | [5] |  |  | $ 4,483 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 4,608 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.31%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.31% |  |  |  | 0.31% |  |  |  | 
| Investment cost | [2] | $ 4,730 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 5,779 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.23%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.23% |  |  |  | 0.23% |  | 
| Investment cost | [5] |  |  | $ 4,102 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 4,230 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.29%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.29% |  |  |  | 0.29% |  |  |  | 
| Investment cost | [2] | $ 4,349 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 5,384 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/2020 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 3,783 | [2],[31],[33],[34] | 3,783 | [5],[12],[15],[16] |  |  |  |  | 
| Investments, at fair value: |  | $ 3,916 | [31],[33],[34] | $ 3,619 | [12],[15],[16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Nov. 16,  2020 | [3],[31],[33],[34] | Nov. 16,  2020 | [12],[15],[16],[42] |  |  |  |  | 
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/2022 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 566 | [2],[31],[33],[34] | $ 319 | [5],[12],[15],[16] |  |  |  |  | 
| Investments, at fair value: |  | $ 1,468 | [31],[33],[34] | $ 611 | [12],[15],[16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 23,  2022 | [3],[31],[33],[34] | Jun. 23,  2022 | [12],[15],[16],[42] |  |  |  |  | 
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software (0.02%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets |  | 0.02% | [24] | 0.02% | [4] | 0.02% | [24] | 0.02% | [4] | 
| Investment cost |  | $ 381 | [2] | $ 381 | [5] |  |  |  |  | 
| Investments, at fair value: |  | 395 |  | $ 378 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[33],[34] | 381 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [33],[34] | $ 395 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3],[33],[34] | Jul. 21,  2022 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Investments (180.18%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 180.18% |  |  |  | 180.18% |  | 
| Investment cost | [5] |  |  | $ 3,247,033 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 3,248,046 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Investments (189.38%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 189.38% |  |  |  | 189.38% |  |  |  | 
| Investment cost | [2] | $ 3,574,576 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 3,571,641 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Investments in Securities (179.92%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 179.92% |  |  |  | 179.92% |  | 
| Investment cost | [5] |  |  | $ 3,242,550 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 3,243,438 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Investments in Securities (189.08%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 189.08% |  |  |  | 189.08% |  |  |  | 
| Investment cost | [2] | $ 3,569,846 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 3,565,862 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Total Debt Investments (169.59%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 169.59% |  |  |  | 169.59% |  | 
| Investment cost | [5] |  |  | $ 3,058,370 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 3,057,299 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Total Warrant Investments (1.88%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 1.88% |  |  |  | 1.88% |  | 
| Investment cost | [5] |  |  | $ 28,954 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 33,969 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Diversified Financial Services (0.03%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets |  |  |  | 0.03% |  |  |  | 0.03% |  | 
| Investment cost |  |  |  | $ 214 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 554 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments (1.73%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 1.73% |  |  |  | 1.73% |  |  |  | 
| Investment cost | [2] | $ 30,399 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 32,693 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools (0.02%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets |  | 0.02% | [24] | 0.02% | [4] | 0.02% | [24] | 0.02% | [4] | 
| Investment cost |  | $ 496 | [2] | $ 496 | [5] |  |  |  |  | 
| Investments, at fair value: |  | 326 |  | 354 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Series Preferred Series B |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 36 | [2] | 36 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 84 |  | $ 20 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 21,  2022 | [3] | Jun. 21,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 46,197 |  | 46,197 |  | 46,197 |  | 46,197 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 460 | [2],[27] | $ 460 | [5],[10] |  |  |  |  | 
| Investments, at fair value: |  | $ 242 | [27] | $ 334 | [10] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec. 23,  2022 | [3],[27] | Dec. 23,  2022 | [10],[42] |  |  |  |  | 
| Shares | shares |  | 53,418 | [27] | 53,418 | [10] | 53,418 | [27] | 53,418 | [10] | 
| Investment, Identifier [Axis]: Warrant Investments and Communications & Networking (0.01%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets |  | 0.01% | [24] | 0.01% | [4] | 0.01% | [24] | 0.01% | [4] | 
| Investment cost |  | $ 123 | [2] | $ 123 | [5] |  |  |  |  | 
| Investments, at fair value: |  | 132 |  | 128 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 123 | [2],[27] | 123 | [5],[10] |  |  |  |  | 
| Investments, at fair value: |  | $ 132 | [27] | $ 128 | [10] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 28,  2022 | [3],[27] | Jun. 28,  2022 | [10],[42] |  |  |  |  | 
| Shares | shares |  | 229,611 | [27] | 229,611 | [10] | 229,611 | [27] | 229,611 | [10] | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products (0.02%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets |  | 0.02% | [24] | 0.02% | [4] | 0.02% | [24] | 0.02% | [4] | 
| Investment cost |  | $ 611 | [2] | $ 611 | [5] |  |  |  |  | 
| Investments, at fair value: |  | 411 |  | 325 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 228 | [2] | 228 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun.  03,  2014 | [3] | Jun.  03,  2014 | [42] |  |  |  |  | 
| Shares | shares |  | 1,662,441 |  | 1,662,441 |  | 1,662,441 |  | 1,662,441 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 365 | [2] | $ 365 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug. 13,  2014 | [3] | Aug. 13,  2014 | [42] |  |  |  |  | 
| Shares | shares |  | 54,054 |  | 54,054 |  | 54,054 |  | 54,054 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 18 | [2] | $ 18 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 411 |  | $ 325 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 27,  2018 | [3] | Jun. 27,  2018 | [42] |  |  |  |  | 
| Shares | shares |  | 686,270 |  | 686,270 |  | 686,270 |  | 686,270 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.23%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.23% |  |  |  | 0.23% |  | 
| Investment cost | [5] |  |  | $ 4,208 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 4,217 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.27%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.27% |  |  |  | 0.27% |  |  |  | 
| Investment cost | [2] | $ 4,369 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 5,053 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services , Total Carwow LTD |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | 184 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 89 |  |  |  |  |  |  |  | 
| Shares | shares |  | 283,420 |  |  |  | 283,420 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 164 | [2],[33],[34] | 164 | [5],[15],[16] |  |  |  |  | 
| Investments, at fair value: |  | $ 69 | [33],[34] | $ 75 | [15],[16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec. 14,  2021 | [3],[33],[34] | Dec. 14,  2021 | [15],[16],[42] |  |  |  |  | 
| Shares | shares |  | 174,163 | [33],[34] | 174,163 | [15],[16] | 174,163 | [33],[34] | 174,163 | [15],[16] | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 2/13/2024, Series Preferred Series D-4 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[33],[34] | $ 20 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [33],[34] | $ 20 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3],[33],[34] | Feb. 13,  2024 |  |  |  |  |  |  |  | 
| Shares | shares | [33],[34] | 109,257 |  |  |  | 109,257 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 20 | [2] | $ 20 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 1 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Oct. 29,  2019 | [3] | Oct. 29,  2019 | [42] |  |  |  |  | 
| Shares | shares |  | 529,661 |  | 529,661 |  | 529,661 |  | 529,661 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 116 | [1],[2] | $ 116 | [5],[14] |  |  |  |  | 
| Investments, at fair value: |  | $ 283 | [1] | $ 298 | [14] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 12,  2021 | [1],[3] | Mar. 12,  2021 | [14],[42] |  |  |  |  | 
| Shares | shares |  | 11,806 | [1] | 11,806 | [14] | 11,806 | [1] | 11,806 | [14] | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Series Preferred Series D |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 39 | [2] | $ 39 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 24 |  | $ 33 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 29,  2019 | [3] | Mar. 29,  2019 | [42] |  |  |  |  | 
| Shares | shares |  | 127,032 |  | 127,032 |  | 127,032 |  | 127,032 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary Shares |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[33],[34] | $ 48 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [33],[34] | $ 53 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3],[33],[34] | Oct.  03,  2023 |  |  |  |  |  |  |  | 
| Shares | shares | [33],[34] | 19,499 |  |  |  | 19,499 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Series Ordinary shares |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[15],[16] |  |  | $ 48 |  |  |  |  |  | 
| Investments, at fair value: | [15],[16] |  |  | $ 51 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [15],[16],[42] |  |  | Oct.  03,  2023 |  |  |  |  |  | 
| Shares | shares | [15],[16] |  |  | 19,499 |  |  |  | 19,499 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [1],[2] | $ 166 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1] | $ 159 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [1],[3] | Dec. 22,  2022 |  |  |  |  |  |  |  | 
| Shares | shares | [1] | 117,042 |  |  |  | 117,042 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Provi., Warrant, Acquisition Date 12/22/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[14] |  |  | $ 166 |  |  |  |  |  | 
| Investments, at fair value: | [14] |  |  | $ 74 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [14],[42] |  |  | Dec. 22,  2022 |  |  |  |  |  | 
| Shares | shares | [14] |  |  | 117,042 |  |  |  | 117,042 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 470 | [1],[2] | $ 470 | [5],[14] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 | [1] | $ 4 | [14] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 12,  2021 | [1],[3] | Mar. 12,  2021 | [14],[42] |  |  |  |  | 
| Shares | shares |  | 13,106 | [1] | 13,106 | [14] | 13,106 | [1] | 13,106 | [14] | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 842 | [2],[36] | $ 842 | [5],[18] |  |  |  |  | 
| Investments, at fair value: |  | $ 3,659 | [36] | $ 3,065 | [18] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 12,  2019 | [3],[36] | Jun. 12,  2019 | [18],[42] |  |  |  |  | 
| Shares | shares |  | 1,379,761 | [36] | 1,379,761 | [18] | 1,379,761 | [36] | 1,379,761 | [18] | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 57 | [2] | $ 57 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 111 |  | $ 58 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Nov. 14,  2022 | [3] | Nov. 14,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 1,607,143 |  | 1,607,143 |  | 1,607,143 |  | 1,607,143 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Series Preferred Series B |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 83 | [2] | $ 83 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 11 |  | $ 5 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug. 23,  2019 | [3] | Aug. 23,  2019 | [42] |  |  |  |  | 
| Shares | shares |  | 444,444 |  | 444,444 |  | 444,444 |  | 444,444 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 16 | [2] | $ 16 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Apr. 20,  2020 | [3] | Apr. 20,  2020 | [42] |  |  |  |  | 
| Shares | shares |  | 600,000 |  | 600,000 |  | 600,000 |  | 600,000 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Series Preferred Series A |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 782 | [2] | $ 782 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 30,  2016 | [3] | Jun. 30,  2016 | [42] |  |  |  |  | 
| Shares | shares |  | 1,800,000 |  | 1,800,000 |  | 1,800,000 |  | 1,800,000 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Series Preferred Series B |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 62 | [2] | $ 62 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug.  01,  2018 | [3] | Aug.  01,  2018 | [42] |  |  |  |  | 
| Shares | shares |  | 1,211,537 |  | 1,211,537 |  | 1,211,537 |  | 1,211,537 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 985 | [2],[27] | $ 844 | [5],[10] |  |  |  |  | 
| Investments, at fair value: |  | $ 633 | [27] | $ 515 | [10] |  |  |  |  | 
| Investments Owned Acquisition Date |  | May  01,  2018 | [3],[27] | May  01,  2018 | [10],[42] |  |  |  |  | 
| Shares | shares |  | 343,497 | [27] | 267,225 | [10] | 343,497 | [27] | 267,225 | [10] | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Skyword, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 140 | [2] | $ 140 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 122 |  | $ 63 |  |  |  |  |  | 
| Shares | shares |  | 2,051,587 |  | 2,051,587 |  | 2,051,587 |  | 2,051,587 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Snagajob.com, Inc. |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 860 | [2] | $ 860 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Shares | shares |  | 3,611,537 |  | 3,611,537 |  | 3,611,537 |  | 3,611,537 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Worldremit Group Limited |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 155 | [2] | $ 155 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 11 |  | $ 23 |  |  |  |  |  | 
| Shares | shares |  | 79,083 |  | 79,083 |  | 79,083 |  | 79,083 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 218 | [2],[27] | $ 218 | [5],[10] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 | [27] | $ 0 | [10] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep. 25,  2020 | [3],[27] | Sep. 25,  2020 | [10],[42] |  |  |  |  | 
| Shares | shares |  | 486,359 | [27] | 486,359 | [10] | 486,359 | [27] | 486,359 | [10] | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 126 | [2],[27] | $ 126 | [5],[10] |  |  |  |  | 
| Investments, at fair value: |  | $ 19 | [27] | $ 16 | [10] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 31,  2022 | [3],[27] | Mar. 31,  2022 | [10],[42] |  |  |  |  | 
| Shares | shares |  | 98,428 | [27] | 98,428 | [10] | 98,428 | [27] | 98,428 | [10] | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Series Preferred Series D |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 129 | [2],[27],[33],[34],[36] | $ 129 | [5],[10],[15],[16],[18] |  |  |  |  | 
| Investments, at fair value: |  | $ 11 | [27],[33],[34],[36] | $ 23 | [10],[15],[16],[18] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Feb. 11,  2021 | [3],[27],[33],[34],[36] | Feb. 11,  2021 | [10],[15],[16],[18],[42] |  |  |  |  | 
| Shares | shares |  | 77,215 | [27],[33],[34],[36] | 77,215 | [10],[15],[16],[18] | 77,215 | [27],[33],[34],[36] | 77,215 | [10],[15],[16],[18] | 
| Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Series Preferred Series E |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 26 | [2],[33],[34],[36] | $ 26 | [5],[15],[16],[18] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 | [33],[34],[36] | $ 0 | [15],[16],[18] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug. 27,  2021 | [3],[33],[34],[36] | Aug. 27,  2021 | [15],[16],[18],[42] |  |  |  |  | 
| Shares | shares |  | 1,868 | [33],[34],[36] | 1,868 | [15],[16],[18] | 1,868 | [33],[34],[36] | 1,868 | [15],[16],[18] | 
| Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  |  |  | $ 214 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 554 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  |  |  | Feb.  03,  2023 |  |  |  |  |  | 
| Shares | shares |  |  |  | 522,930 |  |  |  | 522,930 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services (0.03%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.03% |  |  |  | 0.03% |  |  |  | 
| Investment cost | [2] | $ 214 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 624 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | 214 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 624 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Feb.  03,  2023 |  |  |  |  |  |  |  | 
| Shares | shares |  | 522,930 |  |  |  | 522,930 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Delivery (0.00%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets |  | 0.00% | [24] | 0.00% | [4] | 0.00% | [24] | 0.00% | [4] | 
| Investment cost |  | $ 392 | [2] | $ 392 | [5] |  |  |  |  | 
| Investments, at fair value: |  | 0 |  | 0 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 6/1/2016, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 0 | [2] | 0 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun.  01,  2016 | [3] | Jun.  01,  2016 | [42] |  |  |  |  | 
| Shares | shares |  | 67,069 |  | 67,069 |  | 67,069 |  | 67,069 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 2 | [2] | $ 2 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Oct. 27,  2014 | [3] | Oct. 27,  2014 | [42] |  |  |  |  | 
| Shares | shares |  | 459,183 |  | 459,183 |  | 459,183 |  | 459,183 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 390 | [2],[3] | $ 390 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 | [3] | $ 0 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug. 28,  2014 | [3] | Aug. 28,  2014 | [42] |  |  |  |  | 
| Shares | shares |  | 3,929 | [3] | 3,929 | [42] | 3,929 | [3] | 3,929 | [42] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.46%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.46% |  |  |  | 0.46% |  | 
| Investment cost | [5] |  |  | $ 7,517 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 8,302 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.59%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.59% |  |  |  | 0.59% |  |  |  | 
| Investment cost | [2] | $ 9,251 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 11,133 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and ADMA Biologics, Inc.., Warrant, Acquisition Date 2/24/2014 Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [42] |  |  | 166 |  |  |  |  |  | 
| Investments, at fair value: | [42] |  |  | $ 11 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Feb. 24,  2014 |  |  |  |  |  | 
| Shares | shares | [42] |  |  | 58,000 |  |  |  | 58,000 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 330 | [2],[3],[33] | $ 175 | [16],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 505 | [3],[33] | $ 335 | [16],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 15,  2022 | [3],[33] | Jun. 15,  2022 | [16],[42] |  |  |  |  | 
| Shares | shares |  | 32,128 | [3],[33] | 22,949 | [16],[42] | 32,128 | [3],[33] | 22,949 | [16],[42] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, Warrant, Acquisition Date 12/27/2022, Series Class A Units |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [14] |  |  | $ 237 |  |  |  |  |  | 
| Investments, at fair value: | [14] |  |  | $ 184 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [14],[42] |  |  | Dec. 27,  2022 |  |  |  |  |  | 
| Shares | shares | [14] |  |  | 69,239 |  |  |  | 69,239 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,290 | [2],[3],[27],[33],[36] | $ 1,290 | [10],[16],[18],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 1,645 | [3],[27],[33],[36] | $ 1,657 | [10],[16],[18],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep. 25,  2020 | [3],[27],[33],[36] | Sep. 25,  2020 | [10],[16],[18],[42] |  |  |  |  | 
| Shares | shares |  | 61,004 | [3],[27],[33],[36] | 61,004 | [10],[16],[18],[42] | 61,004 | [3],[27],[33],[36] | 61,004 | [10],[16],[18],[42] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Series Ordinary Shares |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 278 | [2],[3],[33],[34] | $ 278 | [15],[16],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 263 | [3],[33],[34] | $ 285 | [15],[16],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 30,  2023 | [3],[33],[34] | Jun. 30,  2023 | [15],[16],[42] |  |  |  |  | 
| Shares | shares |  | 75,376 | [3],[33],[34] | 75,376 | [15],[16],[42] | 75,376 | [3],[33],[34] | 75,376 | [15],[16],[42] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Series Preferred Series B |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 287 | [1],[2] | $ 287 | [14] |  |  |  |  | 
| Investments, at fair value: |  | $ 231 | [1] | $ 201 | [14] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec.  08,  2021 | [1],[3] | Dec.  08,  2021 | [14],[42] |  |  |  |  | 
| Shares | shares |  | 100,000 | [1] | 100,000 | [14] | 100,000 | [1] | 100,000 | [14] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 37 | [2],[3] | $ 37 | [42] |  |  |  |  | 
| Investments, at fair value: |  | $ 2 | [3] | $ 1 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep. 14,  2020 | [3] | Sep. 14,  2020 | [42] |  |  |  |  | 
| Shares | shares |  | 16,112 | [3] | 16,112 | [42] | 16,112 | [3] | 16,112 | [42] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cuervo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [14] |  |  | $ 233 |  |  |  |  |  | 
| Investments, at fair value: | [14] |  |  | $ 251 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [14],[42] |  |  | Jun.  09,  2023 |  |  |  |  |  | 
| Shares | shares | [14] |  |  | 95,221 |  |  |  | 95,221 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Curevo, Inc., Warrant, Acquisition Date 6/9/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [1],[2] | $ 233 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1] | $ 361 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [1],[3] | Jun.  09,  2023 |  |  |  |  |  |  |  | 
| Shares | shares | [1] | 95,221 |  |  |  | 95,221 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 101 | [2],[33],[34] | $ 101 | [16] |  |  |  |  | 
| Investments, at fair value: |  | $ 219 | [33],[34] | $ 7 | [16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | May 31,  2019 | [3],[33],[34] | May 31,  2019 | [16],[42] |  |  |  |  | 
| Shares | shares |  | 223,642 | [33],[34] | 223,642 | [16] | 223,642 | [33],[34] | 223,642 | [16] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 266 | [2],[3] | $ 266 | [42] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 | [3] | $ 0 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 11,  2014 | [3] | Jun. 11,  2014 | [42] |  |  |  |  | 
| Shares | shares |  | 3 | [3] | 3 | [42] | 3 | [3] | 3 | [42] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 119 | [2],[3] | $ 119 | [42] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 | [3] | $ 0 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Feb. 18,  2016 | [3] | Feb. 18,  2016 | [42] |  |  |  |  | 
| Shares | shares |  | 201 | [3] | 201 | [42] | 201 | [3] | 201 | [42] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 228 | [1],[2],[3] | $ 228 | [14],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 387 | [1],[3] | $ 223 | [14],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug.  09,  2023 | [1],[3] | Aug.  09,  2023 | [14],[42] |  |  |  |  | 
| Shares | shares |  | 238,095 | [1],[3] | 238,095 | [14],[42] | 238,095 | [1],[3] | 238,095 | [14],[42] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 110 | [2],[3] | $ 110 | [42] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 | [3] | $ 0 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec. 20,  2019 | [3] | Dec. 20,  2019 | [42] |  |  |  |  | 
| Shares | shares |  | 2,202 | [3] | 2,202 | [42] | 2,202 | [3] | 2,202 | [42] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 88 | [1],[2],[3],[33] | $ 88 | [14],[16],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 120 | [1],[3],[33] | $ 63 | [14],[16],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Nov.  02,  2022 | [1],[3],[33] | Nov.  02,  2022 | [14],[16],[42] |  |  |  |  | 
| Shares | shares |  | 14,342 | [1],[3],[33] | 14,342 | [14],[16],[42] | 14,342 | [1],[3],[33] | 14,342 | [14],[16],[42] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 570 | [2],[3],[33] | $ 570 | [16],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 2,126 | [3],[33] | $ 1,842 | [16],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | May  09,  2022 | [3],[33] | May  09,  2022 | [16],[42] |  |  |  |  | 
| Shares | shares |  | 13,229 | [3],[33] | 13,229 | [16],[42] | 13,229 | [3],[33] | 13,229 | [16],[42] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 848 | [1],[2],[3],[27],[33],[36] | $ 848 | [10],[14],[16],[18],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 86 | [1],[3],[27],[33],[36] | $ 68 | [10],[14],[16],[18],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep. 17,  2021 | [1],[3],[27],[33],[36] | Sep. 17,  2021 | [10],[14],[16],[18],[42] |  |  |  |  | 
| Shares | shares |  | 64,687 | [1],[3],[27],[33],[36] | 64,687 | [10],[14],[16],[18],[42] | 64,687 | [1],[3],[27],[33],[36] | 64,687 | [10],[14],[16],[18],[42] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Series Preferred Series E |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 20 | [1],[2] | $ 20 | [14] |  |  |  |  | 
| Investments, at fair value: |  | $ 43 | [1] | $ 6 | [14] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 23,  2022 | [1],[3] | Mar. 23,  2022 | [14],[42] |  |  |  |  | 
| Shares | shares |  | 475,510 | [1] | 475,510 | [14] | 475,510 | [1] | 475,510 | [14] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 296 | [2],[3] | $ 296 | [42] |  |  |  |  | 
| Investments, at fair value: |  | $ 7 | [3] | $ 28 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | May 14,  2021 | [3] | May 14,  2021 | [42] |  |  |  |  | 
| Shares | shares |  | 106,035 | [3] | 106,035 | [42] | 106,035 | [3] | 106,035 | [42] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,284 | [2],[3],[27],[33] | $ 1,284 | [10],[16],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 2,209 | [3],[27],[33] | $ 2,583 | [10],[16],[42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Feb. 28,  2019 | [3],[27],[33] | Feb. 28,  2019 | [10],[16],[42] |  |  |  |  | 
| Shares | shares |  | 264,226 | [3],[27],[33] | 264,226 | [10],[16],[42] | 264,226 | [3],[27],[33] | 264,226 | [10],[16],[42] | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  |  |  | $ 256 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 153 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Jun. 15,  2020 |  |  |  |  |  | 
| Shares | shares |  |  |  | 102,216 |  |  |  | 102,216 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Series Common Units |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 256 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 255 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Jun. 15,  2020 |  |  |  |  |  |  |  | 
| Shares | shares |  | 102,216 |  |  |  | 102,216 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/18/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3] | $ 510 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3] | $ 561 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Mar. 18,  2019 |  |  |  |  |  |  |  | 
| Shares | shares | [3] | 1,392,787 |  |  |  | 1,392,787 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/218/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [42] |  |  | $ 510 |  |  |  |  |  | 
| Investments, at fair value: | [42] |  |  | $ 225 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Mar. 18,  2019 |  |  |  |  |  | 
| Shares | shares | [42] |  |  | 1,392,787 |  |  |  | 1,392,787 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and blubird bio, Inc., Warrant, Acquisition Date 3/15/2024, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3] | $ 1,744 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3] | $ 1,534 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Mar. 15,  2024 |  |  |  |  |  |  |  | 
| Shares | shares | [3] | 2,224,137 |  |  |  | 2,224,137 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/22/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [15],[16],[42] |  |  | $ 118 |  |  |  |  |  | 
| Investments, at fair value: | [15],[16],[42] |  |  | $ 179 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [15],[16],[42] |  |  | Dec. 22,  2023 |  |  |  |  |  | 
| Shares | shares | [15],[16],[42] |  |  | 43,689 |  |  |  | 43,689 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/22/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3],[33],[34] | $ 118 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3],[33],[34] | $ 421 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3],[33],[34] | Dec. 22,  2023 |  |  |  |  |  |  |  | 
| Shares | shares | [3],[33],[34] | 43,689 |  |  |  | 43,689 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware (0.02%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets |  | 0.02% | [24] | 0.02% | [4] | 0.02% | [24] | 0.02% | [4] | 
| Investment cost |  | $ 692 | [2] | $ 692 | [5] |  |  |  |  | 
| Investments, at fair value: |  | 313 |  | 391 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 101 | [2],[3] | 101 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 78 | [3] | $ 175 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 15,  2017 | [3] | Mar. 15,  2017 | [42] |  |  |  |  | 
| Shares | shares |  | 49,078 | [3] | 49,078 | [42] | 49,078 | [3] | 49,078 | [42] | 
| Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 34 | [2] | $ 34 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 82 |  | $ 102 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 21,  2022 | [3] | Jun. 21,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 8,503 |  | 8,503 |  | 8,503 |  | 8,503 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 557 | [2] | $ 557 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 153 |  | $ 114 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Nov.  08,  2021 | [3] | Nov.  08,  2021 | [42] |  |  |  |  | 
| Shares | shares |  | 622,255 |  | 622,255 |  | 622,255 |  | 622,255 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other (0.03%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets |  | 0.03% | [24] | 0.03% | [4] | 0.03% | [24] | 0.03% | [4] | 
| Investment cost |  | $ 839 | [2] | $ 750 | [5] |  |  |  |  | 
| Investments, at fair value: |  | 548 |  | 596 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Curana Health Holdings, LLC., Warrant, Acquisition Date 1/4/2024, Series Common Units |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | 89 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 84 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Jan.  04,  2024 |  |  |  |  |  |  |  | 
| Shares | shares |  | 268,446 |  |  |  | 268,446 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Modern Life, Inc, Warrant, Acquisition Date 3/30/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | 164 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 165 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Mar. 30,  2023 |  |  |  |  |  | 
| Shares | shares |  |  |  | 37,618 |  |  |  | 37,618 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Modern Life, Inc., Warrant, Acquisition Date 3/30/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 164 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 118 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Mar. 30,  2023 |  |  |  |  |  |  |  | 
| Shares | shares |  | 37,618 |  |  |  | 37,618 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Recover Together, Inc., , Warrant, Acquisition Date 7/3/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 382 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 327 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Jul.  03,  2023 |  |  |  |  |  | 
| Shares | shares |  |  |  | 194,830 |  |  |  | 194,830 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Recover Together, Inc.., Warrant, Acquisition Date 7/3/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 382 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 253 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Jul.  03,  2023 |  |  |  |  |  |  |  | 
| Shares | shares |  | 194,830 |  |  |  | 194,830 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC, Warrant, Warrant, Acquisition Date 9/28/2023, Series Common Units |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[14] |  |  | $ 83 |  |  |  |  |  | 
| Investments, at fair value: | [14] |  |  | $ 95 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [14],[42] |  |  | Sep. 28,  2023 |  |  |  |  |  | 
| Shares | shares | [14] |  |  | 51,760 |  |  |  | 51,760 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC., Warrant, Acquisition Date 9/28/2023, Series Common Units |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [1],[2] | $ 83 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1] | $ 89 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [1],[3] | Sep. 28,  2023 |  |  |  |  |  |  |  | 
| Shares | shares | [1] | 51,760 |  |  |  | 51,760 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 121 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 4 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Mar. 28,  2022 |  |  |  |  |  |  |  | 
| Shares | shares |  | 192,431 |  |  |  | 192,431 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Warrant, Acquisition Date 3/28/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 121 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 9 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Mar. 28,  2022 |  |  |  |  |  | 
| Shares | shares |  |  |  | 192,431 |  |  |  | 192,431 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Information Services (0.00%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.00% |  |  |  | 0.00% |  |  |  | 
| Investment cost | [2] | $ 702 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 92 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Information Services (0.03%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.03% |  |  |  | 0.03% |  | 
| Investment cost | [5] |  |  | $ 694 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 486 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 207 | [1],[2] | 207 | [5],[14] |  |  |  |  | 
| Investments, at fair value: |  | $ 27 | [1] | $ 33 | [14] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Oct. 21,  2021 | [1],[3] | Oct. 21,  2021 | [14],[42] |  |  |  |  | 
| Shares | shares |  | 176,200 | [1] | 176,200 | [14] | 176,200 | [1] | 176,200 | [14] | 
| Investment, Identifier [Axis]: Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 82 | [2],[33],[34] | $ 82 | [5],[15],[16] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 | [33],[34] | $ 0 | [15],[16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Nov. 19,  2014 | [3],[33],[34] | Nov. 19,  2014 | [15],[16],[42] |  |  |  |  | 
| Shares | shares |  | 65,587 | [33],[34] | 65,587 | [15],[16] | 65,587 | [33],[34] | 65,587 | [15],[16] | 
| Investment, Identifier [Axis]: Warrant Investments and Information Services and NetBase Quid, Inc. (p.k.a NetBase Solutions), Warrant, Acquisition Date 8/22/2017, Series Preferred Series 1 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 356 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Aug. 22,  2017 |  |  |  |  |  |  |  | 
| Shares | shares |  | 60,000 |  |  |  | 60,000 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Information Services and NetBase Solutions, Inc., Warrant, Acquisition Date 8/22/2017, Series Preferred Series 1 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 356 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 362 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Aug. 22,  2017 |  |  |  |  |  | 
| Shares | shares |  |  |  | 60,000 |  |  |  | 60,000 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 57 | [2],[33],[34] | $ 49 | [5],[15],[16] |  |  |  |  | 
| Investments, at fair value: |  | $ 65 | [33],[34] | $ 91 | [15],[16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 29,  2022 | [3],[33],[34] | Jun. 29,  2022 | [15],[16],[42] |  |  |  |  | 
| Shares | shares |  | 129,638 | [33],[34] | 113,828 | [15],[16] | 129,638 | [33],[34] | 113,828 | [15],[16] | 
| Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.07%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.07% |  |  |  | 0.07% |  |  |  | 
| Investment cost | [2] | $ 1,112 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 1,267 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.17%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.17% |  |  |  | 0.17% |  | 
| Investment cost | [5] |  |  | $ 1,112 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 3,000 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 537 | [2] | 537 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 120 |  | $ 279 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 31,  2022 | [3] | Mar. 31,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 392,308 |  | 392,308 |  | 392,308 |  | 392,308 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 528 | [2] | $ 528 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 337 |  | $ 677 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 23,  2022 | [3] | Mar. 23,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 1,111,111 |  | 1,111,111 |  | 1,111,111 |  | 1,111,111 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 47 | [2],[3] | $ 47 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 810 | [3] | $ 2,044 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | May  09,  2018 | [3] | May  09,  2018 | [42] |  |  |  |  | 
| Shares | shares |  | 87,784 | [3] | 87,784 | [42] | 87,784 | [3] | 87,784 | [42] | 
| Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info (0.01%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets |  | 0.01% | [24] | 0.01% | [4] | 0.01% | [24] | 0.01% | [4] | 
| Investment cost |  | $ 67 | [2] | $ 67 | [5] |  |  |  |  | 
| Investments, at fair value: |  | 228 |  | 235 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Series Preferred Series E-1 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 67 | [2] | 67 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 228 |  | $ 235 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec. 30,  2022 | [3] | Dec. 30,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 369,370 |  | 369,370 |  | 369,370 |  | 369,370 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment (0.01%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.01% |  |  |  | 0.01% |  | 
| Investment cost | [5] |  |  | $ 956 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 262 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment (0.03%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.03% |  |  |  | 0.03% |  |  |  | 
| Investment cost | [2] | $ 1,360 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 514 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Series Preferred Series B-1 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 295 | [2] | 294 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Dec. 29,  2017 | [3] | Dec. 29,  2017 | [42] |  |  |  |  | 
| Shares | shares |  | 3,076,323 |  | 3,076,323 |  | 3,076,323 |  | 3,076,323 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Outset Medical Inc, Warrant, Acquisition Date 9/27/2013, Series Common stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[42] |  |  | $ 401 |  |  |  |  |  | 
| Investments, at fair value: | [42] |  |  | $ 78 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Sep. 27,  2013 |  |  |  |  |  | 
| Shares | shares | [42] |  |  | 62,794 |  |  |  | 62,794 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3] | $ 401 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3] | $ 13 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Sep. 27,  2013 |  |  |  |  |  |  |  | 
| Shares | shares | [3] | 62,794 |  |  |  | 62,794 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc, Warrant, Acquisition Date 9/8/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[42] |  |  | $ 200 |  |  |  |  |  | 
| Investments, at fair value: | [42] |  |  | $ 184 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Sep.  08,  2023 |  |  |  |  |  | 
| Shares | shares | [42] |  |  | 728,317 |  |  |  | 728,317 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc., Warrant, Acquisition Date 9/8/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3] | $ 276 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3] | $ 213 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Sep.  08,  2023 |  |  |  |  |  |  |  | 
| Shares | shares | [3] | 1,032,718 |  |  |  | 1,032,718 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Sight Sciences, Inc., Warrant, Acquisition Date 1/22/2024, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[3] | $ 327 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [3] | $ 288 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Jan. 22,  2024 |  |  |  |  |  |  |  | 
| Shares | shares | [3] | 94,980 |  |  |  | 94,980 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 61 | [2],[3] | $ 61 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 | [3] | $ 0 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 31,  2017 | [3] | Mar. 31,  2017 | [42] |  |  |  |  | 
| Shares | shares |  | 15,712 | [3] | 15,712 | [42] | 15,712 | [3] | 15,712 | [42] | 
| Investment, Identifier [Axis]: Warrant Investments and Semiconductors (0.04%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets |  | 0.04% | [24] | 0.04% | [4] | 0.04% | [24] | 0.04% | [4] | 
| Investment cost |  | $ 99 | [2] | $ 99 | [5] |  |  |  |  | 
| Investments, at fair value: |  | 672 |  | 811 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Series Preferred Series D-2 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 99 | [2] | 99 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 672 |  | $ 811 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 26,  2015 | [3] | Jun. 26,  2015 | [42] |  |  |  |  | 
| Shares | shares |  | 750,000 |  | 750,000 |  | 750,000 |  | 750,000 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software (0.54%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.54% |  |  |  | 0.54% |  |  |  | 
| Investment cost | [2] | $ 9,054 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 10,275 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software (0.75%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.75% |  |  |  | 0.75% |  | 
| Investment cost | [5] |  |  | $ 10,445 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 13,549 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Series Preferred Series G |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 74 | [2] | 74 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | May 22,  2015 | [3] | May 22,  2015 | [42] |  |  |  |  | 
| Shares | shares |  | 231,535 |  | 231,535 |  | 231,535 |  | 231,535 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 448 | [2] | $ 448 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 626 |  | $ 430 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep. 23,  2022 | [3] | Sep. 23,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 254,778 |  | 254,778 |  | 254,778 |  | 254,778 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 284 | [2] | $ 284 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 596 |  | $ 666 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Nov. 18,  2020 | [3] | Nov. 18,  2020 | [42] |  |  |  |  | 
| Shares | shares |  | 29,691 |  | 29,691 |  | 29,691 |  | 29,691 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 165 | [1],[2] | $ 165 | [5],[14] |  |  |  |  | 
| Investments, at fair value: |  | $ 59 | [1] | $ 47 | [14] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Oct.  04,  2021 | [1],[3] | Oct.  04,  2021 | [14],[42] |  |  |  |  | 
| Shares | shares |  | 194,629 | [1] | 194,629 | [14] | 194,629 | [1] | 194,629 | [14] | 
| Investment, Identifier [Axis]: Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 117 | [2] | $ 117 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 8 |  | $ 12 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep. 30,  2020 | [3] | Sep. 30,  2020 | [42] |  |  |  |  | 
| Shares | shares |  | 211,342 |  | 211,342 |  | 211,342 |  | 211,342 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 71 | [2] | $ 71 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 33 |  | $ 29 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Nov.  06,  2018 | [3] | Nov.  06,  2018 | [42] |  |  |  |  | 
| Shares | shares |  | 477,454 |  | 477,454 |  | 477,454 |  | 477,454 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Series Preferred Series B |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 54 | [2],[33],[34] | $ 54 | [5],[15],[16] |  |  |  |  | 
| Investments, at fair value: |  | $ 904 | [33],[34] | $ 844 | [15],[16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Apr. 10,  2018 | [3],[33],[34] | Apr. 10,  2018 | [15],[16],[42] |  |  |  |  | 
| Shares | shares |  | 6,763 | [33],[34] | 6,763 | [15],[16] | 6,763 | [33],[34] | 6,763 | [15],[16] | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 462 | [2],[3] | $ 462 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 1,521 | [3] | $ 1,225 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Apr. 25,  2019 | [3] | Apr. 25,  2019 | [42] |  |  |  |  | 
| Shares | shares |  | 105,350 | [3] | 105,350 | [42] | 105,350 | [3] | 105,350 | [42] | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 26 | [2],[27],[33],[34] | $ 26 | [5],[10],[15],[16] |  |  |  |  | 
| Investments, at fair value: |  | $ 65 | [27],[33],[34] | $ 62 | [10],[15],[16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep. 21,  2022 | [3],[27],[33],[34] | Sep. 21,  2022 | [10],[15],[16],[42] |  |  |  |  | 
| Shares | shares |  | 102,898 | [27],[33],[34] | 102,898 | [10],[15],[16] | 102,898 | [27],[33],[34] | 102,898 | [10],[15],[16] | 
| Investment, Identifier [Axis]: Warrant Investments and Software and DNAnexus, Inc., Warrant, Acquisition Date 3/21/2014, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 97 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 47 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Mar. 21,  2014 |  |  |  |  |  | 
| Shares | shares |  |  |  | 909,091 |  |  |  | 909,091 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 461 | [2] | $ 461 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 444 |  | $ 258 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 11,  2019 | [3] | Mar. 11,  2019 | [42] |  |  |  |  | 
| Shares | shares |  | 770,838 |  | 770,838 |  | 770,838 |  | 770,838 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Delphix Corp., Warrant, Acquisition Date 10/8/2019, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 1,594 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 3,801 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Oct.  08,  2019 |  |  |  |  |  | 
| Shares | shares |  |  |  | 718,898 |  |  |  | 718,898 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 545 | [2] | $ 545 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 346 |  | $ 396 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Aug.  02,  2021 | [3] | Aug.  02,  2021 | [42] |  |  |  |  | 
| Shares | shares |  | 727,047 |  | 727,047 |  | 727,047 |  | 727,047 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,452 | [2] | $ 1,452 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 1,089 |  | $ 1,207 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 28,  2023 | [3] | Jun. 28,  2023 | [42] |  |  |  |  | 
| Shares | shares |  | 49,309 |  | 49,309 |  | 49,309 |  | 49,309 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 278 | [2] | $ 278 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 327 |  | $ 413 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 30,  2022 | [3] | Jun. 30,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 95,911 |  | 95,911 |  | 95,911 |  | 95,911 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 8 | [2],[33],[34] | $ 8 | [5],[15],[16] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 | [33],[34] | $ 4 | [15],[16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Apr. 13,  2022 | [3],[33],[34] | Apr. 13,  2022 | [15],[16],[42] |  |  |  |  | 
| Shares | shares |  | 522 | [33],[34] | 522 | [15],[16] | 522 | [33],[34] | 522 | [15],[16] | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 583 | [2] | $ 583 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 207 |  | $ 188 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep. 12,  2022 | [3] | Sep. 12,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 362,837 |  | 362,837 |  | 362,837 |  | 362,837 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Series Preferred Series B |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 96 | [2] | $ 96 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 69 |  | $ 77 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | May 10,  2018 | [3] | May 10,  2018 | [42] |  |  |  |  | 
| Shares | shares |  | 75,917 |  | 75,917 |  | 75,917 |  | 75,917 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 325 | [2] | $ 325 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 497 |  | $ 456 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jul. 29,  2022 | [3] | Jul. 29,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 84,995 |  | 84,995 |  | 84,995 |  | 84,995 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Harness, Inc., Warrant, Acquisition Date 3/12/2024, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 534 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 522 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Mar. 12,  2024 |  |  |  |  |  |  |  | 
| Shares | shares |  | 193,618 |  |  |  | 193,618 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Kore, ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 208 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 243 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Mar. 31,  2023 |  |  |  |  |  | 
| Shares | shares |  |  |  | 64,293 |  |  |  | 64,293 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 208 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 428 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Mar. 31,  2023 |  |  |  |  |  |  |  | 
| Shares | shares |  | 64,293 |  |  |  | 64,293 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 16 | [2],[27],[33],[34] | $ 16 | [5],[10],[15],[16] |  |  |  |  | 
| Investments, at fair value: |  | $ 32 | [27],[33],[34] | $ 35 | [10],[15],[16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jan. 23,  2023 | [3],[27],[33],[34] | Jan. 23,  2023 | [10],[15],[16],[42] |  |  |  |  | 
| Shares | shares |  | 39,948 | [27],[33],[34] | 39,948 | [10],[15],[16] | 39,948 | [27],[33],[34] | 39,948 | [10],[15],[16] | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Series Preferred Series D |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 131 | [2] | $ 131 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 42 |  | $ 49 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Feb. 14,  2018 | [3] | Feb. 14,  2018 | [42] |  |  |  |  | 
| Shares | shares |  | 89,685 |  | 89,685 |  | 89,685 |  | 89,685 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 252 | [2] | $ 252 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 331 |  | $ 306 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep. 30,  2020 | [3] | Sep. 30,  2020 | [42] |  |  |  |  | 
| Shares | shares |  | 82,362 |  | 82,362 |  | 82,362 |  | 82,362 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Onna Technologies, Inc., Warrant 7/5/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 60 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 35 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Jul.  05,  2023 |  |  |  |  |  |  |  | 
| Shares | shares |  | 172,867 |  |  |  | 172,867 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Onna TechnologiesInc, Warrant, Acquisition Date 7/5/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 60 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 39 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Jul.  05,  2023 |  |  |  |  |  | 
| Shares | shares |  |  |  | 172,867 |  |  |  | 172,867 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 0 | [2] | $ 0 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | May 28,  2014 | [3] | May 28,  2014 | [42] |  |  |  |  | 
| Shares | shares |  | 132,168 |  | 132,168 |  | 132,168 |  | 132,168 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 215 | [2] | $ 215 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 544 |  | $ 447 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jun. 30,  2020 | [3] | Jun. 30,  2020 | [42] |  |  |  |  | 
| Shares | shares |  | 69,120 |  | 69,120 |  | 69,120 |  | 69,120 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 96 | [2],[27] | $ 96 | [5],[10] |  |  |  |  | 
| Investments, at fair value: |  | $ 99 | [27] | $ 76 | [10] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 22,  2023 | [3],[27] | Mar. 22,  2023 | [10],[42] |  |  |  |  | 
| Shares | shares |  | 77,934 | [27] | 77,934 | [10] | 77,934 | [27] | 77,934 | [10] | 
| Investment, Identifier [Axis]: Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Series Preferred Series D |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 103 | [2] | $ 103 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 398 |  | $ 386 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Apr. 28,  2020 | [3] | Apr. 28,  2020 | [42] |  |  |  |  | 
| Shares | shares |  | 312,596 |  | 312,596 |  | 312,596 |  | 312,596 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/28/2023, Series Ordinary Shares |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2],[33],[34] | $ 174 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [33],[34] | $ 128 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3],[33],[34] | Jun.  08,  2023 |  |  |  |  |  |  |  | 
| Shares | shares | [33],[34] | 321,956 |  |  |  | 321,956 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/8/2023, Series Ordinary Shares |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[15],[16] |  |  | $ 174 |  |  |  |  |  | 
| Investments, at fair value: | [15],[16] |  |  | $ 128 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [15],[16],[42] |  |  | Jun.  08,  2023 |  |  |  |  |  | 
| Shares | shares | [15],[16] |  |  | 321,956 |  |  |  | 321,956 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Suzy Inc, Warrant, Acquisition Date 8/24/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[14] |  |  | $ 367 |  |  |  |  |  | 
| Investments, at fair value: | [14] |  |  | $ 354 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [14],[42] |  |  | Aug. 24,  2023 |  |  |  |  |  | 
| Shares | shares | [14] |  |  | 292,936 |  |  |  | 292,936 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Suzy, Inc. Warrant, Acquisition Date 8/24/2023, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [1],[2] | $ 367 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1] | $ 319 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [1],[3] | Aug. 24,  2023 |  |  |  |  |  |  |  | 
| Shares | shares | [1] | 292,936 |  |  |  | 292,936 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and The Faction Group LLC, Warrant, Acquisition Date 11/3/2014, Series Preferred Series AA |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 234 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 904 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Nov.  03,  2014 |  |  |  |  |  | 
| Shares | shares |  |  |  | 8,076 |  |  |  | 8,076 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Series Ordinary Shares |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 174 | [2],[33],[34] | $ 174 | [5],[15],[16] |  |  |  |  | 
| Investments, at fair value: |  | $ 264 | [33],[34] | $ 234 | [15],[16] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Mar. 22,  2023 | [3],[33],[34] | Mar. 22,  2023 | [15],[16],[42] |  |  |  |  | 
| Shares | shares |  | 254,877 | [33],[34] | 254,877 | [15],[16] | 254,877 | [33],[34] | 254,877 | [15],[16] | 
| Investment, Identifier [Axis]: Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | $ 1,275 | [1],[2] | $ 1,275 | [5],[14] |  |  |  |  | 
| Investments, at fair value: |  | $ 342 | [1] | $ 186 | [14] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Jan. 21,  2022 | [1],[3] | Jan. 21,  2022 | [14],[42] |  |  |  |  | 
| Shares | shares |  | 152,048 | [1] | 152,048 | [14] | 152,048 | [1] | 152,048 | [14] | 
| Investment, Identifier [Axis]: Warrant Investments and Surgical Devices (0.03%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.03% |  |  |  | 0.03% |  |  |  | 
| Investment cost | [2] | $ 39 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 622 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Surgical Devices (0.04%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.04% |  |  |  | 0.04% |  | 
| Investment cost | [5] |  |  | $ 39 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 676 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 39 | [2],[3] | 39 | [5],[42] |  |  |  |  | 
| Investments, at fair value: |  | $ 622 | [3] | $ 676 | [42] |  |  |  |  | 
| Investments Owned Acquisition Date |  | Sep. 11,  2015 | [3] | Sep. 11,  2015 | [42] |  |  |  |  | 
| Shares | shares |  | 14,440 | [3] | 14,440 | [42] | 14,440 | [3] | 14,440 | [42] | 
| Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology (0.00%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [4] |  |  | 0.00% |  |  |  | 0.00% |  | 
| Investment cost | [5] |  |  | $ 539 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | 83 |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology (0.03%) |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment owned, percent of net assets | [24] | 0.03% |  |  |  | 0.03% |  |  |  | 
| Investment cost | [2] | $ 979 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | 483 |  |  |  |  |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Series Common Stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost |  | 52 | [2] | 52 | [5] |  |  |  |  | 
| Investments, at fair value: |  | $ 43 |  | $ 36 |  |  |  |  |  | 
| Investments Owned Acquisition Date |  | Apr. 15,  2022 | [3] | Apr. 15,  2022 | [42] |  |  |  |  | 
| Shares | shares |  | 18,472 |  | 18,472 |  | 18,472 |  | 18,472 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Electric Hydrogen Co., Warrant, Acquisition Date 3/27/2024, Series Common stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [1],[2] | $ 440 |  |  |  |  |  |  |  | 
| Investments, at fair value: | [1] | $ 440 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [1],[3] | Mar. 27,  2024 |  |  |  |  |  |  |  | 
| Shares | shares | [1] | 197,294 |  |  |  | 197,294 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Series Common stock |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 218 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Apr. 22,  2014 |  |  |  |  |  |  |  | 
| Shares | shares |  | 456,883 |  |  |  | 456,883 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Series Preferred Series A |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 155 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 36 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Apr. 22,  2014 |  |  |  |  |  | 
| Shares | shares |  |  |  | 325,000 |  |  |  | 325,000 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Series Preferred Series B |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 63 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 11 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Apr.  07,  2015 |  |  |  |  |  | 
| Shares | shares |  |  |  | 131,883 |  |  |  | 131,883 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Polyera Corporation, Warrant, Acquisition Date 3/24/2015, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [2] | $ 269 |  |  |  |  |  |  |  | 
| Investments, at fair value: |  | $ 0 |  |  |  |  |  |  |  | 
| Investments Owned Acquisition Date | [3] | Mar. 24,  2015 |  |  |  |  |  |  |  | 
| Shares | shares |  | 150,036 |  |  |  | 150,036 |  |  |  | 
| Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Total Halio, Inc., |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 218 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 47 |  |  |  |  |  | 
| Shares | shares |  |  |  | 456,883 |  |  |  | 456,883 |  | 
| Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Warrant, Polyera Corporation Acquisition Date 3/24/2015, Series Preferred Series C |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5] |  |  | $ 269 |  |  |  |  |  | 
| Investments, at fair value: |  |  |  | $ 0 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [42] |  |  | Mar. 24,  2015 |  |  |  |  |  | 
| Shares | shares |  |  |  | 150,036 |  |  |  | 150,036 |  | 
| Investment, Identifier [Axis]: nvestment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022 |  |  |  |  |  |  |  |  |  | 
| Summary of Investment Holdings [Line Items] |  |  |  |  |  |  |  |  |  | 
| Investment cost | [5],[15],[16] |  |  | $ 381 |  |  |  |  |  | 
| Investments, at fair value: | [15],[16] |  |  | $ 378 |  |  |  |  |  | 
| Investments Owned Acquisition Date | [15],[16],[42] |  |  | Jul. 21,  2022 |  |  |  |  |  | 
|  | 
|  |